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Introduction 
 
In light of the growing obesity pandemic, carbohydrates – also known as sugars – have 
obtained somewhat of a negative reputation. However, carbohydrates are much more than just a 
source of energy, and can also mediate a variety of recognition processes that are central to 
human health. As such, saccharides can be applied in the food and pharmaceutical industries to 
stimulate our immune system (e.g. prebiotics), to control diabetes (e.g. low-calorie sweeteners), 
or as building blocks for anti-cancer and anti-viral drugs (e.g. L-nucleosides) (see chapter II 
section 1 and Table II.1) [20]. It can thus be stated that the synthesis and availability of rare 
sugars holds high commercial value due to this wide range of applications. Unfortunately, only a 
small number of all possible monosaccharides is found in nature in sufficient amounts to allow 
their commercial exploitation. Consequently, so-called rare sugars have to be produced by 
(bio)chemical processes starting from cheap and widely available substrates.  
 
In the Izumoring [91], which is a schematic representation of the current biochemical 
production routes for rare sugars, only one epimerase is mentioned: the D-tagatose 3-epimerase 
(D-TE). However, an epimerization reaction can in theory take place at each of the different 
chiral centers of the sugars and this means C2-, C4- and C5-epimerases and, since D-TE is only 
active on ketoses, C3-epimerases active on aldoses could still extend the production tools 
(biocatalysts) for rare sugars. Recently, some more epimerases have been found to be able to 
convert free monosaccharides or to show potential as new biocatalysts (see chapter II section 1 
and Figure II.2) [20]. Nevertheless, the speed – or better the slowness (or almost inertia) – at 
which these enzymes can convert monosaccharides and the concentrations of substrate needed, 
make that these biocatalysts are not yet economically interesting [197].  
 
Due to the immense progress of  sciences like biochemistry, biotechnology, engineering and 
informatics, scientists nowadays have a variety of tools which they can use to change and modify 
naturally existing enzymes towards biocatalysts harboring the desired characteristics. Some 
examples of this biocatalyst optimization are improved stability of sucrose phosphorylase via 
enzyme engineering [44], enhanced or changed activity on natural and/or non-natural substrates 
[167, 197], but also to obtain new substrate specificities that are not found in natural enzymes 
[59]. 
4 
 
The combination of high economical value of rare sugars, the potential of epimerases in rare 
sugar synthesis and the availability of techniques for enzyme engineering triggered the idea to 
apply enzyme engineering of epimerase for rare sugar production. The rare sugar D-tagatose1 was 
taken as prime rare sugar target, and since its C4-epimer fructose is cheap and widely available 
due to efficient production routes starting from starch, it was chosen to develop a C4-epimerase 
that would be able to convert fructose into tagatose. Enzymes that naturally catalyze a C4-
epimerization, however on different but similar substrates, were taken as starting point (Figure 
I.1 and Figure I.2). The two available epimerases are L-ribulose-5-phosphate 4-epimerase and 
UDP-galactose 4-epimerase. The L-ribulose-5-phosphate 4-epimerase would require the 
adaptation of the substrate binding domain around the phosphate group of the substrate, to enable 
acceptance of a non-phosphorylated hexose rather than a phosphorylated pentose (Figure I.1). On 
the other hand, the UDP-hexose 4-epimerase requires an adaptation to accept much smaller 
substrates, namely free monosaccharides instead of nucleotide activate sugars (Figure I.2). Next 
to fructose/tagatose interconversion, C4-epimerization of glucose into galactose is a second 
target since glucose is cheap and abundant as well and this new source of galactose can be 
applied in tagatose production via current (bio)chemical production routes. 
 
 
L-Ru-5-P D-Xu-5-P
Tagatose
OH
OH
O
O
OH
P O
-
O
-
O
(?)AraD OH
OH
O
O
OH
P O
-
O
-
O OH
OH
OH
OH
O
OH
OH
OH
OH
OH
O
OH
Fructose
 
Figure I.1 Differences (in blue circle) and similarities (in red square) between the natural and desired substrates for 
the L-ribulose-5-phosphate 4-epimerase (AraD) 
                                                                
1 Monosaccharides can occur in 2 different forms or enantiomers, namely the D- and L-form, 
which are each other’s mirror images. Since D-enantiomers are naturally the most occurring 
forms of monosaccharides, by convention the ‘D-’ prefix can be omitted, but for L-sugars the 
prefix cannot be deleted. Example: D-tagatose = tagatose ≠ L-tagatose 
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Figure I.2 The difference between the natural and desired substrates for the UDP-hexose 4-epimerase  is even bigger 
than that needed for the L-ribulose-5-phosphate 4-epimerase. Loss of the UDP-moiety (red) is needed for activity on 
glucose (green), for tagatose additional differences are present between the sugar group 
 
In summary, the goal of this thesis is to gain more knowledge in the determinants for 
substrate specificity of C4-epimerases and to use this information to create C4-epimerases that 
can be used for rare sugar production, with the focus on D-tagatose. At first, a thorough literature 
review on rare sugars, with a focus on the target tagatose, and their biochemical production 
routes as well as on epimerases and enzyme engineering is presented to provide the reader with 
sufficient background information (chapter II). Subsequently, the research results from this 
project are discussed, starting with the cloning and expression of the L-ribulose-5-phosphate 4-
epimerase (chapter III). Then, the development of a selection system to identify improved 
enzyme variants and its application on mutant libraries are described (chapter IV and chapter 
V, respectively). This is followed by the development of a screening assay for the detection of 
mutants harboring tagatose 4-epimerase activity and the use thereof (chapter VI). The next two 
chapters deal with the cloning and characterization of the UDP-hexose 4-epimerase (chapter 
VII) and the mutational analysis of this epimerase (chapter VIII). Finally, an overall discussion 
as well as future perspectives are provided (chapter IX). 
  
6 
 
 
7 
 
II. LITERATURE REVIEW 
 
 
 
 
 
 
 
 
 
 
A part of this Literature review has been published as:  
Beerens, K., Desmet, T., Soetaert, W. (2012). Enzymes for the biocatalytic production of rare 
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1 Biocatalytic production routes for rare sugars 
1.1. Rare sugars and their applications 
The International Society of Rare Sugars (ISRS) has classified monosaccharides and 
derivatives according to their abundance in Nature [91]. Of all possible hexoses and pentoses, 
only seven (Glc, Gal, Man, Fru, Xyl, Rib and L-Ara) were considered to be present in significant 
amounts, whereas twenty hexoses and nine pentoses were described as rare sugars. Another large 
group of rare sugars consists of deoxygenated monosaccharides, which often play a crucial role 
as recognition elements in bioactive molecules [87, 160, 264]. Furthermore, secondary 
modifications like amination or methylation can also occur. Rare sugars cannot be extracted from 
natural sources and thus have to be produced by (bio)chemical reactions. Nevertheless, several of 
these are now commercially available as bulk products, such as D-tagatose and D-sorbose. Others, 
in contrast, are specialty compounds that are used in high-value applications, which is the case 
for most L-sugars. It can be expected that more efficient production routes will increase the 
availability of rare sugars for research purposes, resulting in the discovery of new applications 
and/or as yet unidentified characteristics [91]. 
 
Despite their low natural abundance, rare sugars hold enormous potential for practical 
applications (Table II.1). In the pharmaceutical industry, for example, L-ribose can be used as a 
building block for drugs against cancers and viral infections. Its most important application is in 
antiviral therapy, where it is incorporated in L-nucleosides analogues [94]. The advantages of the 
L-enantiomer are increased antiviral activity, better metabolic stability and more favorable 
toxicological profiles. Since the discovery of Lamivudine (2',3'-dideoxy-3'-thiacytidine, mostly 
referred to as 3TC), more and more L-nucleoside analogues are undergoing clinical trials and/or 
preclinical studies. Furthermore, several other L-sugars can be used to produce L-nucleosides, 
such as L-gulose, L-xylose and L-galactose [94, 168, 276]. L-sugars can also be used as active 
compounds on their own, for instance as glycosidase inhibitors [145] or as insecticides [2].  
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Table II.1 Overview of rare, unmodified monosaccharides and their (potential) applications (update from [2]) 
Sugar Application(s) Reference(s) 
D-allose Treatment of cancer, in particular chronic myeloid leukemia [10, 102, 175, 182, 280] 
 Suppression of thrombus formation and reperfusion injury [13, 103, 184] 
 Cryoprotectant for mammalian cells and organs [245] 
 Immunosuppressant [104] 
D-altrose Synthesis of cyclic carbamates of derived glycosylamines (polymer chemistry) [138, 143] 
D-arabinose Synthesis of antitumor compounds, such as dehydroamino acid derivatives [86, 178, 290] 
 Production of D-erythroascorbic acid and oxalic acid [163] 
D-gulose Drug-formulation agent and food additive [33] 
D-idose Synthesis of cyclic carbamates of derived glycosylamines (polymer chemistry) [138, 143] 
D-lyxose Synthesis of antitumor and immunostimulatory agents [180, 247] 
D-psicose Non-calorie sweetener, treatment of diabetes [16, 97] 
 Potential anthelmintic [229] 
 Precursor of xylosylpsicoses (used as prebiotics, cosmetics and therapeutics) [210] 
D-ribulose Starting material for branched pentoses  (useful in pharmaceutical chemistry) [105] 
D-sorbose Building block for industrial and bio-active products [107, 108] 
 Insect control agent [108] 
D-tagatose Low-calorie sweetener, treatment of diabetes [80, 154, 164, 191] 
 Improvement of human health (e.g. antiplaque, prebiotic) [154, 164, 191] 
 Additive in detergents, cosmetics, and pharmaceutical formulations [154, 191] 
D-talose Anti-tumor and anti-microbial activities, including. marker of O-antigens [190, 278] 
D-xylulose Starting material for branched pentoses (useful in pharmaceutical chemistry) [105] 
L-allose Therapeutic agent for diseases involving vasculogenesis [263] 
L-altrose Component of biologically important oligo- and polysaccharides [106] 
L-fructose Potential inhibitor of various glucosidases [145] 
 Mixture of L- and D-fructose kills ants and house flies [2] 
L-galactose Potential in synthesis of L-nucleoside-based antiviral medications [276] 
 Component of saponins, with applications in food, cosmetics and pharmaceuticals. [195, 276] 
L-glucose Starting material for glycoconjugate vaccines against diseases caused by Shigella sonnei [145] 
 Cytostatic and cytotoxic properties with regards to neoplastic cells (cancer therapy) [2] 
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Table II.1 Overview of rare, unmodified monosaccharides and their (potential) applications (update from [2]) (continuation) 
Sugar Application(s) Reference(s) 
L-gulose Building block of bleomycin A2, a glycopeptide antibiotic (potential anticancer agent) [76, 276] 
 Synthesis of nucleosides that exhibit very potent activity against HBV and HIV [76] 
 Starting material for the production of L-nucleoside-based antiviral medications [276] 
L-idose Derivatives are required in the synthesis of sensitive substrates for α-L-iduronidase [76] 
 Derivatives are used as glycosyl donors in the synthesis of heparin oligosaccharides [252] 
L-lyxose Component of the antibiotic avilamycin A [100] 
 Potential L-fucosidase inhibitor [51] 
L-mannose Component of steroid glycosides [106] 
L-psicose Starting material for the production of L-fructose [113] 
L-ribose Building block for antiviral and anticancer L-nucleosides [94, 171, 291] 
 Building block for glycoconjugates, oligonucleotides and L-aptamers [194] 
 Starting material for the production of L-allose and L-altrose [14] 
 Potential against HBV and Epstein-Barr virus [262] 
L-ribulose Starting material for L-ribose production [66, 68, 236] 
L-sorbose Starting material for the production of L-tagatose [113] 
 Precursor for the synthesis of the potent glycosidase inhibitor 1-deoxygalactonojirimycin [2] 
 Starting material for the production of L-ascorbic acid, also known as vitamin C [113] 
 Starting material for the synthesis of L-talitol [228] 
L-tagatose Potential as a functional sweetener [210] 
 Potential in chemotherapy [210] 
 Precursor of complex materials, such as 1,2,3,4-diisopropylidene tagatofuranose [210] 
 Starting materials for the synthesis of L-deoxygalactonojirimycin [108] 
L-talose Precursor of L-talose nucleosides, inhibitors of the in vitro growth of leukemia L1210 cells [151] 
L-xylose Starting  material for the synthesis of the nucleosides against HBV [168] 
 Synthesis of L-ribofuranose derivatives [47] 
L-xylulose Potential inhibitor of various glucosidases [145, 155] 
Synthesis of L-xylose and L-lyxose [90] 
Indicator of hepatitis or liver cirrhosis [248] 
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Other rare sugars, such as D-tagatose, can serve as low-calorie sweeteners, replacing 
classical table sugar in the food industry. A major advantage is that tagatose has a low glycemic 
index, making it suitable for diabetic patients [164]. In that respect, it is interesting to note that 
tagatose has entered phase III clinical trials to investigate whether it can be used as diabetic 
medication [80]. Similar effects have been attributed to D-psicose, which shows potential as non-
calorie sweetener as well as diabetic and obesity control agent [16]. In contrast, D-allose, an 
isomer of D-psicose, displays rather different properties. Besides its inhibitory effect on both 
carcinogenesis and cancer proliferation, it is also useful in surgery and transplantation as an anti-
inflammatory agent, immunosuppressant and cryoprotectant [159]. 
1.2. Enzymes for rare sugar production 
Basically, three different types of enzymes can be used for the interconversion of 
monosaccharides (Figure II.1). Two of these are classified within the class of isomerases, i.e. 
keto-aldol isomerases (EC 5.3.1) and carbohydrate epimerases (EC 5.1.3). The former (often 
referred to as aldose isomerases or simply as isomerases) catalyze an intramolecular redox 
reaction, exchanging the carbonyl functionality between the C1- and C2-positions [116]. The 
latter, in contrast, catalyze the re-orientation of a hydroxyl group, converting the substrate into 
one of its epimers [226]. The third group of enzymes consists of oxidoreductases (EC 1.1) that 
convert carbohydrates into their corresponding polyols, and vice versa [267]. Oxidoreductases 
acting on ketoses are typically designated as polyol dehydrogenases, whereas those that act on 
aldoses are known as aldose reductases [91]. 
 
All three of these enzyme classes have already been applied for the production of rare 
sugars (see overview in Figure II.2 and Figure II.3), but each have specific advantages and 
disadvantages (Table II.2). Isomerases, for example, are promiscuous biocatalysts that are active 
on a range of simple substrates, i.e. unsubstituted monosaccharides. However, promiscuity is not 
always an advantage because this can result in the formation of side products and complicate the 
downstream processing. This is nicely illustrated with the glucose-6-phosphate isomerase from 
Pyrococcus furiosus, which converts L-tagatose not only to L-talose but also to L-galactose 
(Figure II.4) [286]. Although both products are valuable, it would be more efficient to produce 
them separately with two different isomerases, each specific for one of the aldoses. 
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Figure II.1 The three different enzyme classes that can be used for rare sugar production. Oxidoreductases are 
exemplified by galactitol dehydrogenase (Gal DH), aldose isomerases by L-arabinose isomerase (L-AI) and epimerases 
by D-tagatose 3-epimerase (D-TE) 
 
 
Figure II.2 Overview of the enzymatic interconversions of unmodified monosaccharides that have been reported to 
date: pentoses. Update of the Izumoring process described in [91] 
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Figure II.3 Overview of the enzymatic interconversions of unmodified monosaccharides that have been reported to 
date: hexoses. Update of the Izumoring process described in [91] 
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Table II.2 Comparison of three enzyme classes in rare sugar production 
Enzyme Advantages Disadvantages 
Isomerase Substrates often unsubstituted  Product mixtures are sometimes formed 
 Broad substrate specificity  
Epimerase Shortcut in synthetic route  Substrates often substituted  
 Potential bridge between D- and L-sugars Substrate specificity is rather strict 
Oxidoreductase Bridge between D- and L-sugars Need for cofactor regeneration 
 Substrates often unsubstituted  
   
 
Epimerases are potentially the most useful biocatalysts for the production of rare sugars as 
they can give access to a wide range of structures, in contrast to the two other enzyme classes 
that are limited to modifications of the C1- and C2-positions. Unfortunately, most epimerases are 
only active on sugars that are substituted with a phosphate or nucleotide group, which drastically 
increases production costs. The recently discovered D-tagatose 3-epimerase is a noticeable 
exception that has allowed the production of D-psicose from the cheap substrate D-fructose [250].  
The identification of new epimerases can create interesting shortcuts in current synthetic routes. 
A 2-epimerase, for example, can replace the double keto-aldol isomerization previously required 
for the conversion of D-xylose into D-lyxose (Figure II.2). Furthermore, 5-epimerases could form 
a new bridge between D- and L-hexoses, and the same is true for 4-epimerases acting on pentoses 
(Figure II.5). For instance, glucose could then serve as cheap substrate for L-idose production in 
a single reaction instead of three steps, which is currently the shortest route (Figure II.3).  
 
 
Figure II.4 Isomerization of L-tagatose with glucose-6-phosphate (Glc-6-P) isomerase. Because of the enzyme’s low 
specificity, both L-talose and L-galactose are formed 
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Figure II.5 Interconversion of D- and L-sugars. D-Ribose can only be converted to L-ribose through ribitol as 
intermediate, using oxidoreductases as biocatalysts. However, a putative C4-epimerase would be able to convert D-
lyxose directly into L-ribose. DH Dehydrogenase 
 
For the moment, D-sugars can only be converted into their L-isomers using the 
corresponding polyols as intermediate products. To that end, oxidoreductases are applied in a 
two-step process, i.e. sugar reduction followed by polyol oxidation (Figure II.5). However, 
polyols like xylitol and sorbitol are also valuable compounds in their own right and are used as 
sweeteners with a cooling sensation [88]. Despite their industrial relevance, oxidoreductases 
exhibit one great disadvantage, namely the need for NAD(P)H as expensive cofactor. As a result, 
reactions with oxidoreductases are often performed inside microbial cells so that the cellular 
metabolism can provide the reductive power. Alternatively, specific cofactor regeneration 
systems can be employed when isolated enzymes are to be used (Figure II.6) [72, 108]. 
 
 
Figure II.6 The production of allitol from fructose. Allitol is produced from fructose by a coupling reaction using D-
tagatose 3-epimerase (D-TE) and ribitol dehydrogenase (RDH). Cofactor regeneration is achieved with the help of the 
irreversible formate dehydrogenase (FDH) reaction 
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1.2.1. Oxidoreductases 
Since the development of the chemical hydrogenation method, xylitol has been used on a 
large scale as alternative sweetener [88]. However, research has also been done in order to 
develop microbial production methods for xylitol. To that end, oxidoreductases are often 
employed in metabolically engineered organisms, such as Saccharomyces cerevisiae and 
Candida strains [88, 89]. The main challenge with S. cerevisiae is to increase the uptake of 
xylose as substrate, as well as the regeneration of NADPH through the pentose phosphate 
pathway. Although Candida yeasts are better at taking up xylose and maintaining the 
intracellular redox balance, their application in the food industry is hampered due to the 
opportunistic pathogenic nature of some species. In parallel, the use of xylitol 4-dehydrogenase 
(XDH) as isolated biocatalyst for the production of xylitol has also been optimized. The 
immobilization of the enzyme from Rhizobium etli, for example, has resulted in a 10-fold 
increased thermostability, a broader operational pH range, and excellent reusability [292]. In 
turn, xylitol can serve as substrate for the production of other rare sugars like L-xylulose and L-
xylose. In a recent study, the XDH from Bacillus pallidus has been overexpressed in Escherichia 
coli for L-xylulose production. Although the conversion rates were lower than when the B. 
pallidus strain was used, the advantage of E. coli is that the formation of side products is 
drastically reduced [205, 248]. At higher temperatures, however, L-xylose started to accumulate 
instead of L-xylulose, perhaps due to the activity of endogenous D-arabinose isomerase in E. coli. 
 
The combination of regio- and stereoselectivity for the C2 position allows the mannitol 1-
dehydrogenase (MDH) from Apium graveolens to catalyze several interesting reactions, 
including the conversion of ribitol to L-ribose, D-sorbitol to L-gulose, and galactitol to L-
galactose [243]. A recombinant E. coli harboring this MDH represents a significantly improved 
method for the large-scale production of L-ribose compared to previously used methods [277]. A 
threefold higher productivity was obtained compared to the double isomerization of L-arabinose 
with xylose isomerase [121], and a much higher conversion rate was obtained compared to the 
chemical process, while the environmental hazards could be avoided [124]. 
 
Another dehydrogenase that shows high potential as a biocatalyst in rare sugar production is 
the recently discovered D-arabitol 2-dehydrogenase (D-ADH) from Thermotoga maritime [125]. 
It is the first hyperthermophilic D-ribulose forming D-ADH and thus exhibits several industrial 
advantages. First of all, the enzyme can convert the inexpensive substrate D-arabitol with very 
high selectivity. In addition, the risk of contamination in food production is dramatically lower as 
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it can be used at increased temperatures. And finally, it can be efficiently purified from 
recombinant E. coli by heat precipitation, providing a reliable and cost-effective supply of 
biocatalyst. 
 
Oxidoreductases, and their producing strains, can also be used for the interconversion of 
deoxy-sugars. L-rhamnose is the only cheaply available deoxy-hexose but can be transformed 
into 1- and 6-deoxygenated D/L-psicose, D/L-fructose and L-tagatose by Enterobacter aerogenes 
IK7 [92, 93]. On the other hand, Enterobacter agglomerans 221e can be applied in the synthesis 
of 1- and 6-deoxy-D-tagatose from both enantiomers of fucose [288]. In these processes, the 
deoxy-sugar is first chemically hydrogenated towards the corresponding polyol, which then 
serves as substrate for the enzymatic oxidation. Furthermore, microbial oxidation can also be 
performed on methylated polyols, for instance for production of both enantiomers of 4-C-methyl-
ribulose by Gluconobacter thailandicus NBRC 3254 [122, 211]. 
1.2.2. Isomerases 
Due to the broad substrate specificity of isomerases, these enzymes can be applied in the 
synthesis of various aldoses and ketoses starting from their cheaper counterpart. A well known 
example to illustrate their promiscuity is the fact that xylose isomerase is better known as 
glucose isomerase because it is mainly used for the production of high fructose corn syrup 
(HFCS) rather than for its wild-type conversion (D-xylose to D-xylulose). The importance of 
substrate resemblance for side activities can be further illustrated with the following examples. 
The D-lyxose isomerase from Providencia stuartii was found to be active not only on D-lyxose/D-
xylulose but also on nine other ketose-aldose couples. The highest specific activity was measured 
on aldose substrates with the C2 and C3 hydroxyl groups in the left-hand configuration, just as in 
the wild-type substrate. In contrast, very little activity could be detected on the mirror image 
substrates L-lyxose, L-mannose [142]. Many more isomerases have been shown to be active on 
sugars similar to their wild-type substrates [3, 52, 146, 172, 199, 200, 206, 215, 282].  
 
The promiscuity of isomerases has not only been evaluated with resembling 
monosaccharides but also with respect to the presence of a phosphate group. Indeed, several 
isomerases that are naturally active on phosphorylated sugars have been shown to convert free 
carbohydrates as well. In particular, ribose-5-phosphate isomerase has been shown to be active 
on D/L-ribose, D/L-lyxose, D/L-talose, D/L-mannose, D/L-allose, L-lyxose and L-tagatose [199, 283, 
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285]. Similarly, mannose-6-phosphate isomerase and galactose-6-phosphate isomerase have been 
found to convert free monosaccharide, such as L-ribose [284] and D-allose [200], respectively. 
 
A second feature to take into account is whether the isomerase is specific towards one of the 
two aldoses. If the enzyme is not specific enough, mixtures will be obtained containing three 
sugars, namely the substrate, the desired product and an undesired side product (Figure II.4). 
Consequently, the choice of the proper enzyme will result in both higher yields and easier 
purification. The L-rhamnose isomerase from Bacillus pallidus has been shown to convert D-
psicose/D-allose, L-fructose/L-mannose, D-ribose/D-ribulose and L-talose/L-tagatose without the 
formation of by-products [206]. The opposite is true for the glucose-6-phosphate isomerase from 
Pyrococcus furiosus, which converts L-talose to both L-tagatose and L-galactose, and D-ribulose 
to both D-ribose and D-arabinose [286]. Xylose isomerase is another enzyme that has been shown 
to also catalyze C2-epimerization of different substrates in addition to the expected 
isomerization, leading to side product formation [201, 269]. 
 
To further outline the importance of isomerases in rare sugar synthesis, an overview is given 
from some isomerases that are currently in use or which show great potential in rare sugar 
conversion. 
1.2.2.1. L-arabinose isomerase for tagatose production 
L-arabinose isomerase (L-AI) has been thoroughly studied for the conversion of D-galactose 
into the low-calorie sweetener D-tagatose [49, 50, 55, 207, 215]. Tagatose is almost as sweet as 
sucrose but is metabolized in a different fashion, resulting in a caloric content that is about three 
times lower [80, 154]. Recently, the enzyme from Bacillus stearothermophilus was successfully 
mutated towards an improved industrial biocatalyst. Through rational design, three mutants were 
created based on previously reported data and sequence alignments. Acidotolerance and stability 
was improved by the mutation Q268K and a broader temperature range was achieved by the 
mutation N175H, with the combined double mutant displaying both characteristics [213]. In 
another study, ten positions identified through random mutagenesis of Geobacillus 
thermodenitrificans L-AI were examined in detail. Five of the corresponding variants were 
shown to display a two- to threefold increase in specific activity. Double mutants were then 
created, with C450S/N475K generating a 20% higher tagatose conversion and a fourfold increase 
in specific activity compared to the wild-type enzyme [193]. In addition, production processes 
have also been improved. The addition of boric acid was found to result in increased yields 
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[158], whereas immobilization of the L-AI was performed to obtain a stable and economic 
method for the industrial production of tagatose [192]. 
1.2.2.2. Isomerases for L-ribose production 
Several isomerases have been shown to display a minor side activity on L-ribose, which has 
been the focus of enzyme engineering efforts. The activity of the mannose-6-phosphate 
isomerase from Thermus thermophilus for L-ribose production has, for example, been improved 
by the mutation R142N, resulting in a 1.4- and 1.6-fold increase in specific activity and catalytic 
efficiency (kcat/KM), respectively. This mutant was found through alanine scanning of several 
active-site residues, followed by partial randomization of the most important position. The 
catalytic efficiency of the resulting R142N mutant was 3.8-fold higher than that of Geobacillus 
thermodenitrificans mannose-6-phosphate isomerase, which exhibited the highest catalytic 
efficiency reported to that date. The purified R142N mutant had a volumetric productivity of 107 
g liter-1 h-1 in a L-ribose production process [284]. However, a specific L-ribose isomerase (L-RI) 
has also been isolated from an Acinetobacter strain, with a KM of 44 mM for L-ribose and a 
specific activity of 24.2 µmol mg-1 min-1 for L-ribulose formation [236]. Strangely, the enzyme’s 
specific activity was about ten-fold higher when it was recombinantly expressed in E. coli [176]. 
The L-RI could be a promising biocatalyst for the production of L-ribose, but has not yet been 
evaluated in such a process. 
1.2.2.3. Isomerases for deoxygenated and other modified sugars 
Two isomerases that prefer deoxy-sugars as their substrates are L-fucose isomerase [82, 
123] and L-rhamnose isomerase [146, 147]. These enzymes also tolerate other modifications at 
centers higher than C3 and can use epimeric or functionalized sugars as substrates. Examples 
hereof are terminus-modified fuculose-analogues for L-fucose isomerase [82]. Other related 
enzymes, including xylose (glucose) isomerase, were also shown to accept deoxygenated and/or 
substituted sugars [81, 96, 209]. It can thus be expected that several isomerases will be applied 
for the production of modified sugars in the near future. 
1.2.3. Carbohydrate epimerases 
All biochemical reactions that can be used for the production of rare sugars and polyols 
from readily available raw materials like starch, wood and lactose have been summarized in the 
Izumoring [91]. At that time, only one epimerase was available for such conversions, namely the 
D-tagatose 3-epimerase. Since then, however, two other epimerases have been shown to be 
naturally active on unsubstituted sugars (i.e. cellobiose 2-epimerase and UDP-galactose 4-
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epimerase), whereas the L-ribulose-5-phosphate 4-epimerase has also been found to show 
promise for the production of rare sugars. 
1.2.3.1. Ketohexose 3-epimerase 
D-tagatose 3-epimerase (D-TE) was found to catalyze the epimerization of various ketoses at 
the C3 position, making it a very useful enzyme for rare sugar production. D-TE has already been 
used for the synthesis of various carbohydrates, both in single and multiple enzyme reactions. At 
the lab scale, this enzyme has even been used for the production of all possible ketohexoses [113, 
115]. Furthermore, D-TE is a highly promiscuous enzyme that can accept a large range of 
unnatural substrates, like C-4-methylated pentoses [211], C-5-methylated hexoses [122], 5-
deoxy-ketohexoses [209], as well as several 1- and 6-deoxy-ketohexoses [93]. On the other hand, 
immobilized D-TE has been applied in the mass production of D-psicose from D-fructose [250]. 
Addition of borate to the reaction mixture results in removal of the product as a psicose-borate 
complex and will thus result in improved yields [133]. Two examples of multiple enzyme 
reactions where D-TE is applied are allitol and D-arabinose production starting from fructose and 
xylose, respectively. To that end, the epimerase is combined with dehydrogenases or isomerases 
(Figure II.6) [246, 249]. 
 
A very similar enzyme has been described in Agrobacterium tumefaciens, namely D-psicose 
3-epimerase (D-PE). Unfortunately, due to its short half-life (63 min at 50 °C), it is inefficient for 
the industrial production of psicose. Therefore, enzyme variants were created by error-prone 
PCR and tested for improved thermostability [53]. Two single mutants (I33L and S213C) 
displayed an increased optimal temperature and kinetic stability. Combining both mutations in a 
single enzyme further improved these parameters, resulting in a 30-fold increase in half-life at 
50°C. In a continuous production process with the immobilized double mutant, no decrease in 
activity could be observed after 30 days. This suggests that the I33L/S213C variant may be 
useful as an industrial producer of D-psicose. 
1.2.3.2. UDP-Galactose 4-epimerase 
The second enzyme that shows epimerase activity on free monosaccharides is the E. coli 
UDP-galactose 4-epimerase, which normally uses nucleotide-activated galactose and glucose 
(UDP-Gal/UDP-Glc) as substrates. However, the purified enzyme was found to also catalyze the 
4-epimerization of free galactose, glucose, fructose, tagatose, psicose, and sorbose, albeit with 
very low specific activities (0.3-9.7 nmol mg-1 min-1). Three residues were submitted to site-
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saturation mutagenesis, resulting in the identification of a N179S mutant with a twofold 
improved activity on fructose and tagatose. The enzyme was also tested for 4-epimerization 
activity on allose, gulose, altrose, idose, mannose, and talose but no activity was found on these 
aldohexoses [130]. 
1.2.3.3. Cellobiose 2-epimerase 
A third enzyme that was found to catalyze (rare) carbohydrate epimerizations is the 
cellobiose 2-epimerase (CE) from Caldicellulosiruptor saccharolyticus. This thermophilic 
epimerase not only catalyzes the epimerization of cellobiose, but also shows low activity on 
aldoses harboring hydroxyl group oriented in the left-hand configuration at the C3 position. The 
enzyme exhibited the highest side activity for mannose (to glucose), although this was 20 times 
lower than the activity on cellobiose. Low activities were also detected on D-xylose, L-altrose, L-
idose, and L-arabinose [198]. Very recently, a new mannan catabolic pathway has been described 
in Bacteroides fragilis, including a CE that functions as mannobiose 2-epimerase (MBE) in vivo. 
These findings are supported by a lower Km and higher catalytic efficiency for mannobiose than 
for cellobiose [233]. Further proof of its physiological role can also be found in its preference for 
mannose over glucose as monosaccharide substrate, which was reported for the C. 
saccharolyticus CE [198]. Surprisingly, the latter enzyme also shows slight isomerase activity on 
various monosaccharides when long reaction times and high amounts of enzyme were used 
[198]. This isomerase side activity will lower epimerization yield and complicate the purification 
process. 
1.2.3.4. L-ribulose-5-phosphate 4-epimerase and related aldolases 
Another epimerase that is promising for rare sugar conversions is L-ribulose-5-phosphate 4-
epimerase. This enzyme is structurally and mechanistically related to the dihydroxyacetone 
phosphate dependent L-fuculose-1-phosphate aldolase and L-rhamnulose-1-phosphate aldolase 
[120, 166]. Despite the fact that the wild-type substrates of all these enzymes are phosphorylated 
(deoxy-) sugars, the epimerase shows potential for the production of rare sugars that lack a 
phosphate group. Indeed, by applying error-prone PCR to L-rhamnulose-1-phosphate aldolase, 
variants could be created that display activity towards unsubstituted L-rhamnulose [244]. Since 
the two enzymes are very similar, it is not unreasonable that the same or equivalent mutations 
would have an identical effect on the substrate specificity of the epimerase, thus making it active 
on free ketoses. Furthermore, aldolases can be used in the direct synthesis of rare sugars by aldol 
condensation of smaller carbohydrates. The previously mentioned L-fuculose-1-phosphate 
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aldolase has been used in the production of D-psicose, D-sorbose, L-tagatose, and L-fructose 
starting from DL-glycerol 3-phosphate and D- or L-glyceraldehyde [156]. 
1.3. Rare sugars: conclusions and outlook 
During the past decades, major progress has been made in research on rare carbohydrates. 
The discovery of new enzymes and the engineering of existing biocatalysts have generated new 
opportunities for their application in various industrial sectors. The discovery of a D-tagatose 3-
epimerase (D-TE), for example, has not only allowed the synthesis of all possible ketohexoses, 
but also of methylated and deoxygenated sugars. For other biocatalysts, mutagenesis efforts have 
resulted in improved activity and stability, as illustrated by the R142N variant of mannose-6-
phosphate isomerase and by the I33L/S213C variant of D-psicose 3-epimerase, respectively. 
 
Epimerases, in particular, are exciting biocatalysts as they can facilitate rare sugar 
production through the introduction of major shortcuts in the current production routes. One 
major challenge, however, is the need for epimerases that are active on free monosaccharides 
instead of nucleotide-activated or phosphorylated sugars. Obtaining such epimerases by 
redesigning the active site of known enzymes is not a trivial task. Indeed, the substituents are 
often essential for strong binding of the substrates and can even be crucial for the enzyme’s 
activity through an induced fit mechanism. Alternatively, suitable epimerases could be identified 
by further screening in natural environments, which still is a powerful approach and regularly 
redefines our knowledge of microbial physiology. 
 
A very important step in any enzyme engineering project is the choice of the most suitable 
template. Recently, L-arabinose isomerase (L-AI) and tagatose-6-phosphate isomerase (T6PI) 
have been compared as starting points for increased isomerization activity on galactose [131]. 
Although this would require the loss of a phosphate group in the case of T6PI, this enzyme was 
concluded to be the best template for directed evolution because mutations are less likely to 
diminish its activity. Indeed, L-AI makes use of metal cofactor whose binding can be easily 
disrupted by random mutations. Nevertheless, L-AI would probably be the right choice for 
rational design studies because its crystal structure is available. Future work will reveal which 
enzyme and which strategy will generate powerful new biocatalysts for the production of rare 
sugars. 
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2 The rare sugar target: D-tagatose 
2.1. Introduction 
Tagatose, a rare natural ketohexose, is an isomer of D-galactose and an epimer 
(stereoisomer) of D-fructose (Figure II.7). It is found in small quantities in various foods such as 
sterilized and powdered cow’s milk, a variety of cheeses, yoghurts, and other dairy products. In 
addition, tagatose also naturally occurs in the gum of the West-African tree Sterculia setigera 
[80, 191]. D-Tagatose has attracted a great deal of attention since it was first described as a sugar 
substitute [155]. Since then, several studies have been performed, investigating the different 
aspects of tagatose in food and pharmaceutical formulations, like stability in food and drinks [75, 
165], clinical trials for drug application [80] as well as consumer evaluation [9, 253]. 
 
 
Figure II.7 Fisher projection of D-fructose, D-tagatose and D-galactose, including the (possible) link between the 
sugars. D-Fructose to D-tagatose conversion needs a C4-epimerization whereas D-galactose to D-tagatose conversion 
requires an isomerization 
2.2. Properties 
As all hexoses, the molecular formula of tagatose is C6H12O6 and it has a molecular weight 
of 180.16 g/mol. It is an optically active compound containing 3 chiral carbon atoms. As it is a 
reducing sugar, it is involved in browning during heat treatment. The melting temperature of 
tagatose is 134 °C, which is lower than that of sucrose, resulting in a more readily decomposition 
at higher temperatures. It is stable in a pH 2-7 range and has a high solubility in water, 58% 
(w/w) at 21 °C. Its physical form is a white anhydrous odorless crystalline solid. It is less 
hygroscopic than fructose and has similar humectants properties as sorbitol [154]. 
 
As tagatose is poorly absorbed in the small intestine and the majority of ingested tagatose 
(75 %) will reach the large intestine, it is called a malabsorbing sugar [191]. In the large 
intestine, it is fermented by the intestinal microflora and is converted into short chain fatty acids, 
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which are absorbed almost completely. Absorbance and metabolisation of these short chain fatty 
acids result in a low energy recovery. On the other hand, energy is lost due to increased biomass 
excretion of microflora [28]. Whereas reported caloric values range from -0.12 to 1.4 kcal/mol, 
the FDA approved caloric content  is 1.5 kcal/g. 
 
The taste of tagatose is very comparable to that of sucrose, with a sweetness of 92 % 
compared to sucrose at 10 % solutions. In contrast to polyols, no cooling effect is observed with 
tagatose, nor bitter or off-flavor aftertastes as found with artificial sweetener aspartame [183]. It 
is similar to polyols in having a low caloric value and is also tooth-friendly [191], yet without the 
laxative effect. The glycemic index of tagatose is very low [154], namely 2-3. An overview of 
the physical, chemical, and biological properties of tagatose is given in Table II.3. 
 
Table II.3 D-tagatose and its physical, chemical, and biological properties (Adapted from [80, 154, 191]) 
Property Value and/or comment 
Common name D-tagatose, Tagatose 
IUPAC name  (3S,4S,5R)-1,3,4,5,6-Pentahydroxy-hexan-2-one 
Chemical family Carbohydrate; monosaccharide; ketohexose 
Molecular formula C6H12O6 
Molecular weight 180.16 g/mol 
Structure 3 chiral carbons (C3, C4 & C5); C4-epimer of fructose; isomer of galactose 
Distribution of cyclic forms  α-D-tagato-2,6-pyranose (79%), β-D-tagato-2,6-pyranose (14%), α-D-tagato-
2,5-furanose (2%), and β-D-tagato-2,5-furanose (5%) 
Physical form White anhydrous crystalline solid 
Odor None 
Melting point 134 °C 
Decomposition temperature 120 °C 
Optical rotation αD
20 = -5° (c = 1 in water)   
Solubility in water High solubility: 58% wt/wt at 21°C 
pH stability range 2-7 
Relative sweetness 92% of sucrose (compared in 10% solutions) 
Sweetness profile Mimics sucrose, but with a faster onset than fructose 
Cooling effect None 
Caloric value 1.5 kcal/g approved (reported range: -0.12 – 1.4 kcal/g) 
Glycemic index Very low: 2-3 
Cariogenicity None 
Health promotion Low calorie, prebiotic, low glycemic, no elevation of blood glucose, 
suitable for diabetics, healthy foods, dietary supplements, beneficial drugs 
or drug adjuvants, antioxidant, cytoprotective  
Bulk Similar to sucrose 
Humectant/Hygroscopicity Similar to sorbitol / Less than fructose 
Metabolism Malabsorbing sugar: 25% absorbed, unabsorbed fraction (75%) is 
fermented by the intestinal microflora towards short chain fatty acids which 
results in a low energy recovery. Energy loss due to increased biomass 
excretion of microflora 
Maillard reaction Yes, browning like sucrose 
Applicable in  Chocolate candy, soft confectioneries, hard confectioneries, diet soft drinks, 
ready to eat cereals, frosting, ice cream, frozen yogurt, diet chewing gum 
Regulatory status GRAS status by the FAO/WHO since 2001 for food and beverages 
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2.3. Production methods 
In both the chemical and biochemical manufacturing process, tagatose is made by 
isomerization of galactose. This galactose is obtained by hydrolysis of lactose which is present in 
milk whey, a byproduct of the cheese industry. The released galactose and glucose in the 
hydrolysate are then separated by chromatography to yield pure galactose as substrate for the 
isomerization reaction (Figure II.8). 
 
Lactose
Hydrolysis
mixture of galactose and glucose
galactose
tagatose
glucoseChromatography
L-arabinose 
isomerasecalcium tagatate
Isomerisation 
with Ca(OH)2
Neutralisation
with CO2
 CHEMICAL                                BIOCHEMICAL
 
Figure II.8 Tagatose manufacturing starting from lactose. Left: chemical isomerization under alkaline conditions 
(Ca(OH)2)  and neutralization using CO2. Right: biochemical isomerization using L-arabinose isomerase 
 
2.3.1. Chemical 
The current production process is based on the chemical isomerization of galactose which 
was developed by Spherix Incorporated [19]. Chemical isomerization of galactose to tagatose is 
carried out under alkaline conditions using a hydroxide. Calcium hydroxide is the preferred 
hydroxide because this complexing agent will shift the isomerization equilibrium between 
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galactose and tagatose towards tagatose. This is a result of insoluble complex formation with 
tagatose at elevated pH. The calcium tagatate suspension is then treated with carbon dioxide, the 
preferred acid, to neutralize the mixture and hereby liberate tagatose as well as precipitate 
calcium as calcium carbonate (Figure II.8). Finally, tagatose is further purified, crystallized and 
dried [154, 164]. 
2.3.2. Biochemical 
Several biocatalysts have been studied for biological manufacturing of tagatose (Figure 
II.9). Conversion of galactitol into tagatose has been reported for Arthrobacter globiformis [117], 
Gluconobacter oxydans [170, 220], Mycobacterium smegmatis [118], Enterobacter 
agglomerans, and Klebsiella pneumoniae  [191]. In these micro-organisms, a sorbitol 
dehydrogenase is the responsible enzyme for the biotransformation [220]. A second biocatalytic 
route that has been proposed is the conversion of sorbose into tagatose with the help of D-psicose 
3-epimerase from Agrobacterium tumefaciens [129] or D-tagatose 3-epimerase from 
Pseudomonas cichorii [109, 114, 287]. However, both sorbose and galactitol are expensive 
substrates and thus have limited potential in the commercial production of tagatose. 
 
More economical production routes start from cheap substrates such as galactose or 
fructose. The current production route that starts from fructose is a two step method in which 
fructose is first converted to psicose which is then applied as substrate in the biotransformation 
towards tagatose with the help of Mucoraceae fungi. Various Mucoraceae strains have been 
reported to be able to carry out this reaction. Neither the availability nor the price of psicose are 
limiting factors here, as psicose mass production became industrially feasible after the discovery 
of ketohexose 3-epimerases [129, 250]. The two-step tagatose production from fructose over 
psicose is a good alternative method; however, it still requires further intensive investigation 
[191]. 
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Figure II.9 Different biological manufacturing routes for tagatose. C4? indicates possibilities for C4-epimerization 
reactions in manufacturing of tagatose 
 
A biocatalyst that is currently receiving much interest, and probably the most studied one 
for biochemical isomerization of galactose, is L-arabinose isomerase. The isomerization can be 
both achieved biocatalytically, with purified L-arabinose isomerase, or in a biotransformation 
setting in which the isomerase is still inside living/resting cells. As discussed earlier (see 1.2.2.1), 
site directed and site saturation as well as random mutagenesis were applied to improve L-
arabinose isomerase as an industrial biocatalyst. Characteristics that were improved are 
acidotolerance and stability [213], a broader temperature range [213], tagatose conversion and 
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specific activity [193]. On the other hand, tagatose can also be produced using L-arabinose 
isomerase inside living cells. The advantage of working inside cells is that an equilibrium shift is 
achieved towards tagatose. This is the result of the differential selectivity of the cell membrane, 
leading to higher uptake and lower release rates for galactose than for tagatose and vice versa 
[132]. Alginate immobilized Lactobacillus strains are an attractive substitute for recombinant 
Escherichia coli, as they are approved as GRAS (generally recognized as safe) organisms [279]. 
Another example of in vivo production is that of tagatose production in milk fermentation by 
Lactobacillus and Streptococcus harboring recombinant L-arabinose isomerase [214].  
2.4. Applications 
Tagatose has numerous health benefits, which form the basis of its applications in dietary 
food and beverages, as well as its drugs applications. The main health benefits are summarized 
here. Due to its low caloric content, its consumption results in promotion of weight loss at 
medically desirable rates [41, 154]. Consequently it can also be used for the treatment of obesity 
[41, 177]. As it has no glycemic effect, it is safe for diabetic patients [77], for whom it can also 
be used to reduce symptoms associated with diabetes type 2, as well as symptoms of 
hyperglycemia, anemia and hemophilia [153]. Thus, the low-caloric sweetener is mainly applied 
in dietary foods and beverages such as low-carbohydrate diets, cereals, yoghurt, milk-based 
drinks, soft drinks, health bars, candy, chocolate and other confectionery [191].  
 
Besides being of low-caloric value, tagatose has other benefits in health food products, like 
prebiotic properties, as well as anti-biofilm, anti-plaque, and non-cariogenic [29, 56]. These latter 
features make tagatose very useful in tooth paste and mouth wash. Furthermore, it can be used 
for improvement of pregnancy and fetal development [153], flavor enhancements [191] and for 
organ transplants where it acts as a powerful antioxidant and cytoprotective [202]. Other 
applications for tagatose are in the synthesis of other optically active compounds and as an 
additive in detergents, cosmetics, and pharmaceutical formulations [191]. 
 
More recently, preliminary studies in humans pointed out that tagatose has a low 
postprandial blood glucose and insulin response. Currently, tagatose is being studied in clinical 
phase III trials for use as medication for the treatment of diabetes type 2 as well as prediabetes 
and obesity [80]. Different mechanisms of action have been proposed and combinations of these 
effects are also possible. Tagatose might compete with or partially inhibit glucose transporters in 
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the small intestine leading to delayed absorption. However, this has not been demonstrated in 
animal models [237]. Another proposed mechanism is the inhibition of sucrase and maltase 
which would decrease the digestion of sucrose and starches in the small intestine, respectively. In 
vitro and animal studies support these mechanisms. Another putative mechanism states that 
tagatose may act through its liver metabolism. Tagatose-1-phosphate formation might induce 
glucokinase and inhibit glycogen phosphorylase, both resulting in increased glycogen 
accumulation and decrease of hepatic glucose output. In a phase II clinical trial study, a 1% 
decrease in glycated hemoglobin (HbA1c) was found in type 2 diabetic patients. This overall 
significant decrease in HbA1c indicates a highly improved blood sugar control by the body. 
Furthermore, HDL cholesterol had increased whereas no changes were observed in blood 
pressure, non-HDL cholesterol or other parameters. The ongoing clinical phase III trials will 
provide better insights in tagatose, its mechanism and potential in diabetes and obesity treatment 
[80]. 
 
As indicated for other rare sugars (see 1.1 and Table II.1), it can be stated that tagatose has 
plenty of applications, mainly as low-caloric sweetener in food and flavor industry. Furthermore, 
it still holds great potential in a variety of other industries, such as medication in diabetes type 2, 
prediabetes and obesity. As such, tagatose has a big economical value. 
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3 (Sugar) Epimerases 
3.1. General 
Carbohydrates and their derivatives are essential to different life forms, in which they 
exhibit a wide variety of functions. Among these vital tasks in biology are source of energy, 
structural elements, molecular recognition markers, and they are used as precursors for the 
biosynthesis of other building blocks/molecules such as aromatic amino acids. Furthermore, as 
already stated above in the section on rare sugar production, they have many applications in 
industrial processes (Table II.1). In nature, several kinds of enzymes are used in the metabolism 
and conversion of carbohydrates, such as dehydrogenation, oxidation, reduction, acetylation, 
isomerization, and epimerization.  
 
Epimerization is defined as the inversion of the configuration of asymmetrically substituted 
carbon in linear or cyclic molecules like carbohydrates. Oversimplified, it can be seen as the 
removal of a hydrogen atom on one face of the substrate followed by readdition of the hydrogen 
at the opposite site of that carbon atom (Figure II.10). However, despite the simplicity of 
representation of this reaction, the chemistry behind these transformations is much more 
complex; epimerization does not occur spontaneously as carbohydrates are extremely stable. On 
the other hand, sugar epimerases have been found in all branches of life and, in theory, they can 
change stereochemistry at all different stereocenters of sugars. Some enzymes even epimerize 
two centers simultaneously during turnover, like dTDP-6-deoxy-D-xylo-4-hexulose 3,5-
epimerase.  
 
O
H
OH
O
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Figure II.10 Epimerization; inversion of chirality at a asymmetrically substituted carbon 
 
To date, over 20 types of sugar epimerases have been reported active on C1, C2, C3, C4, 
C5, and C6 centers of mono- and oligosaccharides, using several completely different reaction 
mechanisms to invert chirality. Among these epimerase mechanisms are mutarotation or ring 
opening (e.g. aldose 1-epimerase), proton abstraction/readdition (e.g. D-ribulose-5-phosphate 3-
epimerase), nucleotide elimination (e.g. UDP-N-acetylglucosamine 2-epimerase), carbon-carbon 
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bond cleavage (e.g. L-ribulose-5-phosphate 4-epimerase), and transient keto intermediate (e.g. 
UDP-galactose 4-epimerase) (Table II.4). These latter two mechanisms will be further outlined in 
the literature part on L-ribulose-5-phosphate 4-epimerase (see 3.2) and UDP-galactose 4-
epimerase (see 3.3), respectively. These two C4-epimerases will be discussed in further detail as 
they are applied in this research project. More details on the mechanisms for epimerization can 
be found in the following reviews [5, 112, 226, 251]. 
 
Table II.4 Mechanistic types of epimerization (adapted from [5]) 
Epimerization mechanism Example enzyme Epimerization site 
Mutarotation or ring opening aldose 1-epimerase C1 
Proton abstraction/readdition D-ribulose-5-phosphate 3-epimerase 
tagatose/psicose 3-epimerase 
GDP-4-keto-6-deoxy-D-mannose epimerase/reductase 
dTDP-6-deoxy-D-xylo-4-hexulose 3,5-epimerase 
C3 
C3 
C3, C5 
C3, C5 
Nucleotide elimination UDP-N-acetylglucosamine 2-epimerase 
N-acyl-D-glucosamine 2-epimerase 
C2 
C2 
Carbon-carbon bond cleavage L-ribulose-5-phosphate 4-epimerase C4 
Transient keto intermediate UDP-galactose 4-epimerase 
ADP-L-glycero-D-mannoheptose 6-epimerase 
CDP-tyvelose 2-epimerase 
C4 
C6 
C2 
 
As can be seen in Table II.4, two epimerases active on the C4-stereocenter have been found 
in nature until now. As a C4-epimerization is the desired reaction, these two enzymes will serve 
as a template for enzyme engineering. Therefore, both the L-ribulose-5-phosphate 4-epimerase 
(3.2) and UDP-galactose 4-epimerase (3.3) will be discussed in further detail now. 
3.2. L-ribulose-5-phosphate 4-epimerase 
3.2.1. General 
The bacterial L-ribulose-5-phosphate 4-epimerase (EC 5.1.3.4, AraD) is one of the enzymes 
that enables many bacteria to use L-arabinose as a source of energy by coupling the L-arabinose 
pathway to the pentose phosphate pathway [5]. The gene is located in the araBAD operon and, 
together with L-arabinose isomerase (AraA) and ribulokinase (AraB), it metabolizes L-arabinose 
into D-xylulose-5-phosphate which is subsequently taken up in the pentose phosphate cycle 
(Figure II.11). Other genes involved in this pathway are araC, araE and araFG which are 
necessary for gene regulation, low-affinity and high-affinity transport, respectively [157]. 
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Figure II.11 L-Arabinose pathway in E. coli 
 
In E. coli, two other homologous L-ribulose-5-phosphate 4-epimerases are expressed 
besides AraD, namely the gene products from sgbE and ulaF. These two enzymes also catalyze 
the same reaction but are differently induced, making them active in other pathways. Whereas 
the gene product for araD is expressed in L-arabinose catabolism, SgbE and UlaF are active in 
the degradation of L-lyxose and L-ascorbic acid, respectively. All three epimerases reversibly 
interconvert L-ribulose-5-phosphate and D-xylulose-5-phosphate by inverting the configuration 
of the hydroxyl group at the C4-stereocenter via the same mechanism with the use of a divalent 
metal ion (Figure II.12). 
3.2.2. Mechanism 
As the L-ribulose-5-phosphate 4-epimerase epimerizes a stereocenter that does not bear an 
acidic proton, it cannot apply a simple deprotonation/reprotonation mechanism. Furthermore, it 
was proven that no NAD+ cofactor is involved in the reaction and the oxidation/reduction 
mechanism is thereby excluded. Initially, two mechanisms were proposed for this enzyme, 
namely an aldolase/retroaldolase mechanism applying a carbon-carbon bond cleavage and re-
addition or a dehydratation/rehydratation mechanism in which an enone intermediate is formed 
[74]. Extensive research provided clear evidence for the retroaldolase/aldolase mechanism which 
is describe in more detail below. 
 
Despite the low sequence identity between L-ribulose-5-phosphate (L-Ru-5-P) 4-epimerase 
and L-fuculose-1-phosphate aldolase (FucA), the structural resemblance is striking. The L-
fuculose-1-phosphate (L-Fuc-1-P) aldolase is the best characterized example of the class II 
aldolases and catalyzes the condensation of L-lactaldehyde and dihydroxyaceton phosphate into 
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L-fuculose-1-phosphate or the reverse cleavage reaction [120]. For the aldolase, conserved 
residues include three histidines (His92, His94, and His155) and a glutamate (Glu73) which are 
necessary for binding zinc into the metallo-enzyme. These four residues are structured in more or 
less tetrahedral position around the metal ion. Upon binding of the substrate, the bond between 
the glutamate and zinc ion is broken and L-Fuc-1-P is positioned towards the zinc ion with its 
carbonyl function as well as the hydroxyl group at the C3-stereocenter. The now liberated acidic 
moiety of the glutamate residue, subsequently deprotonates the hydroxyl group at the C4-
stereocenter and hereby initiates the cleavage of the carbon-carbon bond between C3 and C4. In 
this manner, L-lactaldehyde and the metal bound enolate of dihydroxyaceton phosphate (DHAP) 
are formed. After cleavage, the acidic form of Glu73 will protonate the enolate intermediate in 
order to form dihydroxyaceton phosphate (Figure II.12a). 
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Figure II.12 Comparison between the mechanisms of (a) L-Fuc-1-P aldolase and (b) L-Ru-5-P 4-epimerase 
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The strong structural similarity suggested that L-Ru-5-P 4-epimerase and L-Fuc-1-P aldolase 
belong to the same superfamily or have evolved from a common ancestor [251]. Furthermore, it 
provided a first provisional evidence that the epimerase applies the retroaldolase/aldolase 
mechanism. Evidence that supports this relatedness was provided by mutagenesis of some of the 
conserved residues in L-Ru-5-P 4-epimerases, namely His95, His97 and Asp76. Residues were 
mutated towards asparagines and the resulting enzyme variants exhibited a reduced epimerase 
activities, in the range of 3-200-fold reduction. More importantly, enzyme variants also showed 
reduced affinity for divalent zinc ions, and thus require exogenous Zn2+ for full activity. This 
demonstrates their importance in catalysis, namely via their role in binding of the divalent metal 
ion. Further sequence alignments of the epimerase and aldolase suggests His171 to be the fourth 
zinc binding residue. However, this hypothesis remains to be tested by mutagenic studies [120].  
 
For the epimerase, the initial retroaldolase cleavage of the L-Ru-5-P results in the enolate of 
dihydroxyaceton (DHA) and glycolaldehyde phosphate (GAP) as enzyme bound intermediates. 
In the epimerase, the protonation of the enolate intermediate is not promoted by acid/base 
catalytic residues. In this case, the formed aldehyde turns around in the catalytic cleft facing its 
opposite side towards the enolate, which is then followed by the reverse reaction, namely the 
aldol condensation. As a result of the condensation at the other side of the aldehyde, D-xylulose-
5-phosphate is formed resulting in an overall epimerization at C4 (Figure II.12b). Acid/base 
catalysts responsible for this difference were found to be an aspartic acid (Asp120) and a tyrosine 
residue (Tyr229) rather than the Asp76 which corresponds to the Glu73 in the aldolase [148, 
225]. 
 
The overall structural similarity and common metal-binding motif are insufficient to prove 
that both enzymes use the same or a very similar reaction mechanism. This was evidenced by the 
fact that both the wild-type epimerase and its D76N variant catalyzed the aldol condensation of 
dihydroxyaceton and glycolaldehyde phosphate to form a mixture of both L-Ru-5-P and D-
xylulose-5-phosphate [120]. In addition, 13C and deuterium isotopic effect measurements both 
ruled out the dehydration mechanism and conformed epimerization via the retroaldolase/aldolase 
mechanism [149]. Finally, the solving of the epimerases structure by means of X-ray 
crystallography showed more resemblances between both enzymes and gave more insights in 
acid/base catalysts for the epimerase. Overall structural features and important residues and 
motifs, like metal binding motif, acid/base catalysts, phosphate binding site, are described in the 
next paragraphs. 
36 
 
3.2.3. Structure 
3.2.3.1. Tertiary and quaternary structure 
The crystal structure of the Escherichia coli L-ribulose-5-phosphate 4-epimerase was solved 
by X-ray crystallography (Figure II.13a). Like the L-fuculose-1-phosphate aldolase, this enzyme 
consist of four identical subunits and displays a C4 symmetry. Each subunit consists of 231 
amino acids resulting in a molecular weight of 25.5 kDa per subunit, and thus a total mass of 102 
kDa for the tetramer. Each subunit contains one single domain with a typical α/β fold. In this 
fold, a central β-sheet formed by nine β-strands is sandwiched by two layers of α-helices. The 
smaller layer consist of three helices (a2, a5 and a6), whereas the other five helices shape the 
larger layer (a1, a3, a4, a7 and a8). The β-sheet is predominantly antiparallel except between b7 
and b8. At all four subunit interfaces, a zinc ion is present which is necessary for catalytic 
activity. Residues from both adjacent subunits contribute to the active site clefts [166].  
 
(a) (b)  
Figure II.13 (a) Overall structure of the L-ribulose-5-phosphate 4-epimerase tetramer (Adapted from [166]) (b) 
Comparison of the monomer of the epimerase (left) and the L-fuculose-1-phosphate aldolase (Adopted from [251]) 
 
Even though the sequence identity between both enzymes is only 26 %, both enzymes 
display strikingly similar tertiary and quaternary structures. This is very clear when the enzymes 
subunit structures and tetrameric structures are superimposed (Figure II.13b). For subunits, 93 % 
of the α-carbon atoms overlap with standard deviation of only 1.5 Å, whereas the overlay of the 
tetrameric structures results in an α-carbon atoms overlap with 1.9 Å standard deviation. 
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Furthermore, all secondary structure elements from the smaller aldolase are returning in the 
larger epimerase. The main difference is an additional α-helix in the smaller α-helix layer of the 
epimerase. Smaller differences are a longer α-helix a6 and a 310-helix instead of the α-helix a4 in 
the epimerase. Despite the subtle difference between a 310-helix and an α-helix, this difference is 
likely to affect its contribution to catalysis as this helix participates in active site formation [166]. 
In the crystal structure, the first 223 residues of each subunit are ordered, whereas the latter eight 
residues (224-231) are undefined indicating a highly flexible loop. As postulated for the aldolase, 
the epimerases loop is most likely also able to close the active site [166]. The importance of this 
loop is supported by mutagenic studies of the Tyr229’ residue which is part of this loop. 
Mutagenesis of the tyrosine towards a phenylalanine resulted in a dramatically decreased 
activity, more specifically 1700-fold slower [148, 251]. 
3.2.3.2. Cation (zinc) binding site 
As was earlier stated, three conserved histidine residues (His95, His97 and His 171) are 
ligands for binding of the zinc ion. In the aldolase the Glu73 serves as fourth ligand, however in 
the epimerase this residue is replaced by a shorter but topological variant, namely Asp76. Due to 
the shorter side chain of the aspartate, the Asp76 cannot act as the fourth Zn2+ binding ligand. A 
water molecule positioned in front of the Asp76 will serve as the Zn2+ binding ligand (Figure 
II.14) [166]. However, the amount and exact positioning of water molecules remains unclear as 
three waters (octahedral: 3 times His, 3 times water) were observed in EPR spectrum of Mn2+ 
substituted epimerase [148]. On one hand, changing metal ion could influence ligand 
coordination and on the other hand both Zn2+ and Mn2+ are able to accommodate both 4 
(tetrahedral) and 6 (octahedral) ligands in their coordination sphere [166]. 
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Figure II.14 Electron density map of the cation binding site of L-Ru-5-P 4-epimerase shows that the three conserved 
histidines interact with the Zn2+, whereas a water molecule is needed to link the aspartate to the zinc ion (Adopted 
from [166]) 
 
3.2.3.3. Substrate binding site and potential catalytic acid/base residues 
As mentioned earlier, the L-Ru-5-P 4-epimerase and L-Fuc-1-P aldolase are evolutionary 
related and share some common features, such as structure, divalent cation as cofactor and are 
able to deprotonate a hydroxyl group of a phosphoketose at the C4 position. Despite these 
striking similarities, these enzymes catalyze different reactions and act on distinctly 
phosphorylated substrates, at C1 and C5 for the aldolase and epimerase, respectively. Therefore, 
significant differences between residues involved in substrate binding and/or activity are 
observed when comparing both enzymes [225]. Based on sequence alignments between both 
enzymes, residues were chosen that could play a possible role in substrate binding and/or might 
serve as catalytic acid/base residues [166]. Mutagenic studies were performed to determine the 
influence of amino acid substitutions on affinity and activity of the epimerase activity [225]. By 
these studies, the residues that play an important role in substrate binding and reaction 
mechanism (acid/base catalysts) could be indicated with high probability. 
Substrate/Phosphate binding site 
Among the conserved residues are some amino acids that are known to be of importance or 
show potential for phosphate binding, among which are Asn28, Ser44, Gly45, Ser 74 and Ser 75 
(Figure II.15) [166]. Besides these five residues that are conserved among both enzymes, a 
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conserved lysine is found among epimerases, namely Lys42. Site directed mutagenesis of Asn28 
and Lys42 revealed their importance in substrate binding, as the N28A and K42M mutations 
drastically reduced affinity of the epimerase for L-Ru-5-P. The asparagine is expected to form a 
hydrogen bond with the phosphate moiety as was observed for its topological variant in the 
aldolase. The lysine in its turn is located just below the substrates phosphate and impairment with 
the substrate is achieved through electrostatic attraction between the positively charged lysine 
and negatively charged phosphate moiety. Its loss thus resulted in a much higher KM value [225]. 
 
(a)  (b)  
Figure II.15 Substrate binding site of L-Ru-5-P 4-epimerase. The catalytic site is formed within the cleft between 2 
adjacent subunits (grey and purple, respectively). The bound substrates are (a) L-Ru-5-P and (b) D-Xu-5-P and the 
red dotted lines connect the C4 hydroxyl group with the assumed deprotonation residue (Adopted from [225]) 
 
As the substrates of both enzymes are differently phosphorylated (C5 for the epimerase vs. 
C1 for the aldolase), a common phosphate-binding pocket means that the substrates are bound in 
a reversed or ‘flipped’ orientation. This further implicates that acid/base catalytic residues of 
both enzymes are different.   
Catalytic acid/base residues 
Based on a structural search, four conserved residues were pointed out to be potential 
acid/base catalytic residues. These residues are Asp76 and Glu142 from the subunit containing 
the zinc cofactor and Asp120’ and His218’ from the adjacent subunit [166]. The Asp76 is most 
likely to affect epimerization by providing a good bonding with the metal cofactor, whereas loss 
of the carboxylic group of the Asp120 resulted in a 3000-fold decrease in kcat and is thus likely to 
serve as a acid/base residue in epimerization. On the other hand, mutagenesis of the other two 
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residues (E142Q and H218N) only reduced activity by 9- and 24-fold, respectively. This rules 
them out as catalytic residues, nevertheless, they are important for activity and stability. The 
histidine is expected to assist Asp120’ in catalysis and in addition stabilize the active site through 
hydrogen bonding with the conserved Tyr141. Similarly, the glutamate interacts with Arg221’ 
from the adjacent subunit via a salt bridge and is thus likely to stabilize the active site interface 
[225]. Mutagenesis of a tyrosine (Tyr229’) in the flexible C-terminal end of the epimerase 
resulted in a 1700-fold decreased kcat value  and was therefore pointed out as the second 
acid/base residue [148]. Docking of the substrates into the enzymes structure predicts that 
Tyr229’ is responsible for L-Ru-5-P deprotonation and Asp120’ for deprotonation of D-Xu-5-P 
[225]. It is important to notice that residues from both subunits are needed for epimerase activity, 
either for substrate or cofactor binding or for catalysis. 
3.3. UDP-Galactose 4-epimerase 
3.3.1. General 
Uridine diphosphate galactose 4-epimerase, or UDP-Gal 4-epimerase or shortly GalE (EC 
5.1.3.2), is one of the enzymes in the Leloir pathway. This pathway is responsible for the 
conversion of galactose into glucose-1-phosphate with the help of four enzymes. At first, 
galactose mutarotase converts β-galactose into its α-anomer. Next, this α-galactose is 
phosphorylated by a galactokinase to produce galactose-1-phosphate. In the third step, galactose-
1-phosphate uridylyltransferase exchanges the uridylylgroup of UDP-glucose (UDP-Glc) onto 
the galactose-1-phosphate, hereby forming UDP-galactose (UDP-Gal) and glucose-1-phosphate. 
Glucose-1-phosphate will be metabolized further in glycolysis. Finally, UDP-Gal will be 
epimerized by UDP-Gal 4-epimerase for regeneration of UDP-Glc, which can then be applied in 
new cycles with the transferase (Figure II.16) [223]. In case of detrimental mutations in one of 
these enzymes, carriers will suffer from a disease called galactosemia. Vomiting, jaundice, and 
lethargy are early symptoms of this rare but deadly disease. Delayed complications include 
mental retardation, liver cirrhosis, renal failure, and cataracts [101]. Nevertheless, the disease can 
be easily prevented or treated by a galactose and lactose free diet. 
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On the other hand, UDP-sugars are also important as precursors in lipopolysaccharides 
(LPS). LPS is involved in several aspects of cell-cell interactions, such as host-pathogen 
interactions [110] and biofilm formation [187]. Apart from non-modified sugars, also N-
acetylated and carboxylated sugars are found in LPS [32, 83]. Consequently, the corresponding 
UDP-sugars have to be made by the cells and GalE-like UDP-sugars 4-epimerases are used for 
this purpose. The UDP-sugars 4-epimerase family consists of epimerase active on UDP-
Glc/UDP-Gal, N-acetylated forms (UDP-GlcNAc/UDP-GalNAc) [32], uronic acid forms (UDP-
GlcUA/UDP-GalUA) [83] as well as UDP-pentoses (UDP-L-Ara/UDP-Xyl) [137] or on 
combinations thereof [71, 110, 187]. Attempts have been made to elucidate the determinants for 
substrate specificity of UDP-sugars 4-epimerases as this can render information to use these 
epimerases as targets for new antibiotics and drugs [58]. Substrate specificity will be further 
discussed in part 3.3.4. 
 
The UDP-Gal 4-epimerases (and the other GalE-like UDP-sugar 4-epimerases) belong to 
the short-chain dehydrogenase/reductase (SDR) superfamily of proteins. These enzymes show 
great functional diversity and despite their lower sequence identities (typically only 15-30%) 
specific sequence motifs are detectable, reflecting their common folding patterns. SDRs are 
widely spread in nature and involved in different physiological processes such as normal and 
metastatic growth, hypertension and fertility [101]. 
3.3.2. Structure 
UDP-Gal 4-epimerases are formed as homodimers, and the E. coli monomer, for example, 
contains 338 amino acids resulting in a molecular weight of 37.3 kDa [5]. The human epimerase 
is slightly longer (348 amino acids) and its dimer weighs 76.6 kDa (2 times 38.3 kDa). Given 
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that UDP-Gal 4-epimerase is part of the big SDR superfamily, it displays some typical 
characteristics of this superfamily. As such, the SxnYx3K motif as well as the GxxGxxG motif 
are two of the encountered signature sequences [95, 261]. The SxnYx3K contains three conserved 
residues which play a key role in catalysis. The repetitive glycine motif is located in the 
Rossmann fold, which is typical for nucleotide binding enzymes, and the first 2 glycines 
participate in NAD+ binding whereas the third glycine facilitates close packing of the helix to the 
beta-strand [152]. 
 
 
Figure II.17 Overall structure of the UDP-GalNac 4-epimerase from Pleisomonas shigelloides. The N-terminal 
domain is a modified Rossmann fold binding the cofactor NAD(H), whereas the C-terminal domain binds the 
substrate UDP-GlcNAc. Strand numbering from N- to C-terminus, dashed lines represent a non-modeled loop 
(Adopted from [32]) 
 
Crystal structures of UDP-Gal 4-epimerases (GalE) from several sources have been 
determined using X-ray crystallography (Figure II.17). The crystal structure from the E. coli 
enzyme is further explained here. Two different domains are distinguished, namely a N-terminal 
nucleotide binding domain and a smaller C-terminal domain which is responsible for the correct 
positioning of its substrate, a UDP-sugar. The N-terminal domain comprises seven stranded 
parallel β-sheet which are flanked on both sides by α-helices and shape the Rossmann fold [257, 
259]. Two paired Rossmann folds tightly bind one NAD+ cofactor per subunit. In E. coli GalE, 
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the NAD+ interacts more extensively with the protein than was observed with other SDR 
enzymes. A total of 35 protein-NAD+ contacts was observed with distances up to 3.2 Å, of which 
seven were contributed by ordered water molecules, while other SDR enzymes showed 22-27 
contacts. This results in irreversible denaturation of the enzyme after removal of the cofactor 
[254]. However, the NAD+ cofactor could be removed from human GalE without denaturation. 
Here, fewer protein-NAD+ contacts were observed in the crystal structure, which explains the 
reversible character of cofactor binding [260]. The C-terminal domain is built from five β-strands 
and four α-helices. As the domains are necessary for the binding of the cofactor and the 
substrate, respectively, the active site is located between these two domains [257, 259].  
Determination of the structure of human UDP-Gal 4-epimerase, revealed an active site which 
was 15 % larger than that of the E. coli enzyme. A possible explanation was found in the 
secondary role of the human enzyme, namely epimerization of UDP-N-acetylgalactosamine 
(UDP-GalNAc). Activity on the larger acetylated substrates would require a larger active site [5, 
261]. 
3.3.3. Mechanism 
The GalE mechanism was already studied and broadly outlined in the 1970s [272, 273]. The 
first step after substrate binding is the abstraction of the hydroxylic proton at C4 by an enzymatic 
base and the transfer of a hydride from the C4 position of the sugar to NAD+ to form NADH and 
a transient keto sugar. Three important residues are located in the conserved SxnYx3K motif. At 
first, the tyrosine was postulated to be the enzymatic base responsible for deprotonation, as 
occurs in its phenolic form. The nearby lysine residue has a stabilizing effect on this phenolic 
tyrosine [162]. However, except for human GalE, the distance between this tyrosine and the 
sugar moiety of the substrate is too large (4.3 Å) to directly abstract the proton [256]. To 
overcome this distance, a proton shuttle is needed. In GalE, it is provided by the conserved serine 
from the SxnYx3K motif [255]. The enzyme retains the transient keto sugar by anchoring of the 
substrate by its UDP-group. Finally, the reverse of the first step occurs, namely the transfer of the 
hydride back to the C4 of the sugar. This is now transferred on the opposite face, resulting in the 
inversion of the configuration at C4 of the sugar. The proton that was extracted by the serine-
tyrosine proton shuttle is also transferred back to the sugar. A schematic overview of the 
mechanism is given in Figure II.18. 
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Figure II.18 Mechanism of UDP-galactose 4-epimerase 
 
A first important feature is the capability of the enzyme to bind the substrates sugar moiety 
in different positions. The substrate is mainly retained by the enzyme by interactions with the 
UDP-group, whereas only weak binding with the sugar moiety is observed. This led to the 
proposition of a rotation around the bond connecting the glycosyl oxygen atom and the β-
phosphorus atom in the pyrophosphoryl linkage. X-ray crystallography of inactivated enzyme 
(S124A/Y229F) that was crystallized with each substrate separately gave evidence of the rotation 
of the sugar moiety. Significant changes were also observed in the two dihedral angles that 
define the substrate configuration; a 130° rotation was observed for the angle delineated by the 
α,β-bridging oxygen, the β-phosphorus, the glycosyl oxygen, and the hexose C-1, whereas that 
delineated by the β-phosphorus, the glycosyl oxygen and the hexose C1 and C2 differ 30°. This 
mechanism is called ‘revolving door mechanism’ and is unusual in biology [5, 259]. 
 
A second important feature is the fact that the enzyme undergoes a conformational change 
upon binding of the UDP-sugar, which is in fact a result of the binding of the UMP-moiety of the 
substrate. The presence of the UDP-group in the substrate is thus not only necessary to increase 
the affinity of the epimerase for the glucose/galactose, but it also increases the reactivity of the 
enzyme-bound NAD+ cofactor by inducing a different protein conformation [272, 275]. Several 
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studies support this proposal; the enzyme oxidizes free sugars in the presence of UMP or UDP 
and occasionally releases the ketose intermediate into solution, leaving behind an inactivated 
enzyme containing NADH (E·NADH) [30, 34], and enzyme can be chemically reduced by 
treating it with NaBH4, under anaerobic conditions [161]. However, the resulting E·NADH is 
rapidly auto-oxidized in the presence of oxygen which indicates the importance of the uridine 
nucleotide in stabilizing the reduced enzyme. In addition, it has been shown that UMP and UDP 
lower the activation energy by 5.7 and 4.1 kcal mol-1, respectively [62, 161]. NMR studies with 
uridine nucleotide-dependent perturbation of the 31P, 13C and 15N provide further evidence for the 
postulated protein conformational change [42, 135]. The conserved lysine from the SxnYx3K 
motif plays an important role in the activation of the cofactor, as due to the conformational 
change, the 6-ammonium group is hydrogen-bonded to both the 2’- and 3’-hydroxylgroups of the 
nicotinamide riboside of NAD+. This results in a charge displacement from nicotinamide-N1 to 
nicotinamide-C4 which activates the NAD+ to attract a  hydride (Figure II.19) [256]. 
 
 
Figure II.19 Schematic representation of the activation of the GalE·NAD+ complex due to the conformational change 
induced by binding of UDP (Adopted from [226]) 
 
3.3.4. Substrate promiscuity 
As mentioned before, a variety of UDP-sugars 4-epimerases have been found with different 
substrate specificities and promiscuities (see 3.3.1). Among these were epimerases active on 
UDP-Glc/UDP-Gal [261], UDP-GlcNAc/UDP-GalNAc [32], UDP-GlcUA/UDP-GalUA (uronic 
acid form) [83], UDP-L-Ara/UDP-Xyl (pentoses) [137], or multiple of these substrates [71, 110, 
187]. As they are involved in different pathways and functions, such as protein glycosylation and 
production and secretion of virulence factors, these enzymes are possible targets for new 
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therapeutics. Therefore, it is of great importance to understand the molecular basis of substrate 
promiscuity and/or selectivity [71]. 
3.3.4.1. UDP-Glc/UDP-Gal and/or UDP-GlcNAc/UDP-GalNAc (N-acetylation of UDP-
sugars) 
Research conducted to substrate promiscuity of UDP-sugars 4-epimerases has mainly 
focused on the determinants that make the epimerases discriminate between non-acetylated and 
N-acetylated UDP-Glc/UDP-Gal. The discovery of the genuine UDP-GlcNAc 4-epimerase 
(WbpP) from Pseudomonas aeruginosa has led to a classification of UDP-hexose 4-epimerases 
into three groups with distinct substrate promiscuity [58]. Group 1 contains the 4-epimerases that 
exhibit a strong preference for non-acetylated substrates, such as E. coli GalE (eGalE), group 2 
members can epimerize both non-acetylated and N-acetylated substrates equally well, such as the 
human epimerase (hGalE), and group 3 epimerases are strongly specific for N-acetylated 
substrates, like the WbpP from P. aeruginosa [110].  
 
With the structural characterization of WbpP in the presence of both substrates, structures 
from all distinct groups were available for research to understand the structural determinants for 
substrate specificity [110]. Interactions between the enzyme and the substrate in the binding 
pocket were scrutinized, which has led to a structural model showing that only a limited number 
of residues predominantly contribute to the molecular basis for substrate specificity. In this 
model, the substrate-binding pocket is represented as a hexagonal-shaped box (Figure II.20), 
with the bottom formed by the nicotinamide ring of the cofactor and an open top to accommodate 
the ring-flipping movement during catalysis. Three of the six walls of the hexagonal box are 
formed by highly conserved residues: Ser142, Tyr166 and Asn195 in WbpP (Figure II.20 - 
yellow, blue and orange walls, respectively). The serine and tyrosine are part of the SxnYx3K 
catalytic triad. The other three walls (Gly102, Ala209 and Ser306 for WbpP) have been proposed 
to be key determinants for substrate specificity.  
 
The green wall is occupied by a bulky residue Tyr299 in eGalE, which is unable to catalyse 
the epimerization of acetylated substrates, whereas enzymes with a smaller residue are able to 
convert acetylated substrates. A cysteine is found in hGalE [261] and Yersinia enterocolitica Gne 
(yGne) [26], leucine in Campylobacter jejuni Gne (cGne) [27] and Ser306 in WbpP [23] (Figure 
II.20, green wall). Therefore, it was suggested that a wider binding pocket would allow both 
substrates to enter for catalysis, whereas a narrow one would limit catalysis to non-acetylated 
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substrates only and that the enzymes substrate spectrum could be predicted based on the 
sequence only [110]. This theory is supported by mutagenic studies of hGalE and yGne, as 
narrowing binding pockets size, by a C307Y and a C297Y mutant, respectively, resulted in 
significant loss of activity on acetylated substrates without affecting conversion of non-
acetylated substrates [26, 232]. However, reverse mutations challenge this theory, a Y299C 
mutation in eGalE resulted in significant loss of catalysis of non-acetylated substrates [258] and a 
S306Y mutation of WbpP totally abolished the activity of the enzyme [110]. It was suggested 
that broadening the binding pocket, might result in unproductive conformations of the non-
acetylated sugar moiety or that the tyrosine might have a role in catalysis itself. As such, the 
serine residue (S306) in WbpP could achieve a tighter binding pocket packing due to hydrogen 
bond formation with active-site water molecules to other residues in the wall of the hexagonal 
box, such as S142 and N195 [71, 110].  
 
 
Figure II.20 (a) A hexagonal box model was suggested as a representation of substrate specificity of UDP-hexose 4-
epimerases (b) The corresponding residues found in other types of  UDP-hexose 4-epimerases are indicated, including 
neighboring residues (adopted from [71]) 
 
Of the other hexagon walls, experimental data are available dealing with the fifth purple 
wall, namely the A209 in WbpP whereas more bulkier residues like asparagine or histidine are 
found at the equivalent positions in the other epimerases. This will partially or totally close the 
hexagonal box and hereby limit the ability to accommodate acetylated substrates [71]. An 
A209H mutant was made to check the effect of a re-introducing of a bulkier residue on activity 
on acetylated substrates. The mutation resulted in limited ability to epimerize acetylated residues 
and thus partially validates the predictions on this residues function [110]. This position was also 
mutated towards an asparagine, resulting in the A209N mutant. It was expected to change 
specificity from group 3 (preference for acetylated substrates) to group 2 (accept both acetylated 
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and non-acetylated equally well); however, it was found to enhance specificity for acetylated 
substrates, and this was accompanied by a lower catalytic efficiency. The effect is most likely 
arising from a hydrogen bond between the introduced asparagine and Gln201, which retains the 
asparagine in the open conformation. In group 2 members, the asparagine is known to swing 
back and forth, depending on whether or not the substrate is acetylated [71].  
 
The effect of residues in the third non-conserved wall was checked by two single mutants, 
G102K and Q201E, as well as the combined double mutant, G102K/Q201E, in the genuine 
UDP-GlcNAc 4-epimerase WbpP. Both single mutants showed slightly reduced activity on 
acetylated substrates and (almost) abolished activity on non-acetylated substrates. As a result of 
the introduction of both mutations at the same time, a salt bridge could be formed which resulted 
in a rescue of the activity for acetylated substrates, probably due to restoration of the slight 
distortion that was observed in both single mutants. The side chains of these residues were found 
not to be directly involved in controlling access of large substrates to the binding site, but seemed 
to be involved in establishing other interactions that keep the binding pocket more or less 
flexible. Flexibility is needed here to allow a proper positioning of the substrates into the cavity, 
and in this way avoid unproductive configurations [71]. 
 
Other residues that were targeted by site directed mutagenesis were the two serine residues 
that are located next to the catalytic serine, namely S143 and S144. The S143A mutation 
abolished activity on non-acetylated substrates, probably due to loss of the hydrogen bonding, 
whereas the mutant remained active on UDP-GlcNAc/UDP-GalNAc, as additional stabilizing 
interactions with the N-acetyl moiety are present. The second serine was mutated towards a 
lysine and this mutant (S144K) showed no activity at all, nor was dehydratase activity observed. 
This serine thus seems essential for activity; however, the exact function is yet unknown [71]. 
 
The availability of a second group 3 epimerase, the WbgU from Pleisomonas shigelloides, 
and its structure provided more information on the substrate specificity of epimerases in this 
group [32]. Despite the relatively low sequence identity among all three groups, the similarity of 
the enzymes’ tertiary structures is striking with an overall r.m.s.d. of the multiple structure 
alignment being 1.08 Å and variation is most pronounced at the C-terminal end. The model of 
the ‘297-308 belt’ was proposed to determine substrate specificity in group 3 members. The belts 
conformation supports (i) the formation of a hydrophobic cluster which interact with the methyl 
group of the N-acetyl moiety, (ii) a correct positioning of the Asn195, and (iii) orients the 
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substrate so the GlcNAc moiety will form hydrogen bonds with Ser143 and Ser144. Due to this 
belt and the resulting hydrogen bond network, the group 3 members have a distinct conformation 
at this region whereas the conformation of group 1 and group 2 enzymes is very similar. As a 
result, the S306Y mutation, which allows a switch from group 2 to group 1, forms steric clashes 
between the group 3 epimerases and their substrates which results in the observed loss of activity 
[32]. The importance and flexibility of the hydrogen bond network was evidenced by multiple 
single mutants as well as their combined double, triple and quadruple mutants [31]. 
3.3.4.2. UDP-pentose and UDP-uronic acid 4-epimerases 
As not only glucose and galactose, acetylated or not, are found in cell wall polysaccharides, 
there are more UDP-sugars and likewise more specificities for UDP-sugar 4-epimerases. As 
such, epimerases harboring activity on UDP-xylose (UDP-Xyl) or UDP-galacturonic acid (UDP-
GalUA) have been found in plants and bacteria [83, 137]. One UDP-glucose 4-epimerase from 
Pisum sativum (PsGalE) and two from Arabidopsis thaliana (AtGalE) have been found to 
possess activity on both UDP-Glc/UDP-Gal as well as the corresponding UDP-pentoses, UDP-
Xyl and UDP-L-arabinose (UDP-L-Ara). Despite the significant similarities with human GalE, 
the PsGalE failed to act on N-acetylated UDP-sugars, most likely due to the presence of a large 
‘gatekeeper’ residue (Val309) (cfr. Tyr in group 1 vs. Ser in group 2). However, the same 
‘gatekeeper’ allows a very low UDP-GlcNAc 4-epimerase activity in barley GalE [137]. 
Similarly, the UDP-galacturonic acid 4-epimerase from Klebsiella pneumonia shows a broad in 
vitro substrate specificity. It is capable of interconverting UDP-Glc/UDP-Gal and the acetylated 
forms thereof, although with a much lower activity than was observed for its wild-type substrate, 
UDP-GlcUA/UDP-GalUA [83]. However, no intense research has been conducted on the 
determinants for specificity and promiscuity of the UDP-substrates. 
 
In summary, the first proposed model, that of the hexagonal box, provides a good 
representation for determinants and interchangeability of the substrate specificity of group 1 and 
group 2 epimerases. A bulky residue (Tyr) in the green wall most likely indicates activity only on 
non-acetylated substrates, whereas epimerases with a small residue (Ser, Cys) are likely to 
possess activity on acetylated substrates. However, as also group 3 members contain this smaller 
residue here, a biochemical analysis is still necessary for confirmation to which group the 
enzyme belongs. A reason for this is also that interchangeability between group 3 and the other 
two groups is much smaller due to the presence of the ‘297-308 belt’ and the importance of the 
hydrogen bond network that are of great importance for activity and substrate specificity. Further 
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experiments are still needed for a proper understanding of the residues that determine substrate 
specificity in order to validate and strengthen the current models, not only in specificity on 
substrate with or without N-acetylation, but also on UDP-pentoses and uronic acid forms of 
UDP-sugars. 
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4 Enzyme Engineering 
4.1. Introduction 
Micro-organisms and their enzymes have been applied throughout the ages. The oldest and 
best known examples are beer brewing and production of cheese and wine. As enzymes are able 
to catalyze all kinds of chemical reactions, they become more and more available for industrial 
and household applications [197]. Nowadays, enzymes are available in different industries such 
as agriculture, bioenergy, biopharma, food and beverages, household care and many others [188]. 
  
Enzymes apply the same basic principles as conventional chemical catalysts. However, due 
to their more intimate interaction with the substrate, they have an exquisite control of enantio- 
and regioselectivity as well as stereochemistry [59, 197]. Other advantages of the use of enzymes 
in chemistry are the high activity and specificity rates (up to 1017-fold accelerations) [59], the 
sustainability of biocatalysts [197] and they often require less energy and raw material 
consumption as well as generate less waste and toxic side-products [4]. Biocatalysis can thus be 
considered as a form of green chemistry [197]. However, not many enzymes meet the needs of 
industrial or academic chemists as they are more interested in converting unnatural substrates, 
and this in many cases under conditions that are not favored by the enzymes, like high 
temperatures and in the presence of solvents [38]. A good industrial biocatalyst should combine 
high activity and specificity with great enantioselectivity and, on top of that, should be able to 
deal with the harsh conditions of industrial processes [38]. The major drawbacks of many natural 
enzymes are narrow substrate specificity, small pH and temperature optima, and low pH and 
temperature stability [197]. Another problem can be that no enzyme is available in nature to 
catalyze the desired reaction. Here, enzyme engineering can be applied to overcome these issues. 
Furthermore, chemical modification of enzymes can also improve their stability, for example via 
immobilization and/or cross-linking [43, 45, 46, 69, 234, 235]. 
4.2. Enzyme engineering and its types 
Enzyme engineering is the technique of modifying an enzyme's structure, and thus its 
function and characteristics, and/or its catalytic activity towards natural and/or new substrates. 
Successful enzyme engineering will result in an improved biocatalyst harboring the desired 
characteristics. Several characteristics of the biocatalyst can be improved, such as catalytic 
efficiency (or reaction speed), reaction conditions (improved pH or temperature optimum and 
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stability), as well as the enzyme’s selectivity [39]. The latter can be subdivided in 
chemoselectivity, regioselectivity and enantioselectivity referring to substrate promiscuity and 
acceptance, and discrimination of stereoisomers which is of great importance in pharmaceuticals 
(cfr. softenon), respectively. 
 
 
Figure II.21 Comparison of rational protein design and directed evolution. In rational design, mutants are created 
based on available information, such as protein structure. Each variant is expressed, purified and analyzed for 
desired properties. On the other hand, mutagenesis in directed evolution is achieved at random. Protein libraries are 
then usually screened in microtiter plates using previously set selection parameters or in a selection system (not given 
in this figure). Newly gained information based on desired and negative mutants can be used in new round of 
mutagenesis and found mutants can be used as new templates for further improvements (Adopted from [40]) 
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All types of enzyme engineering follow the same pattern, namely a mutagenesis step 
followed by an identification step [39]. In the first step, changes are made at DNA-levels in order 
to generate genetic diversity. Secondly, the library is tested to identify whether improved variants 
were created. These two distinct steps are typically applied in an iterative fashion in order to 
fully optimize the biocatalyst to perform the desired function according to the specified criteria 
[12]. In many ways, the identification step is the most challenging, as without an efficient 
identification strategy, the ability to identify improved variants is fairly low.  
 
Several techniques have been developed to introduce mutations in the corresponding gene. 
In general, the type of enzyme engineering is determined by the type of mutagenesis. When 
mutations are made at random, the engineering is called Directed evolution, whereas Rational 
design deals with directed mutagenesis mainly based on structural and functional insights (Figure 
II.21). These different enzyme engineering techniques will be discussed here, including some 
possible mutagenesis techniques. Afterwards, the difference between selection and screening will 
be clarified. 
4.2.1. Rational design 
When rational design is applied, only specific mutations are made through site directed 
mutagenesis (SDM), or the replacement of one residue by another. It is mostly applied to identify 
important residues, for example for catalysis or specificity, or to conform a proposed hypothesis, 
like a proposed mechanism. In order to use rational design to improve a biocatalyst via enzyme 
engineering, a very good understanding of the enzyme is needed at different aspects, such as 
structure-function relationship of residues, preferably a 3D-structure, the reaction mechanism 
and/or determinants for substrate specificity.  
4.2.2. Directed evolution 
In contrast to rational design, directed evolution does not require any knowledge on 
mechanism or structure as mutations are incorporated at random. It can in fact be seen as a mimic 
of natural or Darwinian evolution in a lab scale timeframe [197]. Generation of mutant libraries 
can be achieved in two manners, namely asexual or sexual. In asexual evolution, mutagenesis is 
applied on preferentially one parental gene encoding the template protein. The most applied 
system is error-prone PCR (epPCR), which exploits the fact that DNA polymerases occasionally 
make errors during replication [208]. To increase error rate, unbalanced dNTP concentrations can 
be used or MnCl2 can be added to the PCR mixtures [39]. However, despite the ease of these 
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methods, they resulted in a mutational bias favoring replacements of As and Ts. Today, 
commercial kits are available containing a mix of two mutator polymerases in order to overcome 
the bias (e.g. GeneMorph II Random Mutagenesis Kits (Stratagene)). On the other hand, sexual 
evolution starts with a pool of homologue parental genes, which are then ‘shuffled’ to obtain 
chimers of two or more parent genes, which are then tested for improved variants [185, 241, 
242]. 
 
A major disadvantage of directed evolution is that very large libraries are created, which 
results in a lot of screening effort, and only shows a limited success rate. Therefore, nowadays 
researchers try to minimize mutant libraries on the one hand and try to increase the quality of 
libraries on the other hand [167]. It thus combines rational design and directed evolution and is 
called semi-rational design. 
4.2.3. Semi-rational design 
In semi-rational design, structural information is combined with random elements to achieve 
high quality libraries [167]. Residues that were selected based on structural insights or that were 
found by random approaches can be saturated by site saturation mutagenesis (SSM). In contrast 
to SDM, in SSM the targeted residue is replaced by all other possible residues using a 
degenerated primer. Saturations can be applied in an iterative fashion to accumulate beneficial 
effects of single mutants (iterative saturation mutagenesis, ISM) or multiple residues can be 
targeted simultaneously to obtain synergetic effects (CASTing, combinatorial active site 
saturation test) [38]. Other optimizations of mutant libraries are achieved by using different 
degenerates codons, like NDT (12 codons, 12 amino acids) instead of NNS or NNK (32 codons, 
20 amino acids) [212] and the use of computational approaches [11, 48, 127]. 
4.2.4. De novo protein design 
Besides the engineering of existing proteins, research is also performed to create totally 
novel proteins by de novo protein design. Here, biocatalysts are not engineered starting from a 
natural protein but are created with the aid of the computational protein design methodology. The 
RosettaMath algorithm was developed by David Baker’s group and is used to create idealized 
active sites, for the introduction of additional functional groups, and to search for appropriate 
protein backbones [216]. The algorithm has been applied in the creation of an enzyme catalyzing 
the Kemp elimination reaction, for which no natural enzyme exists, [221] and the de novo design 
of a retro-aldolase [119]. Despite the enormous value and potential of de novo design, the de 
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novo created enzymes are not ideal biocatalysts and further optimization is needed both for the 
created catalysts as for the computational method. Catalyst optimization is mainly done by 
general enzyme engineering techniques such as directed evolution and (semi-)rational design and 
analysis of these improved variants will generate additional knowledge to improve the design 
methodology [196]. 
4.2.5. Selection vs. Screening 
After the first step of creating mutant libraries, there is the need to identify improved 
enzyme variants, which can be achieved in two different ways. These methods should be specific 
and sensitive enough to identify positive mutants. The first method is called selection and applies 
the principle of Darwinian evolution or ‘survival of the fittest’ [196]. In case enzyme function 
can provide an advantage to the host, a library containing different variants of the enzyme is 
transformed into the selection host, which is then tested for growth on a minimal medium. If the 
mutant expresses an active enzyme variant, the strain will able to convert the provided carbon 
source into useful building blocks and energy to grow. As a result hereof, cells expressing good 
enzyme variants will overgrow the rest of the culture (inactive and slow mutants). Repetitive 
inoculation in fresh medium will further enrich the culture with the best mutant/variant which 
can then be isolated and tested for further confirmation. 
 
For the second method, called screening, each variant is tested individually for the desired 
reaction. Therefore, the library is transformed into an expression host and single colonies are 
transferred from solid medium to liquid medium. A major disadvantage of screening is that each 
mutant has to be tested separately, even those that are inactive, which is typically 50-80 % of a 
library [196]. A simple visual screening uses a colorimetric assay, via chemical or enzymatic 
reactions, to identify product formation. High throughput screening (HTS) refers to automated 
screening in miniaturized vessels in order to process large amounts of mutans [196]. 
 
4.3. Chemical modification of enzymes 
In addition to enzyme engineering, enzyme characteristics can also be modified by 
chemically modifications. As such, immobilization and/or cross-linking can enhance solvent and 
thermostability [45, 46], while imprinted cross-linked enzyme aggregates or iCLEAs have been 
shown to improve activity on natural and non-natural substrates [43, 69]. 
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5 Conclusion 
It is clear that the economical value of tagatose as well as other rare sugars is big. However, 
it still has a bigger potential when one compares the current tagatose market with its competitors. 
In 2006, about 4.6 and 11.9 million metric tons of refined sugars and corn-derived sweeteners 
were used in foods and beverages in the US market, whereas only 205,000 metric tons of other 
caloric sweeteners, like sugar alcohols, were used [17]. Still, global sales of non-sugar 
sweeteners in 2010 was worth $9.2 billion [18]. Nevertheless, seen the big difference between 
the current use of traditional and high caloric sweeteners and the low-caloric alternatives as well 
as the increasing number of obese and diabetic persons (163 and 16 million Americans in 2003, 
respectively [189]), the potential market and with it the economical value of low-caloric 
sweeteners (e.g.  tagatose) is huge. Despite this big potential, the current limiting factor to 
increase tagatose production worldwide is the lack of enough substrate (galactose) for the current 
production routes. A way to circumvent this problem is by tapping another substrate pool to 
make tagatose from cheap raw materials. Cheap and widely available alternatives would be 
fructose or glucose; however, no (bio)catalysts are available to directly convert these inexpensive 
and abundant sugars into tagatose. Multiple step approaches are available but due to the large 
number of steps, the overall conversion is low and several expensive purification steps are 
needed. Ideally, a C4-epimerase would be needed to convert fructose into tagatose or glucose 
into galactose, which can then be used as substrate in the current production routes. No such 
enzymes occur naturally, but enzymes that catalyze C4-epimerazations on similar substrates are 
available. These enzyme can be subjected to enzyme engineering in order to change their 
substrate specificity and make them active on fructose/tagatose or glucose/galactose. Here, the 
engineering of two C4-epimerases with respect to their potential in fructose to tagatose 
conversion will be described. These two enzymes are L-ribulose-5-phosphate 4-epimerase and 
UDP-hexose 4-epimerase and they will need adaptation to accept free monosaccharides instead 
of phosphorylated or nucleotide-activated sugars, respectively. This thesis comprises the cloning 
and expression of the L-ribulose-5-phosphate 4-epimerase (chapter III), the development of a 
selection system for tagatose 4-epimerase activity and the application thereof (chapter IV and 
chapter V, respectively) as well as the development and use of a screening assay for the same 
purpose (chapter VI). Finally, it deals with the cloning, expression and characterization of the 
UDP-hexose 4-epimerase (chapter VII) and its mutational analysis (chapter VIII).   
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1 Introduction 
To date, biochemical production routes are available to produce all simple rare sugars [20, 
91], nevertheless, a lot of these biochemical steps are not very efficient or they have to start from 
substrates that are either too expensive or too scarce or in the worst case both of the above. 
Therefore, it would be interesting to create new biocatalysts that are able to convert widely 
available and cheap substrates into rare, but valuable products. Within the area of sugars, only 
seven monosaccharides (Glc, Gal, Man, Fru, Xyl, Rib and L-Ara) were considered to be present 
in significant amounts, whereas the other twenty hexoses and nine pentoses were described as 
rare sugars. Despite the fact that many isomerases and oxidoreductases are available for rare 
sugar production, only one epimerase (ketohexose 3-epimerase) is available that can be used 
therefore with economical viability [91], whereas some other epimerases that were found more 
recently, show some potential in rare sugar synthesis  (see literature review: chapter II sections 
1.2.3 and 1.3) [20]. 
 
We chose to engineer an existing 4-epimerase towards a tagatose 4-epimerase, therefore, the 
gene of the template epimerase – our starting point, L-ribulose-5-phosphate 4-epimerase from 
Geobacillus thermodenitrificans – had to be cloned into an expression vector. In this chapter, an 
inducible expression vector was made that is fully complementary with the 4 constitutive 
expression vectors (pCXhPxx) available at the Laboratory for Industrial Biotechnology and 
Biocatalysis (InBio) at Ghent University [1]. Subsequently, the cloning of this L-ribulose-5-
phosphate 4-epimerase gene into these pIXPtrc and pCXhPxx expression vectors is described. 
Then, recombinant expression of the gene is compared between all 5 expression vectors in two E. 
coli strains, namely XL10 Gold and BL21 (DE3). 
 
Furthermore, the L-ribulokinase gene (AraB) from E. coli K-12 MG1655 was cloned in this 
pIXPtrc vector and heterologously expressed in E. coli BL21 (DE3) cells. Next, the recombinant 
L-ribulokinase was purified and used in the production of L-ribulose-5-phosphate. After 
purification, the L-ribulose-5-phosphate is then used in the wild-type activity test of the 
recombinant G. thermodenitrificans epimerase. 
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2 Material & Methods 
2.1. Bacterial strains, growth conditions, plasmids and chemicals 
Geobacillus thermodenitrificans LMG 17532T was obtained from the Belgian Co-ordinated 
Collections of Micro-organisms (BCCM) and was grown at 55 °C on Tryptone Soya medium 
containing 15 g/L pancreatic digest of casein, 5 g/L papaic digest of soybean meal, 5 g/L NaCl, 
pH 7.3 and supplemented with 15 g/L of agar for solid media. Escherichia coli K-12 MG1655 
and the other E. coli strains were cultured at 37 °C and 200 rpm in Luria broth (LB) containing 5 
g/L yeast extract, 10 g/L tryptone, 10 g/L NaCl at pH 7.0 or LB agar plates (LB plus 10 g/L 
agar). For cultures of cells containing a plasmid, media was supplemented with 0.1 g/L 
ampicillin. 
 
E. coli XL10 Gold (Stratagene) and E. coli BL21 (DE3) (Stratagene) were used as a cloning 
strain and for recombinant expression, respectively, of both the L-ribulose-5-phosphate 4-
epimerase gene (araD) from G. thermodenitrificans and the L-ribulokinase (AraB) from E. coli 
K-12 MG1655. E. coli cells were made chemically competent using the Inoue method for heat 
shock transformation [224]. 
 
The pGEM-T vector system and pTrc99A expression vector were obtained from Promega 
and the Netherlands Culture Collection of Bacteria (NCCB), respectively, while the four 
pCXhPxx expression plasmids were developed earlier at the Laboratory for Industrial 
Biotechnology and Biocatalysis (InBio) at Ghent University [1, 65].  
 
Clone Manager Professional 8 (Sci Ed Software, USA) was used for designing primers and 
sequence alignments. Standard protocols were used for routine recombinant DNA methodology 
and nucleotide sequencing was performed by LGC Genomics (former Agowa Genomics, 
Germany). Primers were synthesized by Sigma, the High-Fidelity PCR Master mix used for gene 
amplification was obtained from Roche, while restriction enzymes and T4 DNA ligase were 
purchased from New England Biolabs. Kits for gel extractions, PCR purifications and plasmid 
isolation were obtained from Qiagen. All chemicals were obtained from Sigma Aldrich unless 
otherwise stated. 
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2.2. Construction of the expression vectors 
2.2.1. Construction of pIXPtrc 
The sequence encoding for the His-tag and linker in the pCXhP22 [1] was amplified by high 
fidelity PCR using a 50 µL PCR mixture containing 50 % (v/v) of High Fidelity PCR Master mix 
(Roche), 40 pmol of forward and reverse primer (Table III.1), 80 ng pCXhP22 as template and a 
standard PCR protocol as given in Table III.2. After amplification, the PCR fragment was treated 
with 10 U of NcoI and SacI each to prepare the fragment for cloning into a likewise treated 
empty pTrc99A vector (Pharmacia Biotech Inc.). DpnI (10 U) restriction enzyme was added to 
the restriction mixture as well in order to remove the PCR template. Ligation of the cut and 
purified fragments (QiaQuick PCR purification kit, Qiagen) was achieved by using a 3/1 
insert/vector ratio and 3 Weiss units of T4 DNA ligase at 22 °C for 1h. The ligation mixture was 
then transformed into E. coli XL10 Gold cells, the plasmid was purified and checked for 
correctness by sequencing. 
 
Table III.1 Primers for the amplification of the His-tag from pCXhP22, araD and araB from G. thermodenitrificans 
and E. coli K-12 MG1655, respectively. Restriction sites are underlined in the primer sequence 
Gene product Primer Sequence (5’→3’) Restriction site 
His-tag Fwd CCATGGGGGGTTCTCATCATCATC NcoI 
 Rev GAGCTCTCCCATATGGTCGAC SacI 
araD_Gt Fwd CTTAAGATGCTTGAGGAGCTGAAACGG AflII 
 Rev ACTAGTTTATTGTCCATAGTAAGCGTTTAC SpeI 
araB_Ec Fwd GGATCCCATGGCGATTGCAATTGGCCTC BamHI 
 Rev CTGCAGTTATAGAGTCGCAACGGCCTGG PstI 
 
2.2.2. Cloning the genes into pIXPtrc and pCXhPxx (Figure III.1) 
At first, genomic DNA (gDNA) was extracted from an overnight grown culture using the 
‘GenElute Bacterial Genomic DNA kit’ from Sigma. The protocol for Gram-positive bacteria 
was used for the gDNA from G. thermodenitrificans, while the Gram-negative protocol was 
applied to obtain the E. coli K-12 MG1655 gDNA. The araD and araB genes from G. 
thermodenitrificans and E. coli K-12 MG1655, respectively, were amplified from gDNA by high 
fidelity PCR using the primer pair listed in Table III.1. The PCR mixtures contained 25 µL of 
High Fidelity PCR Master mix (Roche), 40 pmol of forward and reverse primer and 8 % (v/v) 
DMSO in a total volume of  50 µl. The PCR cycling conditions are shown in Table III.2. 
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Table III.2 Standard PCR cycling conditions 
Cycles Time Temperature 
1 x 4 min 94 °C 
35 x 45 s 94 °C 
 45 s 55 °C 
 1 min/kb + 30 s 72 °C 
1 x 7 min 72 °C 
 
After amplification, the resulting fragment was purified and cloned into the pGEM-T vector 
according to supplier’s protocol. The ligation mixture was then transformed into competent E. 
coli XL10 Gold cells by a heat shock [224] and plated out on Luria Broth (LB) agar. Single 
colonies were then grown in liquid LB for plasmid extraction to both check the gene sequence 
and to propagate the gene fragments. Both pGEM-T plasmids were then cleaved using 10 U of 
the appropriate restriction enzymes (AflII/SpeI and BamHI/PstI for araD and araB, respectively) 
at 37 °C for 1 h. Subsequently, both genes were ligated in a similarly treated pIXhPtrc vector 
again using a 3/1 insert/vector ratio and 3 Weiss units of T4 DNA ligase at 22 °C for 1h. The 
resulting plasmids are called pIXhPtrc-araD and pIXhPtrc-araB, respectively, and were checked 
by sequencing. 
 
The araD gene was also cloned into the set of constitutive expression vectors that was 
created earlier at the Laboratory for Industrial Biotechnology and Biocatalysis (InBio) at Ghent 
University [1]. Therefore, the araD gene fragment was cleaved from the pIXhPtrc-araD vector 
using 10 U of both AflII and SpeI restriction enzymes, the 4 empty constitutive expression 
vectors were treated in the same way, and the fragments were connected using the same ligation 
condition as mentioned above. The constitutive expression vectors obtained after plasmid 
extraction were named pCXhPxx-araD. 
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Figure III.1: Cloning strategy for the construction of the inducible expression vector pIXhPtrc-araD 
 
2.3. (Optimization of) Recombinant enzyme expression 
The constructed expression plasmids were transformed into E. coli XL10 Gold and BL21 
(DE3) cells. A single colony was picked from each transformation and inoculated into 5 mL LB 
medium supplemented with ampicillin. After overnight growth, the culture was used as inoculum 
(2 % v/v) for an enzyme expression in 50 ml LB medium with ampicillin. The cultures were 
grown until the beginning of the exponential phase (OD600 ≈ 0.6) and subsequently 0.1 mM 
IPTG was added to the culture with the inducible expression plasmid to induce heterologous 
expression. Subsequently, all cultures were grown for another 6 h to express heterologous 
protein.  
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For the inducible expression system, the ideal amount of IPTG was checked by inducing 
recombinant protein with different amounts of IPTG. Fresh expression culture was grown until 
OD600 ≈ 0.6 and then 0.1 mM, 0.5 mM or 1 mM IPTG was added to the culture and growth was 
continued for another 6 h. Afterwards, 1 ml samples of the cultures were centrifuged for 5 min at 
14000 rpm and the obtained pellets were frozen at -20 °C.  
 
Crude enzyme extracts were obtained by chemo-enzymatic lysis of the frozen cell pellets 
containing the heterologously expressed enzyme. Therefore, frozen pellets were thawed on ice, 
dissolved in 200 µL of lysis solution (50 mM Tris-HCl pH 7.5, 1 mM EDTA, 4 mM MgCl2, 50 
mM NaCl, 0.1 mM PMSF and 1 mg/ml lysozyme) and lysis was achieved by 5 min incubation at 
room temperature. Insoluble fraction and cell debris were pelleted by centrifugation in a table top 
centrifuge at full speed and supernatant was transferred to a new tube. Both soluble and insoluble 
fractions were checked on SDS-PAGE and Western blotting with anti-His6 antibodies. 
 
The expression of the L-Ru-5-P 4-epimerase (AraD) was optimized by comparing 
expression from the inducible and constitutive vectors. Furthermore, expression was analyzed in 
E. coli BL21 and XL10 Gold, and finally IPTG concentration for induced expression was 
sampled with 3 different IPTG concentrations, namely 0.1 – 0.5 – 1.0 mM IPTG. For L-
ribulokinase (AraB) only expression in BL21 on the inducible expression vector was checked 
with 3 different IPTG concentrations (0.1 – 0.5 – 1.0 mM IPTG). 
2.4. L-Ribulose-5-phosphate production and purification 
L-ribulose-5-phosphate (L-Ru-5-P) was needed for the wild-type activity tests of the L-
ribulose-5-phosphate epimerase, therefore, the gene coding for the ribulokinase from E. coli K-
12 MG1655 was cloned into the pIXhPtrc expression vector and brought to expression in E. coli 
BL21 (DE3) as described above. Due to the presence of an N-terminal His-tag, the ribulokinase 
could easily be purified from the obtained cell extract by Ni-NTA chromatography according to 
the supplier’s protocol (ThermoScientific), with wash and elution buffers containing 20 mM and 
500 mM imidazole, respectively. After elution, the buffer from the purified ribulokinase was 
exchanged to 50 mM glycyl glycine buffer (gly-gly) using a Centricon YM-30 (Millipore). The 
protein concentration of the ribulokinase mixture was analyzed with the Pierce® BCA Protein 
assay kit (ThermoScientific). 
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The purified ribulokinase was then applied in the phosphorylation reaction of L-ribulose, 
similarly to the production described earlier by Anderson [7]. The L-ribulose had been made 
earlier by dehydrogenation of ribitol by De Muynck [66] at the Laboratory for Industrial 
Biotechnology and Biocatalysis (InBio) at Ghent University. For this reaction, equimolar 
amounts of L-ribulose, MgCl2 and ATP (30 mM each) were dissolved together with 50 mM KF, 
5 mM reduced L-glutathion and 12.5 μM EDTA in 40 ml of 50 mM gly-gly buffer pH 7.5. The 
phosphorylation reaction was initiated by addition of large amounts His-tag purified ribulokinase 
and performed at room temperature. The pH of the reaction was followed and maintained at pH 
7.5 by titration of NaOH as the phosphorylation of L-ribulose results in the acidification of the 
solution. 
 
Purification of the produced L-Ru-5-P was accomplished as described earlier by Anderson 
[7] and the potassium salt was obtained after barium precipitation with K2SO4  [238]. 
Summarized, after the reaction had stopped, acetic acid is added to a final concentration of 0.2 
M. Subsequently, the precipitate is filtered and the pH of the supernatant solutions set to pH 6.7 
with NaOH. The L-Ru-5-P is purified and separated from the nucleotides by addition of barium 
acetate to a concentration of 0.1 M, after which the precipitate is filtered off. The supernatant is 
acidified to pH 2.0 with HCl, and absorbance is checked at OD260 nm. Contaminants were 
removed by repetitive treatment with activated charcoal until OD260 nm had reached a minimum. 
The activated charcoal was removed by filtration and in each round smaller amounts of activated 
charcoal were used. After absorbance had reached its minimum, the solution was adjusted to pH 
6.7 with NaOH and 4 volumes of ethanol were added. This 80 % (v/v) ethanol mixture was then 
chilled overnight in ice water to precipitate the L-Ru-5-P. The precipitate is collected by 
centrifugation and washed twice with fresh and chilled 80 % (v/v) ethanol. The solution was 
poured off and the precipitate dried using a vacuum to remove traces of water and ethanol 
(SpeedVac, Savant). The resulting barium salt of L-Ru-5-P is quickly washed with water twice, 
before addition of equimolar amounts of K2SO4 to re-dissolve the L-Ru-5-P as potassium salt and 
precipitate the barium as sulfate. The BaSO4 precipitate was removed by filtration and a powder 
of L-Ru-5-P potassium salt was obtained by vacuum drying using a SpeedVac. 
2.5. HPLC analysis of L-Ru-5-P 
Two High Performance Liquid Chromatography (HPLC) methods were used to analyze the 
purity of the produced L-Ru-5-P. The first method applies an isocratic flow of 5 mM H2S04 over 
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an Aminex HPX‐87H column (Bio-Rad Laboratories) at 30 °C at a flow rate of 0.6 ml/min. The 
HPLC system (Varian Prostar) was composed of a Varian Prostar 410 auto sampler, a Varian 
Prostar 230 pump, a Varian Prostar 320 UV/Vis detector and a Varian Prostar 350 RI differential 
refractive index. The second method uses a similar HPLC system attached to a ELSD 2000ES 
detector (Alltech). The Hypercarb column (Thermoscientific) was incubated at 30 °C and the 
gradient used is given in Table III.3. Solvents A, B and C are milliQ water, 100 % acetonitril and 
15 % formic acid in milliQ water, respectively. 
 
Table III.3 Elution gradient profile of the Hypercarb sugar method 
Time (min) A (%) B (%) C (%) 
0 96 4 0 
5 92 8 0 
7 75 25 0 
10 75 25 0 
20 0 25 75 
22 50 50 0 
27 50 50 0 
30 96 4 0 
50 96 4 0 
 
2.6. Enzyme activity assays: in vivo and in vitro 
Activity of the recombinant L-Ru-5-P 4-epimerase is checked both in vivo and in vitro. For 
in vivo activity, the selection strain SelTag2 or SelTag3 (see chapter IV) was transformed with 
the pIXhPtrc-araD plasmid and its growth in L-arabinose minimal medium (L-AMM) was 
compared with that of the selection strain without the expression plasmid in the same medium. 
More details about the composition of the minimal medium and growth conditions are found in 
the Material & Methods section of chapter IV. 
 
For in vitro activity assays, the epimerization reaction was tested from L-Ru-5-P towards D-
Xu-5-P as was earlier described [63, 225]. The reaction mixture contained 25 mM gly-gly buffer 
pH 7.6, 5 mM D-ribose-5-P, 0.1 mM thiamine pyrophosphate, 0.3 mM of MgCl2, 0.15 mM 
NADH, 0.25 U/ml transketolase, 50 U/ml triosephosphate isomerase, 5 U/ml α-glycerol 
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phosphate dehydrogenase, 0.25 mM L-Ru-5-P (potassium salt). The reaction mixture was 
incubated at 37 °C for 10 min to remove impurities in the L-Ru-5-P by reaction with the coupled 
enzymes. The reaction was started by addition of 2 µg of purified L-Ru-5-P 4-epimerase to the 
reaction mixture (finally 200 µl) and followed by measuring the drop in absorbance at 340 nm. 
 
Affinity for L-Ru-5-P (Km) was determined using 12 different L-Ru-5-P concentrations from 
0.078 mM to 10 mM and results were plotted in a Lineweaver-Burk linearization for calculation. 
Thermostability of the enzyme was determined by measuring the half-life (t50) at 37 °C. Effect of 
Zn2+, Co2+ and Mg2+ concentration were determined by addition of different concentrations of 
these metal ions (0-0.5 mM) to EDTA treated enzyme. EDTA treatment performed as described 
earlier [74] and afterwards EDTA was removed by a wash step with 25 mM gly-gly buffer pH 
7.6 over a Amicon® Ultra 30K Centricons (Millipore). 
 
3 Results and Discussion 
3.1. Construction of the expression vectors 
3.1.1. Preparation of the pIXhPtrc vector 
High fidelity amplification of the sequence containing the coding sequence (CDS) of the 
His-tag and the multiple closing site of the pCXhP22 plasmid was successful, resulting in the 
amplification of a 156 bp fragment, as expected. The PCR fragment was then cloned into the 
pTrc99A vector as described in the Material & Methods section and the pIXhPtrc was obtained 
by plasmid extraction. Plasmid sequencing revealed that the cloning was successful and that no 
errors were introduced. Thus, an inducible expression vector – pIXhPtrc – complementing the 4 
constitutive expression vectors available at the Laboratory for Industrial Biotechnology and 
Biocatalysis (InBio) at Ghent University [1] – pCXhPxx – has been created successfully. 
3.1.2. pIXPtrc-AraD and pCXhPxx-AraD 
The high fidelity PCRs on the genomic DNA of G. thermodenitrificans and E. coli K-12 
MG1655 resulted in fragments of the expected length, namely 699 bp for araD and 1714 bp 
araB. Both amplified fragments were successfully cloned in the pGEM-T vector for propagation 
of the gene fragment. After plasmid extraction, both the araD gene fragment and ribulokinase 
gene were cloned in the inducible pIXhPtrc expression vector. Plasmid sequencing revealed that 
the ribulokinase gene had been correctly inserted into the inducible expression vector; however, 
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the plasmid containing the L-Ru-5-P 4-epimerase gene (araD) was found to possess a 5 
nucleotide insert between the His-tag and the gene. As this ‘cttaa’ insert results in a frame shift in 
the gene, it had to be removed first to be able to express the L-Ru-5-P 4-epimerase correctly. 
 
For the deletion of the ‘cttaa’ insert in the pIXhPtrc-AraD plasmid, a high fidelity and whole 
plasmid PCR was performed using the QuickChange® XL Site-Directed Mutagenesis Kit 
(Stratagene) according to supplier’s protocol and the deletion primers and cycling conditions 
mentioned in Table III.4 and Table III.5, respectively. After DpnI treatment and transformation, 
extracted plasmid was sequenced and this revealed that the insert had been removed and thus 
now the pIXhPtrc-AraD is correct for further work. 
 
Table III.4 Primers for the deletion of the ‘cttaa’ insert in pIXhPtrc-AraD (* indicates the position of the deletion) 
Primer Sequence (5’→3’) 
Deletion_Fwd GACGATAAGGATCCAACC*CTTAAGATGCTTGAGGAG 
Deletion_Rev CTCCTCAAGCATCTTAAG*GGTTGGATCCTTATCGTC 
 
Table III.5 Whole plasmid PCR cycling conditions for deletion of the ‘cttaa’ insert 
 
 
Subsequently, the AraD gene fragment was cloned into the 4 constitutive pCXhPxx 
expression vectors as mentioned in the Material & Methods section above. All 4 constitutive 
expression vectors were found to contain no errors and thus cloning was successful. 
3.2. Recombinant L-ribulose-5-phosphate 4-epimerase expression 
For high-throughput screening purpose, L-Ru-5-P 4-epimerase expression was checked 
under different conditions in order to determine ideal conditions for high enzyme concentration 
and activity. Since no substrate (L-Ru-5-P) was yet available to test the epimerization reaction, it 
was chosen to compare enzyme expression on SDS-PAGE. Both inducible and constitutive 
Cycles Time Temperature 
1 x 1 min 95 °C 
18 x 50 s 95 °C 
 50 s 60 °C 
 1 min/kb + 30 s 68 °C 
1 x 7 min 68 °C 
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expression resulted in an L-Ru-5-P 4-epimerase containing a N-terminal His-tag and linker with 
an overall calculated molecular mass of 29.4 kDa/subunit. 
 
At first, expression in E. coli BL21 and XL10 Gold cells using the pIXhPtrc-AraD vector 
was compared. Under the same conditions, higher recombinant protein concentrations were 
observed when expressing the enzyme in E. coli BL21. This observation is expected since E. coli 
BL21 is lacking the protease genes lon and ompT, therefore resulting in higher protein 
concentrations.  
 
Secondly, expression using the inducible and the constitutive vectors was compared against 
each other. Two times of induction were tested for the inducible expression vector, namely 
induction at the beginning of the exponential phase (OD600 ≈ 0.6) and induction from the start on. 
SDS-PAGE analysis and Western blotting revealed that recombinant enzyme concentration was 
correlated with the promoter strength of the constitutive vector used. The lowest L-Ru-5-P 4-
epimerase concentration was observed with the promoter 78, intermediate concentrations were 
seen with both P34 and P22, while the use of promoter 14 yielded the highest enzyme 
concentrations for the constitutive expression vectors. When comparing the inducible Trc 
promoter with the 4 constitutive promoters, induced enzyme expression is at least as high for the 
highest constitutive expression (P14). Furthermore, no big difference is observed for the time of 
induction of the pIXhPtrc-AraD vector. IPTG can be added both at the start of growth as well as 
in the beginning of the exponential phase, these conditions will be used for screening and 
enzyme production, respectively. 
 
Finally, the concentration of IPTG to induce the LacIq – Trc operator and promoter system 
of pIXhPtrc-AraD was sampled. Therefore, the influence of low (0.1 mM), intermediate (0.5 
mM) and high (1.0 mM) IPTG concentrations were determined. Since no big improvements were 
observed using higher IPTG concentrations, low IPTG concentration (0.1 mM) will be used. 
Under all of the above conditions, the L-Ru-5-P 4-epimerase was present in the soluble enzyme 
fraction, which is also a good indication since increased portions in the insoluble fraction would 
have led to loss of active enzyme in the form of aggregates or inclusion bodies. 
 
To summarize, recombinant expression will be achieved in E. coli BL21 cells using the 
inducible pIXhPtrc-AraD vector and induction by addition of 0.1 mM IPTG. For larger enzyme 
productions, cells will first be grown to OD600 ≈ 0.6, before inducing them with IPTG, whereas 
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for (high throughput) screening, IPTG will be added from the start on to minimize pipetting steps 
and workload. 
3.3. Ribulokinase production, L-ribulose-5-phosphate production and 
purification 
To easily obtain pure recombinant ribulokinase, it was expressed containing an N-terminal 
His-tag, resulting in a ribulokinase with a calculated molecular mass of 64.7 kDa/subunit (Figure 
III.2). In order to obtain high levels of recombinant ribulokinase, the production thereof was 
optimized in E. coli BL21 cells using the pIXhPtrc-AraB vector. The cells were grown until 
exponential phase was reached and then induced with 3 different IPTG concentrations (0.1 mM, 
0.5 mM and 1.0 mM IPTG). Levels of recombinant protein production were analyzed on SDS-
PAGE. Comparison of soluble and insoluble fraction clearly indicate that the recombinant 
ribulokinase is only present in the soluble phase. Since no great increase in recombinant protein 
content was observed by increasing IPTG concentrations, a larger scale ribulokinase production 
was achieved using 0.1 mM IPTG.  
 
 
Figure III.2 SDS-PAGE of the recombinant expressed ribulokinase and its His-tag purification. CE, cell extract; FT, 
flow through; W1-W3, Wash fractions 1-3; E1-2, Eluent fractions 1-2; Ins., Insoluble; M, Marker. 
 
Ribulokinase activity was first checked by performing the reaction as mentioned in the 
Material & Methods section on a small scale (10 ml). Since pH of the reaction mixture after 
addition of the purified enzyme gradually decreased, it indicates that the purified ribulokinase is 
active and could be used in a large scale production of L-Ru-5-P.  
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Large scale production of L-Ru-5-P was then achieved according to the protocol described 
earlier. After the acidification of the solution had stopped, extra ribulokinase was added to the 
reaction mixture to ensure maximal conversion. No further acidification was observed, meaning 
that the enzyme had not lost its activity but that the reaction had completed. The produced L-Ru-
5-P was subsequently purified as described earlier. However, the barium salt of L-Ru-5-P is 
obtained by this purification and was found to contain remainders of L-ribulose by HPLC 
analysis. Since the barium salt of L-Ru-5-P has low solubility in water, the L-ribulose could easily 
be washed away with water. After 2 wash steps, the barium was removed from the L-Ru-5-P by 
barium precipitation with K2SO4, leaving behind the potassium salt of L-Ru-5-P in solution. 
Barium sulfate could easily be removed by filtration and the L-Ru-5-P was obtained from the 
filtrate by vacuum drying. HPLC analysis showed that the produced L-Ru-5-P was now pure 
(Figure III.3). After purification and vacuum drying around 238 mg of L-Ru-5-P was obtained, 
which means that an overall production and recovery of 54 % (238 mg/438 mg) was achieved. 
 
 
Figure III.3 HPLC analysis (Aminex) of L-Ru-5-P K-salt (blue) and L-ribulose (red) 
 
3.4. Enzyme activity assays: in vivo and in vitro 
In vivo activity test is described in the next chapter at section 3.3. In vitro activity assay 
determined that the His-tagged purified epimerase had a specific activity of 1 U/mg. With a 
Lineweaver-Burk linearization, it was calculated to have a Km of 1.4 mM for L-Ru-5-P (Figure 
III.4). This is almost three times as high as the Km of the E. coli L-Ru-5-P 4-epimerase under 
similar conditions (22°C, pH 7.5, activated by 0.1 mM MgCl2) [148]. 
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The enzyme was found to have a half-life of slightly more than 1 day (24,3 h) at 37 °C 
(Figure III.5). Effect of metal ions revealed that the highest activity was found with 0.3 mM of 
Mg2+, while equivalent amounts of Co2+ activated the enzyme almost equally. Effect of the 
desired cofactor, Zn2+, could not be determined since zinc has an inhibitory effect on the coupled 
enzyme assay. Nevertheless, it is likely to have a similar activating effect as was found for the 
Aerobacter epimerase [74]. 
 
Figure III.4 Lineweaver-Burk linearization for L-Ru-5-P 4-epimerase 
 
Figure III.5 Inactivation of the L-Ru-5-P 4-epimerase at 37 °C 
Lineweaver-Burk linearization for L-Ru-5-P 4-epimerase
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4 Conclusion 
The His-tag, linker and multiple cloning site of the pCXhP22 plasmid for constitutive 
expression [1] was cloned successfully into the pTrc99A vector, resulting in the inducible 
expression vector pIXhPtrc. This pIXhPtrc vector is now fully complementary with the 4 
constitutive expression vectors that were already available at the Laboratory for Industrial 
Biotechnology and Biocatalysis (InBio) at Ghent University. Now, a set of 5 plasmids is 
available in which cloning can be achieved using the same restriction enzymes. Depending on 
the restriction enzymes used, one can add a short His-tag (NheI) or a longer His-tag with linker 
and enterokinase cleavage site (AflII) to the recombinant protein or express it as native protein 
(NcoI). Both His-tags are N-terminal and facilitate purification of the expressed enzyme by 
means of Ni-NTA chromatography. 
 
The L-Ru-5-P 4-epimerase gene from G. thermodenitrificans was successfully cloned into 
all 5 expression vectors. Heterologous expression was found to give highest recombinant enzyme 
concentrations in E. coli BL21 cells. Since expression using the inducible pIXhPtrc-AraD 
resulted in the highest L-Ru-5-P 4-epimerase concentrations, this vector will be used from here 
on and induction will be achieved by addition of 0.1 mM IPTG. Since no big difference was 
found between immediate induction and induction at OD600 ≈ 0.6, induction time will depend on 
the type of experiment. In case of high throughput screening (chapter VI), IPTG will be added 
from the beginning to minimize pipetting steps and chance on contamination, while for larger 
recombinant enzyme production cells will first be grown to the start of the exponential phase 
before induction. 
 
The ribulokinase gene from E. coli K-12 MG1655 was also successfully cloned into the 
inducible expression vector, resulting in the pIXhPtrc-AraB plasmid. Subsequently, the plasmid 
was transformed into E. coli BL21 cells for recombinant expression, resulting in a 64.7 kDa His-
tagged ribulokinase. This was then purified and applied in the production of L-Ru-5-P, starting 
from L-ribulose and ATP. After purification, around 238 mg of L-Ru-5-P (as potassium salt) 
could be obtained with an overall production and recovery rate of 54 %. The produced L-Ru-5-P 
was then used for the characterization of the epimerase. The enzyme has a Km value of 1.4 mM, a 
half-life at 37 °C of slightly more than 1 day and, as expected, it can be activated by metal ions. 
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IV. DEVELOPMENT OF A 
SELECTION SYSTEM FOR TAGATOSE 
4-EPIMERASE ACTIVITY 
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1 Introduction 
After correctly cloning the araD gene into the expression vectors, the next hurdle could be 
taken, namely the development of a selection strain which can be used to look for improved 
variants after mutagenesis has been applied on the G. thermodenitrificans epimerase gene. In a 
selection system, Darwinian evolution is applied to identify the best variant in a mutant library. 
As such, if an active (or improved) enzyme is expressed in the selection strain, this mutant will 
be able to consume the given carbon source (better) and have an advantage over all other mutants 
in the selection culture. Through this advantage the fittest in the mixture will finally overgrow 
the others, a classic example of Darwin’s theory of ‘survival of the fittest’ [60, 150]. 
 
In order to obtain a selection strain suitable for Darwinian evolution experiments, an E. coli 
strain had to be able to grow on the product of the tagatose 4-epimerase reaction and unable to 
grow on the substrate, nevertheless, it should be able to absorb the substrate. Since E. coli strains 
are natural fructose consumers and unable to use tagatose as carbon source, it was chosen to 
select for the reverse reaction. Uptake of tagatose in E. coli K-12 MG1655 is primarily regulated 
via the methylgalactoside transport system, mglABC [132]. As such, tagatose will be given to the 
cells as a sole carbon source and if the mutated epimerase is able to convert it into fructose, the 
cell will be able to grow and enrich itself in the culture medium. By means of inoculating 
enriched cultures into fresh medium, the best mutant will finally overgrow all inactive and less 
active variants and the plasmid can be obtained to identify this mutation. 
 
To prevent potential loss of the G. thermodenitrificans L-Ru-5-P 4-epimerase gene by 
recombination with homologue genes present in the E. coli genome, these homologous genes 
were removed by the method of gene disruption [61]. Three homologous genes are present in the 
E. coli genome, namely araD, ulaF and sgbE, all encoding a L-Ru-5-P 4-epimerase in different 
pathways. AraD, ulaF and sgbE are located in the L-arabinose operon for L-arabinose 
degradation, ulaAp operon for anaerobic L-ascorbate utilization and yiaKp operon for metabolism 
of L-lyxose and L-xylulose, respectively [126, 128]. It was chosen to create the selection strains 
using different E. coli strains as starting points. E. coli CGSC#10993 was chosen as this strain 
already contains 2 of the 3 knock-outs (KO) needed, namely full KO of the araBAD operon, thus 
loss of the araD gene, and the replacement of the ulaF gene by the kanamycin resistance marker. 
Furthermore this strain contained a lacZ deletion, lacks the operon for rhamnose degradation and 
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some other characteristics [15]. On the other hand, E. coli K-12 MG1655, of which the full 
genome is known, is seen as a standard E. coli [36]. In the CGSC#10993, only the sgbE gene has 
to be removed, whereas all three L-Ru-5-P 4-epimerase genes (araD, ulaF and sgbE) have to be 
removed sequentially. Selection strains are named SelTag for Selection strain for Tagatose 4-
epimerase activity. 
 
2 Material & Methods 
2.1. Bacterial strains, plasmids, growth conditions and chemicals 
Two strains were used as starting point for the creation of a selection strain for detection of 
tagatose 4-epimerase activity, namely E. coli CGSC#10993, which was obtained from the Coli 
Genetic Stock Center (CGSC) of the Yale University (USA), and E. coli K-12 MG1655 [36]. 
They were routinely grown at 37 °C and 200 rpm on LB medium (5 g/L yeast extract, 10 g/L 
tryptone, 10 g/L NaCl, pH 7.0) or LB agar plates (LB plus 10 g/L agar), supplemented with 0.1 
g/L ampicillin or carbenicillin. The inducible pIXhPtrc-AraD and constitutive pCXhPxx-AraD 
expression plasmids encoding the L-Ru-5-P 4-epimerase from G. thermodenitrificans were 
created earlier (chapter III). 
 
L-Arabinose, ampicillin, carbenicillin, chloramphenicol and kanamycin were purchased 
from Sigma-Aldrich. Taq polymerase and restriction enzyme DpnI were purchased from New 
England Biolabs and High-Fidelity DNA polymerase was obtained from Roche Applied Science. 
PCR primers were designed with Clone Manager Professional8 (Sci Ed Software, USA) and 
synthesized by Sigma. The Clone Manager Professional 8 software was also used for sequence 
alignments. 
 
The plasmids used for the creation of the selection strain by knock-out strategy, pKD3, 
pKD4, pKD46 and pCP20, were a kind gift from prof. R. Cunin (Laboratory for Microbiology 
and Genetics, Free University of Brussels, Belgium). pKD3 (CmR) and pKD4 (KmR) contain an 
FRT-flanked antibiotic resistance gene for chloramphenicol [67] and kanamycin (kan) resistance, 
respectively. The two helper plasmids, pKD46 (AmpR) and pCP20 (AmpR), carry the genes for 
the λ Red recombinase and the FLP recombinase, respectively. Both plasmids are low copy 
number plasmids and are easily curable through their temperature sensitive replicons. Therefore, 
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strains containing the pKD46 or pCP20 helper plasmids were grown at 30 °C, unless the strains 
had to be cured from these plasmids, in which case they were grown at 42 °C. 
2.2. Construction of the SelTag-strains by gene disruption 
Creation of gene knock-outs is accomplished by the method of gene disruption described 
earlier by Datsenko & Wanner [61]. In summary, a first helper plasmid containing the λ Red 
recombinase (pKD46) is brought in the cells and the recombinase is induced by growth on L-
arabinose. Subsequently, an antibiotic resistance gene flanked by two FRT sites (flippase 
recognition target) and DNA fragments homologous to the flanking of the target gene is brought 
in the cells. The recombinase will exchange the gene with the antibiotic marker (2.2.1) and 
correct integration can be tested by a simple PCR (2.2.2). After correct integration has been 
achieved, antibiotic marker can be removed by the flippase brought to expression by the second 
helper plasmid (pCP20) (2.2.3). If more genes have to be knocked out, the protocol can be 
repeated from the start. 
 
 
Figure IV.1 Schematic overview of the gene disruption strategy. H1 and H2 refer to the homology extensions, P1 and 
P2 refer to priming sites. Taken from [61] 
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2.2.1. Gene disruption 
At first, pKD46 was transformed into both E. coli CGSC#10993 and E. coli K-12 MG1655. 
The pKD46 plasmid carries the L-arabinose induced araC-PBAD promoter as well as the λ Red 
recombinase genes: γ, β and exo, whose products are called Gam, Bet and Exo, respectively. 
Gam inhibits the host RecBCD exonuclease V, in order to allow Bet and Exo to access DNA 
ends to promote recombination with the genomic DNA (gDNA). Transformants were then grown 
in 5 mL LB cultures supplemented with 0.1 g/l carbenicillin and 1 mM L-arabinose at 30 °C until 
OD600 ≈ 0.6-1.0. Subsequently, these cells were harvested by centrifugation and made 
electrocompetent by washing them 3 times with ice-cold distilled water and finally concentrating 
them up to 200 times. 
 
Secondly, PCR products that had been created by amplifying pKD3 and pKD4 with 
appropriate primers for recombination (see Table IV.1) and the PCR mixture and cycling 
conditions mentioned in Table IV.2 and Table IV.3, were digested with DpnI, gel purified and 
finally transformed into the pKD46 containing cells. Electroporation was achieved by using a 
GenePulser II (Bio-Rad), 2 mm cuvettes (Eurogentec), 50 μl of freshly made electrocompetent 
cells and 3 μl of PCR product. After electroporation, 1 ml of LB medium was added to the cells 
and incubated for 1h at 37 °C, before spreading them on LB-agar containing the appropriate 
antibiotics. This was done to select for cells with built-in CmR or KmR resistance gene in their 
gDNA. The resulting transformants were then tested with colony-PCR to ensure that the 
resistance gene had been introduced at the correct position in the gDNA. Meanwhile, cells were 
plated on fresh LB-agar and grown at 42 °C to cure them from the pKD46 plasmid. 
2.2.2. Verification by colony PCR 
Verification whether the resistance gene had been introduced at the correct position was 
performed by inoculating a fresh colony into a PCR mix containing 2.5 nmol of each control 
primer (Table IV.1), 0.2 mM dNTP mix, appropriate buffer and 0.5 U of Taq polymerase, with 
milliQ water up to 25 μl. The PCR program consisted of the following cycles: initial denaturation 
at 95 ° C for 4 min, 30 cycles of 95 °C (30 s), 58 °C (30 s) and 72 °C (1 min/kb) for 
amplification and final elongation for 7 min at 72 °C. PCR products were verified by 
electrophoresis using 1 % agarose gels. 
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Table IV.1 Primers used for gene disruption and control thereof. Primer sequences in capital letters are homologous (H1 and H2) to the flanking regions of the target genes, to 
create a place for recombination. The sequences in small letters are the parts homologous to the pKD3 and pKD4 helper plasmids, P1 and P2. 
Primer Sequence (5’→3’) 
Fw-o-sgbE-P1 GGAGATTATTCAGGCGCGGCGTTGGATTGAAGCGCGTATGCAGGAGGCTGGATTTATgtgtaggctggagctgcttc 
Rv-o-sgbE-P2 GCAAGGAACATATCAATTCGTAGTGCCGGGGCGATGAAGCCCCGGCGTGAGGGAcatatgaatatcctccttag 
Fw-sgbE-out GCCGGTTCTTTCCTGATTGAGATG 
Rv-sgbE-out TGGAAGCGGCGTTACAG 
Fw-o-AraD-P1 GCTTGAGTATAGCCTGGTTTCGTTTGATTGGCTGTGGTTTTATACAGTCAgtgtaggctggagctgcttc 
Rv-o-AraD-P2 CGATTTTGTAGGCCGGATAAGCAAAGCGCATCCGGCACGAAGGAGTCAACcatatgaatatcctccttag 
Fw-AraD-out * GCCAGAAGGAGACTTCTGTCCCTTG 
Rv-AraD-out * AAAGCGCATCCGGCATTCAACGCCTG 
Fw-AraD-out2 TAACCTGCAACGGCCCGTTGTC 
Rv-AraD-out3 GTATTACGGGTTTCGTCGCTAAG 
Fw-o-UlaF-P1 ATTGGGTGAAAGCGCGCATGGCGAAAGCGGGCATGGTGGAGGCGGCATAAgtgtaggctggagctgcttc 
Rv-o-UlaF-P2 GGAATTAGACCAGTTATCTCCCGAGGAAGGAAATTTCCGCAGCGCGTGTTcatatgaatatcctccttag 
Fw-UlaF-out TTGAGATGTGGAGCGAAACG 
Rv-UlaF-out TCGCTAGCACCAGGTATAAC 
* Since these primers were found to bind on multiple sites, a new pair of control primers was used (Fw-AraD-out2 and Rv-AraD-out3) 
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Table IV.2 PCR mixture for the creation of linear DNA 
for gene disruption 
Component Amount 
Pfu Ultra DNA polymerase 2.5 U 
10x Pfu Ultra HF AD buffer 1 x 
dNTPs 0.2 mM 
Primers 0.4 µM each 
Template: pKD3 or pDK4 50-100 ng 
Total 50 µl 
Table IV.3 PCR cycling conditions for linear DNA 
creation for gene disruption 
Cycles Time Temperature 
1 x 1 min 95 °C 
30 x 30 s 95 °C 
 30 s 60 °C 
 1 min/kb + 30 s 72 °C 
1 x 7 min 72 °C 
 
2.2.3. Elimination of the antibiotic resistance gene 
The pCP20 plasmid shows a thermal induction of the FLP synthesis and therefore the 
created CmR and KmR mutants were made electrocompetent and transformed with pCP20, and 
plated at LB-agar with ampicillin and placed at 30 °C. After growth, transformants were tested 
for loss of the FRT-flanked resistance gene with colony PCR as mentioned above. Finally cells 
were cured from the helper plasmid pCP20 by growth at 42 °C and then tested again with colony 
PCR and for carbenicillin sensitivity to confirm loss of pCP20. At last, verification fragments 
were amplified using a high fidelity polymerase, purified and sequenced as to confirm that the 
correct gene had been disrupted. Sequencing was performed by VIB Genetic Service Facility 
(Belgium) or Agowa (Germany). After the cells are cured from the pCP20 plasmid, cells are 
made competent again and transformed with pKD46 to prepare the disruption of another gene. 
2.2.4. Speeding up the gene disruption protocol 
Since three genes had to be removed from the E. coli K-12 MG1655 strain, we tried to 
speed up the gene disruption protocol. Optimization of the protocol was achieved by eliminating 
some of the labor intensive and time consuming steps. Instead of curing the strain from the 
pKD46 plasmid (growth at 42 °C) after a first gene was replaced with one of the antibiotic 
markers, the cells were grown at 30 °C and made competent to transform with a second linear 
DNA made with the second antibiotic marker. After good disruption of the second gene, the cells 
were cured from pKD46 and transformed with pCP20 to simultaneously lose both antibiotic 
markers. As such, the work and time of two curing steps as well as two rounds of competent 
making and transformation could be saved. 
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2.3. Growth tests on different minimal media 
2.3.1. Medium composition 
The minimal medium (MM) used in the growth test of the selection strains is an M9 based 
medium. Apart from 1X M9 salts (6 g/l Na2HPO4, 3 g/l KHPO4, 1 g/l NH4Cl, 0.5 g/l NaCl), the 
medium contains 20 mg/l proline, 1 mM thiamine-HCl, 0.1 mM CaCl2, 1 mM MgS04, 18 µM 
FeCl2 and 6.7 µM ZnCl2. To this, different sugars were added as a sole carbon source at a 
concentration of 20 g/l. As such, the created selection strains (SelTagN°) were tested for growth 
on L-Arabinose MM (L-AMM), Fructose MM (FMM) and Tagatose MM (TMM). IPTG and the 
appropriate antibiotics were added at concentration mentioned earlier for induction and 
prevention of plasmid loss and contamination, respectively.  
2.3.2. Wash and growth conditions 
For the growth tests of the SelTag strains, the strains with or without pIXhPtrc-AraD, were 
first grown in LB medium at 37 °C and 200 rpm. Cells were then harvested by centrifugation and 
washed twice with phosphate buffered saline (PBS; 8 g/l NaCl, 0.2 g/l KCl, 1.44 g/l Na2HPO4, 
0.27 g/l KH2PO4, pH 7.4) and then inoculated (2 % inoculum) into 3 ml of fresh minimal 
medium supplemented with IPTG and the necessary antibiotics. Cells were grown in a 24-
deepwell plate at 37 °C and 220 rpm. Cell growth was followed by measuring cell density (OD600 
nm).  
 
3 Results and Discussion 
3.1. Construction of the SelTag-strains by gene disruption 
Starting from 2 different E. coli strains, 3 selection strains were created that can be used for 
the selection of mutants bearing tagatose 4-epimerase activity. Starting from E. coli 
CGSC#10993, the SelTag1 strain was created by knocking out the sgbE gene and removal of the 
kanamycin resistance marker that was inserted at the position of the ulaF gene. Initially, this had 
happened by accident, but it triggered the idea of a possible speeding up of the gene disruption of 
the selection strain based on E. coli K-12 MG1655 (see paragraph 2.2.4 and 3.2). Using the same 
method of gene disruption, all three genes encoding an L-Ru-5-P 4-epimerase in E. coli K-12 
MG1655 (araD, ulaF and sgbE) had successfully been knocked-out (Figure IV.2). This mutant 
was named SelTag2. Due to the presence of repetitive parts in between the araA and araD genes 
in the E. coli K-12 MG1655 genome, a slightly bigger part of DNA (153 bp) had been knocked-
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out. Nonetheless, the removal of this extra DNA part should not be a problem for the selection 
strain as the removed part does not code for a gene and also the flanking araA gene stays intact. 
 
 
Figure IV.2 DNA fragments obtained after colony PCR on SelTag2 confirm successful gene disruption. Fragments 
obtained are around 264 bp, 414 bp and 326 bp, corresponding to the theoretical lenght of successful gene knock-outs. 
 
Due to problems of contamination in the selection cultures (see chapter V), it was later 
chosen to use the last ‘intermediate step’ of the creation of the SelTag2 strain as this strain still 
contained the kanamycin resistance gene at the position of the ulaF gene (ulaF::kan in SelTag3 
instead of ΔulaF in SelTag2). Due to the presence of an additional antibiotic, chances of 
contamination will decrease. By analogy with the 2 other strains, this one was called SelTag3. 
3.2. Speeding up the gene disruption protocol 
Since, both antibiotic resistance genes were deleted by the flippase at the same time, the 
optimizing of the gene disruption protocol was successful. In this manner, the work load and 
time of two curing steps (first pKD46, then pCP20) as well as two rounds of competent making 
and transformation (first pCP20, then pKD46) could be saved. This had resulted in speeding up 
the protocol for 2 gene disruptions by 2-3 days. Since this simultaneous removal of both 
antibiotic markers was successful, it would not be unlikely that more than 2 antibiotic markers 
could be removed at the same time as well. However, it would be best to have extra antibiotic 
markers to be able to select for disruption of a third, fourth, … gene, for instance a gentamycin 
resistance gene. With 3 antibiotic resistance genes, disruption of 3 genes following this 
optimized protocol would save twice the 2-3 days of work, or a full week. Since there is a small 
risk that an earlier introduced marker is replaced by a new one, it is important to plate the cells 
on medium containing all antibiotics. On the other hand, disruption of the correct gene is 
checked by colony PCR using gene specific primers as well, nevertheless, it can be good to 
check previous genes by colony PCR too. 
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3.3. Growth tests on different minimal media 
3.3.1. SelTag1 = E. coli CGSC#10993 ΔsgbE ΔulaF 
As expected, the SelTag1 strain was found to be unable to grow on tagatose (TMM) and on 
L-arabinose (L-AMM) since E. coli are naturally no tagatose consumers and, on the other hand, 
the full araBAD operon for L-arabinose degradation has been deleted, respectively. Surprisingly, 
the SelTag1 strain was also found to be unable to grow on fructose (FMM). The mother strain of 
this SelTag1, namely E. coli CGSC#10993, was also found to be unable to grow on fructose, 
which explains why the SelTag1 does not grow on fructose (Table IV.4). However, considering 
the mutations mentioned on the CGSC website for this strain, it would be expected that the E. 
coli CGSC#10993 strain would be able to grow on fructose. Nonetheless, the strain is most likely 
to harbor extra mutations than only those mentioned on the website, and seen the inability to 
grow on fructose, these mutations are likely to be found in fructose degradation pathways. Since 
SelTag1 is unable to grow on fructose, it cannot be used as a selection strain for the detection of 
tagatose 4-epimerase activity. Therefore, the creation of a new selection strain was started from 
the standard E. coli K-12 MG1655, which is known to grow on fructose. 
 
Table IV.4 Growth of the different strains on Fructose minimal medium (MM), Tagatose MM and L-Arabinose MM. 
Ability and inability to grow are indicated with + and – , respectively. The expectation of growth is given between 
brackets 
Strain L-AMM FMM TMM 
E. coli CGSC#10993 –  (–) –  (+) –  (–) 
SelTag1 –  (–) –  (+) –  (–) 
E. coli K-12 MG1655 +  (+) +  (+) –  (–) 
SelTag2 –  (–) +  (+) –  (–) 
SelTag2+pIXhPtrc-AraD +  (+) +  (+) –  (–) 
SelTag2+pCXPhxx-AraD +  (+) +  (+) –  (–) 
SelTag3 –  (–) +  (+) –  (–) 
SelTag3+pIXhPtrc-AraD +  (+) +  (+) –  (–) 
SelTag3+pCXPhxx-AraD +  (+) +  (+) –  (–) 
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3.3.2. SelTag2 (3) = E. coli K-12 MG1655 ΔaraD ΔsgbE Δula (ulaF::kan) 
The growth tests of the SelTag2 strain revealed that growth on L-arabinose had been made 
impossible, which is normal since one of the genes in the L-arabinose degradation pathway has 
been knocked out (Table IV.4). On the other hand, supplementation of this L-Ru-5-P 4-epimerase 
through the recombinant expression of the G. thermodenitrificans L-Ru-5-P 4-epimerase of the 
inducible or constitutive expression plasmids could undo the loss of the native L-Ru-5-P 4-
epimerase. On one hand, this confirms that the removal of the extra 153 bp DNA part is not 
deleterious for the nearby L-arabinose isomerase (araA) gene (cfr. 3.1). More importantly, this 
also confirms that the G. thermodenitrificans L-Ru-5-P 4-epimerase is expressed in an active 
form, which is a prime requirement for enzyme engineering. Furthermore, SelTag2 was able to 
grow on fructose and unable to grow on tagatose, making it useful as selection strain for the 
detection of enzymes harboring tagatose 4-epimerase activity. 
 
The same results concerning growth are expected for the SelTag3 strain, since it only differs 
from the SelTag2 strain at the position of the ulaF gene. It still contains the kanamycin marker 
here, instead of the deletion of this gene (ulaF::kan instead of ΔulaF). As such, the same growth 
curves were observed for the SelTag3 strain (E. coli K-12 MG1655 ΔaraD ΔsgbE ulaF::kan) 
compared to SelTag2 (E. coli K-12 MG1655 ΔaraD ΔsgbE ΔulaF). Like SelTag2, this SelTag3 
strain can thus also be used for selection towards a tagatose 4-epimerase. The advantage of 
SelTag3 over SelTag2 lies in the presence of a kanamycin resistance marker which can reduce 
the risk of contamination due to the presence of extra antibiotic in the medium. 
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4 Conclusion 
In this chapter, 3 strains have been created starting from the E. coli CGSC#10993 or from 
the standard E. coli K-12 MG1655 by knocking out all genes encoding homologues L-Ru-5-P 4-
epimerases. Removal of these genes will reduce the risk of loss of the G. thermodenitrificans L-
Ru-5-P 4-epimerase gene present on the pIXhPtrc-AraD plasmid  as a result of recombination. 
The first selection strain, SelTag1, was based on E. coli CGSC#10993 and is not useful since it is 
unable to grow on fructose as a sole carbon source.  
 
Nevertheless, the selection strains based on the E. coli K-12 MG1655, namely SelTag2 and 
SelTag3, are found to be useful in a selection system towards a tagatose 4-epimerase. since they 
are able to grow on fructose, unable to do so on tagatose and express the G. thermodenitrificans 
L-Ru-5-P 4-epimerase in an active form. SelTag3 has the advantage of harboring an extra 
antibiotic resistance marker which reduces the chance of contamination in the case of slow 
growth of the selection strain. 
 
While making these different selection strains, the protocol of gene disruption was 
optimized speaking of time frame and workload. By simultaneous removal of 2 antibiotic 
resistance markers, 2 to 3 days of work could be spared, hereby speeding up the protocol. This 
also opens the door for further speeding up the protocol for simultaneous removal of more than 2 
genes. However, it is necessary to use new resistance markers to be able to select for gene 
disruption, a possible new resistance marker can be that for gentamicin. 
88 
 
  
89 
 
V. MUTAGENESIS OF L-RU-5-P 4-
EPIMERASE AND SELECTION 
TOWARDS IMPROVED MUTANTS 
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1 Introduction 
After the development of two useful selection strains for tagatose to fructose conversion, the 
focus was shifted towards the enzyme, namely an L-Ru-5-P 4-epimerase. Amongst the different 
strategies available for enzyme engineering are random and (semi-)rational mutagenesis. 
Random mutagenesis can always be applied since no or little information about the target 
enzyme is needed [40]. Mutations are made at random via different strategies, such as error 
prone PCR and shuffling [208, 241]. In the research project, random mutagenesis was achieved 
by applying error-prone PCR on the full gene as well as parts of the gene. 
 
In recent decades, the field of informatics and mathematics has become an important field in 
biochemical or biotechnological sciences, since several mathematical models have been 
translated in useful bio-informatica tools. Among these programs are visualizing programs such 
as the PyMOL Molecular Graphics System [70] but also molecular modeling programs like 
YASARA [139]. With the use of this latter program, a homology model can be made for new 
enzymes based on available crystal structures of homologous enzymes. Since multiple structures 
of other L-Ru-5-P 4-epimerases and related homologous enzymes are available [78, 140, 141, 
166], a homology model for the G. thermodenitrificans L-Ru-5-P 4-epimerase can be made using 
the molecular modeling program YASARA [139] and the mentioned crystal structures. The 
creation of this homology model allows us to have a look at the enzyme’s active site, including 
the residues important for substrate binding. Furthermore, previous (engineering) studies of other 
L-Ru-5-P 4-epimerases and the homologous aldolases provide us with a lot of information as 
well. This information will be used together with the created homology model to more rationally 
identify residues that might be of importance to change the substrate specificity of the epimerase 
from phosphorylated pentoses (L-Ru-5-P/D-Xu-5-P) towards free hexoses (tagatose/fructose) 
(Figure I.1). Target residues will then be mutated towards all possible amino acids. This 
approach is called semi-rational as residues are chosen based on rational information but 
mutagenesis is not fully rational since saturation is applied.  
 
In this chapter, the creation of a homology model for the G. thermodenitrificans L-Ru-5-P 4-
epimerase is described, along with the random and site saturation mutagenesis of the enzyme. 
After mutagenesis, mutant libraries were transformed into the previously created selection 
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strains, SelTag2 or SelTag3 (chapter IV), and grown in tagatose minimal medium in order to 
identify improved enzyme variants. 
 
2 Material & Methods 
2.1. Bacterial strains, plasmids, growth conditions and chemicals 
Both the inducible expression plasmid pIXhPtrc-AraD containing the G. 
thermodenitrificans L-Ru-5-P 4-epimerase gene and the selection strains SelTag2 and SelTag3 
have been created earlier (chapter III and chapter IV, respectively). Standard growth conditions 
and media were used as mentioned in the previous chapters. Primers were ordered at Sigma-
Aldrich, the same counts for chemical unless otherwise stated. Aligments of the L-Ru-5-P 4-
epimerase with other enzymes and sequence analysis of this 4-epimerase were performed using 
the online available ClustalW2 alignement program [144] as well as the NCBI BLAST tool [6]. 
 
Minimal medium (TMM) composition was used as described in chapter IV section 2.3.1, 
however, with 250 mM or 500 mM of tagatose. Experiments were also performed in tagatose 
synthetic medium (TSM). This synthetic medium contained 2 g/l NH4Cl, 5 g/l (NH4)2SO4, 2.993 
g/l KH2PO4, 7.315 g/l K2HPO4, 8.372 g/l MOPS, 0.5 g/l NaCl, 0.5 g/l MgSO4.7H2O, 250 mM or 
500 mM of tagatose (Nutrilab), 1 ml/l vitamin solution, 100 µl/l molybdate solution, and 1 ml/l 
selenium solution. The medium was set to a pH of 7 with 1 M KOH. Vitamin solution consisted 
of 3.6 g/l FeCl2.4H2O, 5 g/l CaCl2.2H2O, 1.3 g/l MnCl2.2H2O, 0.38 g/l CuCl2.2H2O, 0.5 g/l 
CoCl2.6H2O, 0.94 g/l ZnCl2, 0.0311 g/l H3BO4, 0.4 g/l Na2EDTA.2H2O and 1.01 g/l thiamine-
HCl. The molybdate solution contained 0.967 g/l Na2MoO4.2H2O. The selenium solution 
contained 42 g/l SeO2. 
2.2. Homology model of the L-Ru-5-P 4-epimerase 
To determine the residues and/or regions of the 4-epimerase that might be important to 
change the substrate specificity of the epimerase, alignment studies with other members of the 
araD-like aldolase/epimerase family were performed, important residues were identified in 
previously published literature, and finally important residues were chosen by looking at the 
substrate binding domain of the G. thermodenitrificans L-Ru-5-P 4-epimerase. Therefore, a 
homology model of the G. thermodenitrificans L-Ru-5-P 4-epimerase was made using the 
molecular modeling program YASARA [139] based on the crystal structures of L-Ru-5-P 4-
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epimerase (PDB: 1JDI), L-rhamnulose-1-phosphate aldolase (PDB: 1GT7) and L-fuculose-1-
phosphate aldolase (PDB: 1DZU), all from E. coli, and with default settings. The resulting 
homology model was saved as a pbd-file, which was then used to look at the substrate binding 
domain, and more specifically the phosphate binding site, using the YASARA program [139] 
and the PyMOL Molecular Graphics System [70].  
 
The substrates L-Ru-5-P and D-Xu-5-P were docked into the created homology model using 
the docking tool of the molecular modeling program YASARA [139]. Furthermore, the substrate 
analogue phosphoglycolohydroxamic acid (PGH) that was found in the crystal structure of E. 
coli L-fuculose-1-phosphate aldolase (PDB: 4FUA) was brought in the homology model by 
superposition of both structures with the help of the MUSTANG alignment tool [134] in 
YASARA [139] 
2.3. Random mutagenesis: error prone PCR 
For random mutagenesis, the GeneMorph II EZClone Domain Mutagenesis kit (Stratagene) 
and primers mentioned in Table V.1 were used, applying a mutation frequency of 0-10 
mutations/kb, which would result in 0-7 mutations on the araD gene.  
 
Table V.1 Primers used for random mutagenesis of the araD_Gt gene 
Primer Sequence (5’→3’) 
EP_AraD_Fwd GGATCCAACCCTTAAGATG 
EP_AraD_Fwd_internal GACTTGGGCGACTGTTTGG 
EP_AraD_Rev_internal AACAACGGCATTGTGGACTG 
EP_AraD_Rev GAGCTCTCCCATATGGTCGAC 
 
2.4. (Semi-)Rational mutagenesis: Site saturation mutagenesis 
For site saturation mutagenesis (SSM), the Sanchis protocol was used [227]. Briefly summarized, 
reaction mixtures contained 50–100 ng of wild-type plasmid as template, 5 pmol of mutagenic 
primer and a non-mutagenic reverse primer or two mutagenic primers (primer sequence see 
Table V.2), 0.2 mM dNTP mix, 2.5 U of PfuUltraTM High-Fidelity DNA polymerase and the 
supplied buffer (Stratagene) in a final volume of 50 μL. The PCR program consists of the 
following steps: initial denaturation 3 min at 95 °C, followed by 5 cycles of 30 s denaturation at 
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95 °C, annealing 45 s at 53 °C, extension 1 min/kb according to the megaprimer size at 72 °C. 
Second stage contained the whole plasmid amplification starting from the created megaprimer by 
20-25 cycles of 30 s at 95 °C and extension at 2 min/kb of template at 68 °C, and program was 
ended by a final extension of 2 min/kb of template at 68 °C. PCR mixtures where then digested 
with DpnI to remove template DNA, purified using the QIAquick PCR purifcation kit (Qiagen) 
and transformed into electrocompetent BL21 cells as described above. Plasmids were then 
extracted and mutagenesis was checked by sequencing. 
 
Table V.2 Mutagenic primers used for site saturation mutagenesis of the araD_Gt gene; target codon are underlined 
Primer Sequence (5’→3’) 
N28X_Fw TGTGACATTTACATGGGGANNSGTGAGCGGGATTGACCGGG 
W26X-G27X-N28X_Fw AGCTCCCACAATACCGCCTTGTGACATTTACANNKNNKNNKGT
GAGCGGGATTGACCGGGAGCGCG 
K42X_Fw GGGAGCGCGGGTTGGTTGTCATTNNSCCAAGTGGGTTGG 
K42X-P43X-S44X_Fw GATTGACCGGGAGCGCGGGTTGGTTGTCATTNNKNNKNNKGG
GTTGGCGTATGACAGACT 
S73X_Rv ATGGGTCGGAGTGTCCGAWNNCGGTTTCCACTCTCCTTC 
S74X_Rv GAGATGGGTCGGAGTGTCWNNTGACGGTTTCCACTCTCC 
D75X_Rv CCAGAGATGGGTCGGAGTWNNCGATGACGGTTTCCACTC 
S73X-S74X _Rv GCCAGAGATGGGTCGGAGTGTCMNNMNNCGGTTTCCACTCTC
CTTCC 
S73X-S74X-D75X_Rv GTTTATACAGCCAGAGATGGGTCGGAGTWNNWNNWNNCGGT
TTCCACTCTCCTTCCACCACC 
T95X_Rv AACAGTCGCCCAAGTCGAATGMNNATGCACAATTCCTCCGAT
TCC 
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2.5. Selection of mutant libraries 
2.5.1. Liquid minimal medium 
Mutant libraries are transformed into the selection strain by electroporation and a small 
portion (10%) of the transformation mix is plated on LB-agar to calculate the amount of colony 
forming units (CFU) in the selection culture. A second part (10-25 %) was grown overnight in 
liquid Luria broth to check the libraries’ quality by sequencing. The rest of the library was grown 
in liquid Luria broth to start the selection pre-culture. This selection pre-culture was first grown 
for 2-6 h and then tagatose was added for overnight growth. After overnight growth, a portion of 
the cells was harvested by centrifugation, washed twice with phosphate buffered saline (PBS; 8 
g/l NaCl, 0.2 g/l KCl, 1.44 g/l Na2HPO4, 0.27 g/l KH2PO4, pH 7.4) and subsequently inoculated 
(2 % inoculum) in fresh TMM (chapter IV 2.3.1) or TSM (2.1) supplemented with the 
appropriate antibiotics and IPTG. Cells were grown at 37 °C, 200 rpm and growth was followed 
by measuring cell density at OD600 nm. 
2.5.2. Solid minimal medium 
Growth tests were also performed using solid minimal medium containing tagatose. General 
composition of the TMM-agar medium was the same as described above, supplemented with 15 
g/l agar (Difco). Here, carbenicillin was added to allow longer incubation periods since it is 
found to be more stable in culture media. Triphenyl tetrazolium chloride (BD Difco™ TTC 
Solution) was added to a concentration of 0.1 g/l after the medium was autoclaved in order to 
obtain a red color in the colonies that are able to grow on the provided tagatose. The red color is 
obtained by reduction of the TTC when cells are able to grow on tagatose and hereby create 
reductive power [37]. 
 
3 Results and Discussion 
3.1. Sequence analysis and homology model 
A sequence alignment (Figure V.1) of the Geobacillus L-Ru-5-P 4-epimerase with the 
related aldolases reveals low amino acids identity with the L-rhamnulose-1-P aldolase and L-
fuculose-1-P aldolase, and around 65 % identity with the E. coli epimerase. The conserved 
residues from the AraD-like aldolase/epimerase family are found in the Geobacillus epimerase as 
well. 
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Figure V.1 Sequence alignment of L-Ru-5-P 4-epimerase from Geobacillus (AraD_Gt) and E. coli (AraD_Eco) with L-
rhamnulose-1-P aldolase and L-fuculose-1-P aldolase (FucA_Eco and RhaD_Eco, respectively) . Conserved residue 
are marked in bold and randomized residues are highlighted in green 
 
The homology model of the Geobacillus L-Ru-5-P 4-epimerase was created based on 
structures of the AraD-like aldolase/epimerase family members. It seems to be of good quality 
since it aligns very well with the E. coli epimerase, with a rmsd of only 0.5 Å over the 217 
aligned residues. Substrate analogue phosphoglycolohydroxamic acid (PGH) was introduced by 
superposition with the L-fuculose-1-P aldolase the crystal structure. This was possible since these 
enzymes’ overall structure and conserved residues align very well. 
 
A look at the residues close to the phosphate group of the phosphoglycolohydroxamic acid 
(PGH) reveals that most of the residues mentioned in the next paragraph (3.2) are indeed in close 
contact with the phosphate of the substrate analogue, making them good candidates for SSM in 
order to obtain a binding region for the hydroxylic groups of ketohexoses. 
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Figure V.2 Homology model of the Geobacillus L-Ru-5-P 4-epimerase with the substrate analogue 
phosphoglycolohydroxamic acid (PGH). The residues targeted with SSM and histidines for Zn2+ binding are 
highlighted 
 
3.2. Determining residues for SSM (Figure V.2) 
The residues targeted by SSM were chosen based on previous engineering results on L-Ru-
5-P 4-epimerase [166] as well as the related L-rhamnulose-1-phosphate aldolase [141] and L-
fuculose-1-phosphate aldolase [78]. Furthermore, the created homology model of the epimerase 
and available crystal structures from the above mentioned enzymes were used to have a look in 
the active site, and more specifically at the substrate and phosphate binding site, of the 
epimerase. With these tools, 5 residues were identified as important for SSM (N28, K42, S73, 
S74 and T95) and 5 neighboring residues were taken along with them (W26, G27, P43, S44 and 
D75). The following paragraphs will further explain why these particular residues were chosen. 
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Four residues have been proposed to form the phosphate binding pocket in E. coli L-Ru-5-P 
4-epimerase based on alignment with the 2 related aldolases, namely S44, G45, S74, S75. These 
residues constitute the phosphate binding pocket in the L-fuculose-1-P aldolase and its 
corresponding residues in the Geobacillus epimerase are S44, G45, S73, S74 [149].  Later on, a 
conserved asparagine (N28) and lysine (K42) in the active site were added to this list [166]. Most 
of these conserved residues are suspected to form hydrogen bonds with the phosphate moiety via 
their β-hydroxyl groups (S), α- or γ-amide groups (G/N). On the other hand, the lysine was found 
to be positioned at the bottom of the putative phosphate binding pocket, where it is likely to form 
a salt bridge with the phosphate group [166]. These latter two residues had been subject of 
mutagenesis for removal of their specific side groups (N28A and K42M). Due to these 
mutations, affinity of the epimerase for L-Ru-5-P had drastically dropped. An increase in Km 
from 0.047 mM to 1.2 mM and > 2 mM was observed, respectively, confirming their role in 
substrate binding [225]. The corresponding residues of the mentioned amino acids (N28, K42, 
S73, S74, S44) were targeted by SSM to introduce variety in the phosphate binding region and in 
this way engineer this pocket towards a pocket that will retain a poly-hydroxyl moiety instead. 
Extra interaction could be formed with the hydroxyl group at C5 and C6 as well with the carbon 
atoms themselves.  
 
Since most of the residues are likely to be able to interact with C5, C6 and their hydroxyl 
groups, and an altered positioning of these residues might also improve binding of the non-
phosphorylated ketohexose, some neighboring residues were targeted by SSM as well: W26, 
G27, P43 and D75. The 10th residue that was subjected to SSM is the threonine (T95) found 
between two of the histidines (H94, H96) that are known to bind the metal ion. In a similar 
engineering project, a double mutation was found to convert the L-rhamnulose-1-P aldolase from 
E. coli into an L-rhamnulose aldolase [244]. This double mutant contained the following two 
mutations: C142Y and T158S. The first (C142) corresponds with the T95 in the Geobacillus 
epimerase, while the T158 is located in a helix which is absent in the epimerase. With the help of 
the primer listed in Table V.2, several single to quadruple SSM libraries were created combining 
mutagenesis of the above mentioned residues (Table V.3). 
3.3. Random mutagenesis: library quality and selection 
It was chosen to work with different levels of mutation frequency to obtain divergent 
libraries. A low mutation frequency might not introduce enough mutations, whereas the chance 
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of detrimental mutations is bigger with a high mutation frequency. Sequencing of 3 times 3 
single colonies grown on LB medium showed that random mutagenesis was successful. They 
were found to have 0-7 nucleotide changes which resulted in 0-3 amino acid substitutions. The 
observed mutation frequency matched with the theoretical mutation frequency. More variation 
was introduced in the libraries by applying random mutagenesis on the entire gene (full enzyme) 
or only parts of the gene (N-terminal or C-terminal part of the enzyme). 
 
The mutant libraries showed very slow growth and in many cases cultures only reached 
OD600 nm ≈ 0.4 after around 10 days. Due to this slow growth, some of the selection cultures of 
the SelTag2 selection strain became contaminated. Therefore, it was chosen to work with an 
intermediate strain from the making of SelTag2. This intermediate strain still contains the 
kanamycin marker at the position of the ulaF gene (ulaF::kan) and so kanamycin can be added to 
the medium to reduce the chance of contamination (see also chapter IV 0). 
 
Over 40 different random mutagenesis libraries, with distinct mutation frequencies, were 
created and transformed in the SelTag2 or SelTag3 selection strain. Around 3 million CFU were 
inoculated in TMM or TSM, which resulted in the finding of a potential hit, containing 2 
mutations A8V-T23A and a silent one (T115T). Based on their position in the structure, near the 
enzyme’s surface, and the small difference between the original and new residue, it is unlikely 
that this mutant is a true hit. Nonetheless, the T23A mutation could have an effect on the 
alignment of the residues a bit more C-terminal, more specifically those around N28. 
3.4. Site saturation mutagenesis: library quality and selection 
A total a 10 different residues was subjected to site saturation mutagenesis using 10 
different primers containing NNS or NNK degenerated codons. As such, the residue could be 
switched to all 20 amino acids using 32 codons (Appendix III). Of the 10 primers, 6 contained a 
single degenerated codon, one a two degenerated codons and the other three could result in triple 
SSM mutants. Some primers were used separately (with non-mutagenic primers), while different 
combinations of 2 mutagenic primers were made as well, resulting in SSM of 1-4 positions.  
 
The library part plated out on solid media was used to determine the size of each mutant 
library (see below and Table V.3). Sequencing results confirm that SSM gave libraries of good to 
very good quality (Figure V.3), approximating the ideal distribution. An ideal library would 
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consist of percentage A/C/G/T-distributions of 25/25/25/25 for ‘N’ and 0/50/50/0 for ‘S’. 
Nevertheless, in many cases the natural nucleotide (or codon) is in many cases overrepresented. 
This is logical since degenerated codons with less difference to the natural codon experience less 
repulsion during primer annealing. Nonetheless, due to oversampling by using bigger libraries, 
the chance of starting with a full library (all possible codons) is increased. For a single SSM 
library with NNS or NNK degenerated codon, the library should contain around 100 CFU to 
have 95 % coverage (Appendix III) [212]. 
 
 
Position 
in codon 
   
Position 
in codon 
 
Res. 1 2 3 nucl. 
 
Res. 1 2 3 nucl. 
N28 
49 44 0 A 
 
N28 
64 59 0 A 
11 10 31 C 
 
7 8 21 C 
20 26 47 G 
 
14 18 37 G 
20 20 22 T 
 
15 15 42 T 
K42 
30 35 0 A 
 
K42 
51 51 2 A 
14 20 48 C 
 
12 15 34 C 
28 18 52 G 
 
20 16 63 G 
28 27 0 T 
 
17 18 1 T 
S73 
31 22 12 A 
 
S73 
27 18 25 A 
24 19 63 C 
 
20 50 47 C 
20 39 25 G 
 
16 13 23 G 
25 20 0 T 
 
37 19 5 T 
S74 
26 26 4 A 
 
S74 
18 15 0 A 
25 36 46 C 
 
19 61 39 C 
17 20 50 G 
 
13 13 61 G 
32 18 0 T 
 
50 11 0 T 
D75 
30 43 4 A 
 
D75 
20 72 7 A 
23 20 57 C 
 
16 12 74 C 
31 20 37 G 
 
55 9 19 G 
16 17 2 T 
 
9 7 0 T 
Figure V.3 Example of the quality of a SSM library (NNS) at different positions. Percentage of each nucleotide at the 
different positions is given, original nucleotide is underlined. Ideal library would have a N: 25/25/25/25 and S: 
0/50/50/0 A/C/G/T-distribution 
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An overview of the number of CFU that was transformed in the selection strains and 
selected for growth, and thus epimerase activity, in tagatose minimal medium (TMM) or tagatose 
synthetic medium (TSM) is given in Table V.3. For most of the libraries, the number of CFU 
needed to reach the screening effort for at least 95 % coverage [212] was reached by single 
libraries or combining different transformations in the same library or when multiple smaller 
libraries were combined. 
 
Table V.3 Overview of the created libraries, their size, screening effort and coverage 
Residue(s) targeted # NNS Screening effort 
needed (CFU) 
Library size 
(CFU) 
Coverage 
(%) 
N28X 1 94 > 10000 100 % 
K42X 1 94 > 10000 100 % 
S73X 1 94 ± 1100 100 % 
S74X 1 94 ± 1700 100 % 
D75X 1 94  ± 900 100 % 
T95X 1 94 > 1500 100 % 
N28X, S73X 2 3066  ± 4400 100 % 
N28X, S74X 2 3066  ± 3800 100 % 
N28X, D75X 2 3066  ± 4400 100 % 
N28X, T95X 2 3066  > 5000  100 % 
K42X, S73X 2 3066  ± 550 18 % 
K42X, S74X 2 3066  ± 2800 90 % 
K42X, D75X 2 3066  ± 2200 72 % 
K42X, T95X 2 3066  ± 4400 100 % 
S73X-S74X 2 3066  ± 20000 100 % 
N28X, S73X-S74X 3 98163 ± 10000 ± 10 % 
K42X, S73X-S74X 3 98163 ± 10000 ± 10 % 
W26X-G27X-N28X 3 98163 ± 5000 ± 5 % 
K42X-P43X-S44X 3 98163 ± 2500 ± 2.5 % 
S73X-S74X-D75X 3 98163 > 130000 100 % 
N28X, S73X-S74X-D75X 4 3141251 > 20000 ± 1 % 
K42X, S73X-S74X-D75X 4 3141251 > 25000 ± 1 % 
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As was observed for the selection cultures of random mutagenesis, the SSM libraries also 
showed very slow growth to OD600 nm ≈ 0.4 (again in ± 10 days). Nevertheless, some of the 
libraries were found to be fully enriched towards one mutant after several inoculations in fresh 
TMM. Among these mutations were K42S, K42A, K42V, N28R and S73R. Three smaller 
residues were found in libraries at which K42 was randomized: more specifically serine, alanine 
and valine. As the distance between the hydroxyl group of serine and the introduced 
hydroxymethyl group is over 5 Å, it is too far away for H-bond formation. Due to the three 
smaller residues, the active site might have been slightly prolonged. The introduction of bulkier 
and charged groups (N28R, S73R) in the phosphate binding region would have the opposite 
effect and reduce the size of the active site as well as occupy the space that is needed for the 
extra hydroxymethyl of the hexoses. Surprisingly, one of the libraries had fully enriched to a stop 
codon mutant, resulting in a truncated epimerase unlikely to be active. Perhaps this minimal 
growth observed is due to traces of Luria broth from the inoculums, nevertheless, it is still 
strange that this would lead to the enrichment of a single mutant. Inoculated libraries had been 
checked by sequencing of the inoculums (examples are given in Figure V.3), while five single 
colonies had been sequenced after plating out the selection culture, clearly pointing out towards 
enrichment. 
3.5. Solid minimal medium 
Due to very slow growth at the solid tagatose minimal medium, only very tiny colonies 
were observed after several days of incubation at 37 °C. Slight red coloring was observed on the 
colonies. However, as a result of the very slow growth, the plates and colonies had dried out 
before the colonies could be inoculated on fresh medium. This could mean either two things, at 
first, the selection on solid medium works but the initial activity in the strains is to low to achieve 
growth before the plates and colonies or dried out. On the other hand, this minimal growth could 
also be a result of growth on traces of Luria broth from the inoculum. This could have been 
checked by inoculation of the selection strain not expressing the epimerase. 
3.6. Fructokinase problem 
Due to the (extreme) slow growth of the libraries, the selection system was scrutinized in 
order to double check the strain and the assumptions that were made to use it as a selection 
strain. Problems that could occur are the lack of tagatose transport systems, too low 
concentration of  tagatose in the cells and problems downstream of the epimerization reaction. 
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Uptake of tagatose should not be the problem, since E. coli K-12 MG1655 is able to absorb 
tagatose via the methylgalactoside transport system, mglABC [132]. Even though it has a higher 
flux transporting tagatose out than in, due to high concentration of tagatose in the medium, the 
mlgABC transport system should be able to transport it inside the cells [132]. Nonetheless, 
intracellular levels of tagatose might not reach high levels.  
 
According to the growth tests that were performed, E. coli K-12 MG1655 and the selection 
strains based on it were able to grow well on fructose. However, there is a difference in fructose 
consumption between the growth test and in the selection strain, that was overlooked. In E. coli, 
three routes of fructose utilization are present, of which one is predominant [136]. Here, fructose 
is transported in the cell via the phosphotransferase system or PTS and is simultaneously 
phosphorylated to fructose-1-P, to which then a second phosphate group is coupled (Fru-1,6-bis-
P) and broken down to yield energy and building blocks. The second route is similar but yields 
fructose-6-P, which is then converted to Fru-1,6-bis-P. In the third route, fructose diffuses into 
the cell via an isoform of the major glucose permease of the PTS (no PTS involved). It enters the 
cell as fructose and has to be phosphorylated by ATP and a manno(fructo)kinase (Mak+). 
However, it was found that the manno(fructo)kinase from E. coli K-12 MG1655 works very 
slow, partially due to lower expression as a result of a rare start codon (personal communication 
Joeri Beauprez) [174, 240]. 
 
In our selection system, tagatose is absorbed and epimerization would result in non-
phosphorylated fructose in the cell. As a result, two consecutive bottlenecks are present, namely 
the epimerase and the manno(fructo)kinase. This second bottleneck hampers the utilization of 
formed fructose. In a perfect selection strain, only one bottleneck should be present and that is 
the target enzyme, in this case the epimerase. The fructokinase problem could be solved by 
constitutive overexpression of a fructokinase on a plasmid or via introduction in the genome 
(personal communication Joeri Beauprez). 
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4 Conclusion 
In this chapter, two types of mutagenesis are applied on the L-Ru-5-P 4-epimerase: random 
mutagenesis via error prone PCR and a semi-rational approach through site saturation 
mutagenesis of carefully selected residues. Both types of libraries are then transformed into the 
earlier developed selection strains SelTag2 and SelTag3, followed by inoculation in minimal 
medium with tagatose as a sole carbon source (TMM) for selection of improved variants. 
 
Of over 40 different random mutagenesis libraries created with different levels of mutation 
frequency, a total of around 3 million CFU were transformed in the selection strains. Up to 
300,000 mutants were created in 22 different saturation libraries, in which 1 to 4 codons were 
simultaneously degenerated using NNS or NNK codons. For smaller libraries (SSM of 1-2 
residues), the amount of mutants/CFU for at least 95 % coverage was reached, whereas for 
bigger libraries (3-4 residues), these numbers were not achieved. Nonetheless, still several 
thousands of CFU were inoculated in selection cultures, covering 1-10 % of the CFU needed for 
95 % coverage. 
 
The majority of the targeted residues is located in the phosphate binding pocket of the 
epimerase, since the desired substrates are hexoses instead of phosphorylated pentoses. A 
disadvantage with the targeted or phosphate binding residues is that they are (semi-)conserved 
residues, which could also mean that they might be of importance for other enzyme features as 
well, such as folding or stability. On the other hand, since all AraD-like aldolase/epimerase 
family members are active on phosphorylated carbohydrates and the substrate specificity of the 
epimerase is desired to be extended or changed to non-phosphorylated sugars in this project, it is 
not unlikely that (semi-)conserved residues have to be targeted.  
 
Via this selection approach, the following mutants had enriched after several rounds of 
selection in TMM: K42S, K42A, K42V, N28R and S73R in site saturation libraries and the 
double mutation A8V-T23A(-T115T) after random mutagenesis. Since one of the libraries had 
fully enriched to a mutant containing a stop codon, it is not unlikely that there are more false 
positives among the other mentioned hits. This stop codon would make that only a truncated, 
very likely inactive enzyme is expressed. Whether they are true hits rather than false positives 
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will be examined later on using the screening assay for detection of tagatose 4-epimerase that 
was developed (see chapter VI).  
 
Due to the very slow growth of the libraries in the SelTag strains (OD600 nm ≈ 0.4 only 
reached in approximately 10 days), the selection system was scrutinized. This inspection 
revealed that there is likely to be a second bottleneck, namely the first step in the utilization of 
fructose. In the growth tests, fructose was imported as fructose-1-P that is easily further broken 
down, resulting in proper growth. In the selection system, on the other hand, fructose has to be 
phosphorylated first and the fructokinase, in the strain used, is not sufficient. Due to this second 
bottleneck, the growth and consequently also the selection is hampered. A perfect selection strain 
would only have one bottleneck and that is the target enzyme. Constitutive overexpression of an 
active fructokinase could overcome this second bottleneck and improve the selection strain. 
More information and possibilities on how to improve the selection strain are discussed in the 
General discussion & Future Perspectives (Chapter IX). 
 
Nevertheless, engineering of the L-Ru-5-P 4-epimerase towards a 4-epimerase active on 
non-phosphorylated sugars still seems feasible since similar results were encountered through 
this approach on the related L-rhamnulose-1-phosphate aldolase [244]. In the next chapter, the 
development of a screening assay for detection of tagatose 4-epimerase is described. It will also 
be applied on several libraries as well as to confirm whether the found mutants are true positive 
hits. 
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VI. DEVELOPMENT AND 
APPLICATION OF A SCREENING 
ASSAY 
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1 Introduction 
In chapter IV and chapter V the development and application of a selection system are 
described, respectively. However, next to the use of selection as a way to detect improved 
enzyme variants in a mutant library, one can also perform screening to do this. In a screening 
assay, each mutant will be tested separately for the desired function or characteristic. 
Nevertheless, one must have a preferably easy, yet robust and accurate reaction to test the created 
mutant libraries. In this chapter, the development of a screening assay for the detection of 
tagatose 4-epimerase activity is described. 
 
Shortly summarized, the screening assay goes as follows (Figure VI.2). If an enzyme variant 
is able to convert tagatose, its C4-epimer fructose will be formed (epimerization step). In the first 
step of the screening assay, this formed fructose will be converted to glucose with the help of 
soluble glucose (xylose) isomerase (SGI). In the second step, the formed glucose will react with 
two coupling enzymes, namely glucose oxidase (GOD) and peroxidase (POD), and a 
chromogenic agent (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) or ABTS) towards a 
green color [274]. This screening protocol is called the SGI-GOD-POD method according to the 
3 enzymes that are applied in a coupled fashion. 
 
2 Material & Methods 
2.1. Bacterial strains, plasmids, growth conditions 
E. coli BL21 (DE3) cells will be used for the expression of the recombinant L-Ru-5-P 4-
epimerase. The epimerase will be expressed from the inducible pIXhPtrc-AraD expression vector 
created earlier (chapter III). Growth will be achieved on solid and in liquid LB medium supplied 
with ampicillin to select for the plasmid and IPTG for induction as described above. Mutagenesis 
was performed as described in chapter V. 
2.2. Chemicals and enzymes 
Soluble glucose isomerase (Gensweet SGI) was kindly provided by Genencor Belgium. 
This glucose isomerase is in fact a xylose isomerase from Streptomyces rubiginosus and has a 
molecular weight of 160 kDa. Since this SGI solution contains not only the isomerase but also 
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many stabilizers, both PD-10 desalting columns (GE Healthcare) and Amicon® Ultra 30K 
Centricons (Millipore) were applied to clean up the enzyme solution. Chemicals were purchased 
from Sigma-Aldrich unless otherwise stated. 
2.3. Development of the screening assay for tagatose 4-epimerase activity 
2.3.1. Soluble glucose isomerase 
Isomerization of fructose to glucose by the SGI solution was performed similar to the 
reaction described by Tukel and Alagoz [266]. The final SGI reaction mixture contained 20 mM 
MgSO4, 1 mM COCl2 in 250 mM Tris-HCl buffer pH 7.5. The mixture was incubated during 20 
min at 60 °C and inactivated by a 10 min heat treatment at 100 °C. 
2.3.2. Glucose oxidase – Peroxidase (GOD–POD) 
In the next step, the glucose concentration was measured, using the coupled enzyme assay 
of glucose oxidase and peroxidase [274]. In the GOD-POD method, the present glucose will 
serve as substrate for the coupled enzymes and finally oxidase a chromogenic substrate, in this 
case 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) or shortly ABTS. The GOD-POD 
mixture contains 45,2594 mg GOD, 173 µL POD stock solution (40 mg/mL) and 50 mg ABTS 
in 100 mL 0.2 M acetate buffer pH 4.5. The GOD-POD method has successfully been 
implemented earlier in enzyme engineering screening assays [64]. 
2.3.3. Coupling SGI and GOD-POD 
In order to remove any GOD-POD disturbing effects of chemicals (like stabilizers) present 
in the SGI solution, purification was accomplished by PD-10 desalting columns (GE Healthcare) 
as well as by buffer exchange using Amicon® Ultra 30K Centricons (Millipore). To identify ideal 
enzyme concentrations, the SGI solution has been tested undiluted and 10 to 1000 times diluted 
in SGI buffer (20 mM MgSO4, 1 mM COCl2 as cofactors in Tris-HCl buffer at different buffer 
strengths and pH).  
 
Buffer strengths and pH of the different buffers were also checked to fully optimize the 
consecutive steps of the screening protocol and provide each step its ideal pH value. First, 125 
mM to 1M of Tris-HCl buffer pH 8.5 was tested for its effect on the pH of both the SGI step and 
the GOD-POD step. Secondly, the ideal pH of the SGI buffer was tested at 250 mM Tris-HCl 
buffer in a range of pH 8.5 to pH 9.5. 
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Subsequently, the full SGI-GOD-POD reaction was tested for different fructose 
concentrations and high tagatose concentrations. Finally, a standard curve of fructose (0–2 mM) 
in the presence of excess of tagatose (0.5 M) was tested to determine the minimal detectable 
concentration. 
2.4. Screening the libraries 
Mutant libraries were picked for solid LB media by using the QPix2 colony picker 
(Genetix) and transferred to microtiter plates (MTP, Nunc) containing 175 µL of liquid LB in 
each well and grown overnight at 37 °C and vigorous shaking (220-250 rpm). This first plate is 
called master plate and after overnight growth a copy was made by inoculation of the grown 
cultures into fresh LB with 0.1 mM IPTG to trigger induction of heterologous expression 
(production plate) and grown again overnight for epimerase production. Then, cells were 
harvested by centrifugation of the production plates during 10 min at 3500 rpm (Rotixa 50 RS 
Hettich zentrifugen) and medium is discarded. The plates containing the cell pellets were frozen 
at -20 °C for at least 2 h. Subsequently, pellets are defrosted (30 min at 37 °C) and lysed by 
adding 100 µl of TrueLyse (50 mM Tris-HCl pH 7.5, 1 mM EDTA, 4 mM MgCl2, 50 mM NaCl, 
1 mg/ml lysozyme, 0.1 mM PMSF), lysis is then achieved by 30 min incubation at 37 °C. Cell 
debris was removed by centrifugation of the production plates during 10 min at 3500 rpm and 50 
µl of cell extract was transferred to a new plate to which the tagatose solution was added to start 
the epimerization reaction at 37 °C for 1 h. 
 
3 Results and Discussion 
3.1. Development of the screening assay for tagatose 4-epimerase activity 
It was found that undiluted SGI solution gave rise to color formation equal to that of around 
350 µM of glucose when coupling the SGI step and the GOD-POD method (Figure VI.1). Since 
this is around the upper limit of linear detection by the GOD-POD, this disturbing effect had to 
be solved. Two different routes were used to overcome this issue. Removal of disturbing 
compounds was achieved by buffer exchange using PD-10 desalting columns or Amicon® Ultra 
30K Centricons. Since the SGI solution is a highly concentrated enzyme solution, this 
purification did not proceed as smoothly as desired. On the other hand, the SGI solution is highly 
concentrated and thus dilution of hereof might solve this problem to a large extent as well. 
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Figure VI.1 Interference of the SGI solution on the GOD-POD measurement 
 
Indeed, it was found that a 10 times dilution of the SGI solution reduced the ‘contaminating 
factor’ of SGI towards a level around 50 µM glucose. The 100 and 1000 times diluted samples 
further reduced the ‘contaminating factor’ to levels of around 10 µM of glucose, rendering these 
dilutions very useful for further screening assay development (Figure VI.1). Besides a nice base-
line or zero-point, the mixture should contain enough enzyme to convert the present fructose 
relatively fast into glucose in order to obtain an easy, fast and robust screening assay. In other 
words, do the 100x and 1000x dilution still contain sufficient catalytic power to convert the 
fructose in a desirable time frame or have they become too diluted? 
 
Our results suggest that the 100x dilution still has enough enzyme units present to convert 
most of the fructose (1 mM) present in 20 min, whereas further dilution (1000x) reduces the 
activity too much. This suggests that a 100 times diluted SGI solution still contains both enough 
catalytic potential and reduces the GOD-POD coloring in the absence of glucose as a result of 
contaminants in the SGI solution. On the other hand, the 1000x dilutions reduced this latter 
coloring. However, it was too diluted concerning enzyme units. Another way to purify the 
glucose (xylose) isomerase (GI/XI) would be a cooling crystallization process, starting with the 
GI/XI in a 0.17 M MgSO4 solution [270]. 
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At last, the buffer strength and the pH of the SGI buffer was optimized so that all enzymes 
in each step could react at optimal conditions. An SGI buffer containing 250 mM of Tris-HCl 
was found to be strong enough to increase pH after the epimerization step to an optimal range for 
the SGI and this without affecting the pH of the GOD-POD step too hard. Under these 
conditions, an SGI buffer set at pH 9.5 gave more optimal conditions than at lower pH values. 
3.2. Overview of the  screening assay (Figure VI.2) 
Step 1: Epimerization 
The screening assay will thus consist of a first epimerization step, in which hopefully a 
mutant will convert tagatose into fructose. In the epimerization reaction, 50 µl of crude cell 
extract (50 mM Tris-HCl pH 7.5) will be added to 150 µl of 0.5 M tagatose in 33 mM 
glycylglycine buffer pH 7.6 containing 0.4 mM of MgCl2 as cofactor. This reaction will then 
proceed during 1 h at 37 °C or 60 °C. 
 
Step 2: SGI 
Then, 40 µl of SGI solution (0.25 M Tris-HCl, 100 mM MgSO4, 5mM CoCl2, pH 9.5) will 
be added to 160 µl of the epimerization reaction mix from step 1. The resulting mix will then be 
incubated at 60 °C during 1.5 h to ensure that equilibrium between fructose and glucose will be 
reached. 
 
Step 3: GOD-POD 
After cooling the SGI mix, 50 µl of this solution will be mixed with 200 µl of GOD-POD 
solution  (composition see above) and incubated at 37 °C during 30 min to allow color 
development. Afterwards, the absorbance at 405 nm is checked to look for increased 
fructose/glucose concentrations. 
 
OH
OH
OH
OH
O
OH
OH
OH
OH
OH
O
OH
FructoseTagatose
OH
OH
OH
OH
OH
O
Glucose
Mutant                        SGI                         GOD-POD Green
color
(OD405 nm)
 
Figure VI.2 Overview of the screening protocol 
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3.3. Standard curve and CV 
When applying this 3 step protocol on a standard curve containing 0 to 2 mM of fructose in 
an excess of 500 mM tagatose, a clear linear curve is obtained up to 800 µM of fructose, while 
the detection limit of this protocol lies around 50-100 μM of fructose even in the presence of 
excess amounts of tagatose (500 mM) (Figure VI.3). Repetition of the protocol for the standard 
curve was found to be high and thus an easy and robust screening protocol has been developed 
that can be used in the detection of tagatose 4-epimerase activity. Variation on two plates 
containing all wild-type epimerases showed that the assay had little variation, namely a 
coefficient of variation (CV) of around 10 % (Figure VI.4). 
 
 
Figure VI.3 Standard curve of the screening protocol 
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Figure VI.4 Screening of two plates containing the wild-type epimerase shows little variation for the developed 
screening assay, CV of 7.4 % (blue) and 11.3 % (red) 
 
3.4. Screening for tagatose 4-epimerase activity 
Several of the different libraries mentioned in chapter V section 3.4, were subjected to 
screening. From all 6 single SSM libraries, at least 2 MTPs (192 CFU) had been screened, 
covering the 94 CF needed for full coverage of the library (Appendix III) [212]. In none of these 
libraries, hits could be found that clearly and unambiguously showed (improved) tagatose 4-
epimerase activity. This contradicts the results from selection in which enrichment towards one 
single variant was found, suggesting the hits from selection might not possess any tagatose 4-
epimerase activity at all. 
 
From both the triple mutant library (S73X-S74X-D75X) and quadruple mutant library 
(N28X combined with S73X-S74X-D75X), 8 MTPs had been screened, covering smaller 
portions of the libraries. From the other libraries mentioned in chapter V section 3.4, the colonies 
formed on LB-agar after plating out a part of the library to count the amount of CFU in the 
selection libraries (see chapter V) were picked and transferred to liquid media for growth and 
subsequent screening. As such, another 20 MTP or almost 2000 CFU had been grown and tested 
with the screening assay. The colonies that were found to potentially hold tagatose 4-epimerase 
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activity (green color formation) were sequenced and tested in multiples, together with the 
potential hits that were found via selection.  
 
In order to check whether the potential hits found via the selection strains or screening assay 
were true hits, all these mutants had been grown in eight-fold together with the wild-type and a 
negative control (no epimerase), both in eight-fold as well. For none of these variants, higher 
levels of fructose could be detected than observed for the wild-type or the negative control. Even 
with the use of longer incubation times for the epimerization step (up to 24 h) and/or 
epimerization at higher temperature (60 °C),  no tagatose 4-epimerase activity could be detected 
for the potential hits. As a result hereof, these potential hits were classified as false positives. 
 
The wild-type epimerase, the K42S and the N28R mutants had been tested by using high 
amounts of purified epimerase as well, but for none of these fructose formation could be proven 
by either HPLC analysis (Hypercarb sugar method in chapter III section 2.5) or by the coupled 
screening assay described in this chapter.  
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4 Conclusion 
In this chapter, a coupled enzyme assay is described that can be applied in the search for 
C4-epimerase activity on tagatose. The assay is easy, accurate and has the big advantage of being 
able to detect as little as 50-100 µM of fructose in the presence of excess amount of tagatose 
(500 mM). This means that high substrate concentrations can be used, which is necessary since it 
is expected that the epimerase will only have (very) low affinity for the non-natural substrates 
(free monosaccharide). On the other hand, the low detection limit – even in excess amounts of 
tagatose – has the advantage that samples do not have to be diluted as the substrate does not 
interfere with the assay and, as such, even very low activity should be detectable. 
 
Furthermore, a test with a full plate of wild-type epimerase revealed that the epimerase has 
no or only extremely low activity on tagatose and only low variation is found on this plate. This 
together with the developed screening assay, would mean that an improved variant would 
immediately pop out of the plate since it would be the only one with green color formation. 
Subsequently, the developed screening assay was applied on single SSM libraries of the targeted 
residues as well as on combinations of these residues. In total, over 8000 CFU had been tested 
for tagatose 4-epimerase activity, but despite the ability of the screening assay to detect low 
amounts of fructose in excess amounts of tagatose, none of the created mutants showed to 
possess proper amounts of tagatose 4-epimerase activity. Even using high concentrations of 
purified epimerase and longer incubation times, no tagatose to fructose conversion could be 
detected for the wild-type epimerase and two mutants (K42S, N28R) with HPLC analysis or the 
developed screening assay. 
  
118 
 
 
  
119 
 
VII. CHARACTERIZATION OF  
UDP-HEXOSE 4-EPIMERASE 
 
 
 
 
 
 
A part of this chapter has been published as:  
Beerens, K., Desmet, T., Soetaert, W. (Epub ahaed of print, 2012). Characterization and 
mutational analysis of the UDP-Glc(NAc) 4-epimerase from Marinithermus hydrothermalis. 
Applied Microbiology and Biotechnology, DOI: 10.1007/s00253-012-4635-6 
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1 Introduction 
As mentioned in the general introduction (chapter I), two naturally occurring enzymes are 
able to epimerize (modified) carbohydrates at the C4-OH position, namely L-Ru-5-P 4-
epimerases and UDP-hexose 4-epimerases. In the previous 4 chapters (chapter III-VI), the 
different steps in the enzyme engineering of the G. thermodenitrificans L-Ru-5-P 4-epimerase are 
described. In the following 2 chapters (chapters VII-VIII), the other type of 4-epimerase is 
utilized as a template for enzyme engineering, that is a UDP-hexose 4-epimerase. 
 
The putative UDP-hexose 4-epimerase (GalE) from the thermophilic bacterium 
Marinithermus hydrothermalis will be used as template. This enzyme was chosen since it had not 
been characterized previously and is expected to be more thermostable than the E. coli GalE, an 
enzyme that has been reported to show very slight epimerase activity on free monosaccharides 
[130]. 
 
Despite the similar reaction of both enzymes (both C4-epimerizations), there is a big 
difference between the chemistry of both enzymes. Whereas the L-Ru-5-P 4-epimerase is active 
on a phosphorylated pentose and applies an aldolase/retroaldolase mechanism (C-C bond 
cleavage), the UDP-hexose 4-epimerase uses nucleotide activated sugars as substrates and acts 
via a transient keto intermediate with NAD+ as cofactor (more info see chapter II 3 (Sugar) 
Epimerases). To make the GalE epimerase active on free monosaccharides, a bigger adaptation 
of the substrate binding site is needed compared to the adaptation needed for the L-Ru-5-P 4-
epimerase, namely the loss of the UDP-group (the biggest part of the substrate) (Figure I.2). 
 
In this chapter, the cloning, expression and characterization of the putative UDP-hexose 4-
epimerase from M. hydrothermalis (mGalE) is described. This characterization is focused on 
optimal reaction conditions (pH and temperature), its substrate specificity (non-acetylated vs. N-
acetylated UDP-sugars and kinetics) as well as its thermostability. 
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2 Material & Methods 
2.1. Bacterial strains and growth conditions, plasmids and chemicals 
The codon optimized sequence encoding mGalE (NCBI YP_004368664.1) with a His6-tag 
attached to its N-termimus (Figure VII.1) was ordered from GenScript (USA). The empty 
pIXhPtrc plasmid was created earlier (see chapter III 2.2.1). Restriction enzymes and T4 DNA 
ligase were purchased from New England Biolabs. Kits for gel extractions, PCR purifications 
and plasmid isolation were obtained from Qiagen. UDP-sugars were obtained from Carbosynth, 
while all other chemicals were obtained from Sigma Aldrich, unless otherwise stated. 
 
E. coli BL21 (DE3) was used both for cloning the galE gene corresponding to the 
Marinithermus hydrothermalis UDP-glucose/N-acetyl-glucosamine 4-epimerase and for the 
recombinant expression of the epimerase. E. coli cells were cultured at 37 °C in Luria broth (LB: 
5 g/L yeast extract, 10 g/L bactotrypton, 10 g/L NaCl, pH 7.0) or LB agar plates (LB plus 10 g/L 
agar) containing 100 µg/ml ampicillin. For recombinant expression, cells were grown until 
OD600nm reached 0.6, before induction with 150 µM of IPTG and subsequently grown for another 
6h before being harvested by centrifugation. 
2.2. Sequence analysis and homology models 
Determination of the conserved residues and/or regions of the UDP-hexose 4-epimerases, 
and to a larger extent the short-chain dehydrogenases/reductases (SDR), was performed by 
alignment studies. Alignments with other GalEs and sequence analysis of the mGalE enzyme 
were performed using the online available ClustalW2 alignment program [144], as well as the 
NCBI BLAST tool [6]. Homology models from both the wild-type enzyme as well as the 
different mutants were made using the molecular modeling program YASARA [139] based on 5 
crystal structures from E. coli GalE each containing a different substrates or substrate analogues 
(eGalE, pdb-codes: 1LRJ, 1UDA, 1UDB, 1UDC and 1XEL) and with default settings. 
Homology models were also created based on the available crystal structures from the other 
types of UDP-hexoses 4-epimerases, namely human GalE (hGalE, PDB entries 1EK5 and 1EK6) 
and WbpP (PDB entries 1SB8 and 1SB9) representing group 2 and group 3. Resulting homology 
models were saved as pbd-files and compared to each other as well as with other available crystal 
structures with the YASARA program [139], the YASARA/WHATIF twinset [268] and the 
PyMOL Molecular Graphics System [70]. 
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Figure VII.1 Codon optimized gene and protein sequence of mGalE, including a His-tag with linker and enterokinase 
cleavage site. The start codon of the His-tagged mGalE and native mGalE are given in the blue boxes, the His-tag is 
underlined and the NcoI and SpeI restriction sites are marked on the gene sequence 
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2.3. Construction of the expression vector (pIXhPtrc-mGalE) 
A codon optimized sequence encoding the mGalE epimerase, including an N-terminal His-
tag was ordered at GenScript (USA). The gene was cut from the supplied plasmid using 10 U of 
both NcoI and SpeI restriction enzymes (NEB) and subsequently cloned into a likewise treated 
empty pIXhPtrc plasmid using a 3/1 insert/vector ratio and 3 Weiss units of T4 DNA ligase 
(NEB) at 22 °C for 1h. After transformation in E. coli BL21 cells, plasmid was extracted using 
the QIAprep spin miniprep kit (Qiagen) after which correct insertion was checked by sequencing 
(Agowa, Germany). Transformation was performed using 1-2 µL of DNA, 40 µL of electro 
competent BL21 cells, and a Bio-Rad Gene Pulser (2.5 kV, 25 µF, 200 Ω) in an 0.2 cm 
electroporation cuvette. 
2.4. Recombinant enzyme expression and His-tag purification 
For recombinant enzyme production, 10 mL of an overnight culture grown on LB medium 
was incubated in 500 mL of LB medium containing 100 µg/mL ampicillin in a 2 L shake flask 
which was then incubated at 37 °C and at 200 rpm shaking speed. Cells were grown until the 
beginning of the exponential phase (OD600nm ≈ 0.6) had been reached, after which induction was 
achieved by addition of IPTG to a final concentration of 150 µM. Cells were kept at 37 °C, 200 
rpm for another 6 h for expression and then biomass was harvested by centrifugation for 20 min 
at 5000 g at 4 °C. Finally, the cell pellets were stored at -20 °C. 
 
For the purification of the expressed epimerase, frozen pellets were thawed on ice for 15 
min and consequently dissolved in lysis buffer containing 300 mM NaCl, 50 mM NaH2PO4, 10 
mM imidazole, 0.1 mM PMSF, 1 mg/mL lysozyme and 6 U/L Benzonase® nuclease (Merck). 
Lysis was achieved during a 30 min incubation on ice followed by sonication with a Branson 
sonifier 250 (3 times 2.5 min at level 3 and 50 % duty cycle). Cell debris was pelleted by 
centrifugation (30 min, 13000 g, 4 °C) and the His-tagged protein was purified from the lysate by 
Ni-NTA chromatography according to the suppliers protocol (ThermoScientific), wash and 
elution buffer contained 35 mM and 250 mM imidazole, respectively. After elution, a buffer 
exchange was achieved using Centricon YM-30 (Millipore) and 10 mM Tris-HCl buffer, pH 7.5 
to remove imidazole. The protein concentration of the samples were analyzed with the Pierce® 
BCA Protein assay kit (ThermoScientific). 
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2.5. Enzyme activity assays 
2.5.1. Activity on UDP-Gal 
The activity (as initial velocity) of mGalE on UDP-Gal was spectrophotometerically 
determined using a colorimetric assay described earlier [179]. This assay determines the amount 
of glucose which is released after acid hydrolysis of the formed UDP-glucose. In general, 
epimerase reaction mixtures consisted of 5 mM Tris-HCl buffer pH 8.6 (for temperature studies) 
or pH 7.5 (for kinetic experiments) and 2 mM of UDP-galactose at 45 °C. Both substrate and 
enzyme (50 µg/mL final concentration) were separately preheated for 15 min at 45°C, after 
which the reaction was initiated by merging both fractions. Samples (25 µL) were taken at 
different time points (each 15-30 s for 90-180 s) and set to pH 2.0 to by addition of 5 µL of 0.1 N 
HCl for inhibition. After boiling samples for 6 min in a 110 °C dry bath, neutralization was 
achieved with equimolar amounts of 0.1 N NaOH. Then, released glucose was measured by 
addition of 200 µl of GOD-POD solution (composition see chapter VI 2.3.2) to 25 µL of 
quenched and neutralized sample. This final reaction was incubated for 30 min at 37 °C before 
measuring OD405nm. The standard series, containing 0.05-1.00 mM of UDP-Glc in 5 mM Tris-
HCl buffer pH 7.5 and UDP-Gal to a final concentration of 2 mM of UDP-sugar, was treated the 
same way. 
 
Optimal temperature was determined in 5 mM Tris-HCl pH 8.6 with varying temperatures 
covering a 45-100 °C range. Thermostability studies were performed in the same way, except 
that the purified enzyme solution was incubated at 45 °C or 60 °C for different time periods 
before initiating the reaction to measure initial reaction rate. 
For the determination of the pH optimum, activity assays were performed at 45°C in 5 mM 
of the following buffers: Tris-HCl + 0.1 N HCl pH 2, acetate pH 4.0 and 5.0, citrate pH 6, 
GlyGly pH 7.6, Tris-HCl pH 7.0, 7.5, 8.0, 8.6, 9.0, glycine pH 8.6, 9.6, 10.6, hereby covering a 
range of pH 2 to pH 10.6.  
 
Kinetic studies were performed in 5 mM Tris-HCl pH 7.5 at 45 °C, with 8 different 
substrate concentrations varying from 300 µM to 3 mM. Each time, a series of different ratios of 
UDP-Glc and UDP-Gal, with a total concentration of 2 mM UDP-sugar, was equally treated to 
serve a standard. For kinetic studies 2 standard series were used, one containing a total of 2 mM 
UDP-sugar for higher concentrations and one with 0.5 mM UDP-sugar for the lower range. 
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2.5.2. Activity on UDP-Glc 
The formation of UDP-Gal from UDP-Glc was measured in a similar fashion. First, acid 
hydrolysis was achieved like described above, namely by addition of 5 µL of 0.1 N HCl to 25 µL 
of sample followed by boiling the samples during 6 min. Secondly, after neutralization of the 
sample, released galactose content in the mixture was measured using the commercially available 
Lactose/D-Galactose Assay Kit (Megazyme). The suppliers instructions were followed; however, 
the used volumes were ten times lower to ensure processing in micro titer plates. As such, 252 
µL of assay solution was added to 20 µL of quenched and neutralized samples. The standard 
containing 0.05-1.00 mM of UDP-Gal in 5 mM Tris-HCl buffer pH 7.5 , plus UDP-Glc to a final 
concentration of 2 mM of UDP-sugar, was treated the same way. 
2.5.3. Conversion of N-acetylated UDP-sugars 
Conversion of the N-acetylated UDP-sugars, UDP-GalNAc and UDP-GlcNAc, was 
performed under the same conditions as used for non-acetylated UDP-sugars, namely in 5 mM 
Tris-HCl buffer pH 7.5, at 45 °C and with 50 µg/mL purified protein. Initial activity tests were 
performed using 2 mM of UDP-GlcNAc and the same 8 substrate concentrations as for UDP-Gal 
were used in the kinetic experiment (300 µM – 3 mM). Samples were taken for 2.5 min with 30 s 
intervals and immediately inactivated by placing them in an 110 °C dry bath (FB15103, Fisher 
Scientific). After inactivation, samples were cooled down on ice and diluted (6-30x) to a total 
concentration of 50-100 µM of N-acetylated UDP-sugars. Samples (10 µL) were then analyzed 
using a HPAEC-PAD system (ICS-3000 system, Dionex) with a CarboPac PA20 column 
(Dionex) at 30°C. Therefore, a sodium acetate (NaOAc) gradient from 0.50 M to 0.68 M was 
applied over a time span of 12 min. Afterwards NaOAc concentration was brought back to 0.50 
M in 1 min and the column was re-equilibrated during 1 min. Flow rate and NaOH concentration 
were kept constant during analysis and re-equilibration at 0.5 mL/min and 100 mM, respectively. 
For both N-acetylated UDP-sugars a standard series was run between a concentration of 1 µM 
and 100 µM. 
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3 Results and Discussion 
3.1. Sequence analysis and homology models 
A multiple alignment (Figure VII.2) of UDP-hexose 4-epimerases revealed that the UDP-
hexose 4-epimerase from Marinithermus hydrothermalis shares 30 % amino acid identity with 
the E. coli GalE, 27 % with the human GalE, and 30 % with the WbpP enzyme from 
Pseudomonas aeruginosa, which are typical representatives of the three different types of 
substrate specificities [71, 110]. A higher identity of 66 % was found with the UDP-hexose 4-
epimerases from Thermus thermophilis and T. aquaticus (tGalE), which are active on UDP-
GalNAc as well as on UDP-Gal [187]. 
 
Furthermore, both important conserved regions are present in this enzyme, namely the 
GxxGxxG motif in the N-terminal domain which is likely to be involved in the binding of β-
NAD+ and the catalytic triade SxnYx3K. Based upon sequence alignments, S116 was postulated 
to serve as catalytic amino acid in the Thermus thermophilis and T. aquaticus [187]. However, 
based upon our  alignments, both S116 and T117 could be the catalytic amino acid, whereas the 
positioning of both residues in the homology model has revealed that T117 is positioned close to 
the substrate’s C4-OH, whereas S116 is pointing away from the active site (Figure VII.3). It is 
known that in some cases a threonine can replace a serine in a catalytic function, as has been 
proven for some SDR family members [35, 85, 181]; however, to our knowledge it would be the 
first GalE bearing a TxnYx3K triad. The activity test of the following two enzyme variants will 
provide final proof: S116A and T117A (see chapter VIII). 
 
Another reason for this uncertainty is the presence of two consecutive glycine residues 
(G118-G119) close to the catalytic triad. This unique feature is a notable difference between 
GalE from Thermus species and other UDP-hexose 4-epimerases, in which a single alanine or 
serine is found at that position. Furthermore, the effect of this double glycine feature will also be 
examined by mutating them towards a single alanine or serine, as found in other GalE enzymes. 
(see chapter VIII). 
 
More importantly, a serine residue (S279) is observed at the gatekeeper position in both 
mGalE and tGalE, pointing towards a similar substrate preference. This suggests that mGalE is 
likely to be active on UDP-GalNAc in addition to UDP-Gal, as was also found to be the case for 
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the highly similar T. thermophilis and T. aquaticus GalEs [187]. Activity on non-acetylated and 
acetylated substrates was investigated (see 3.4). 
 
 
Figure VII.2 Multiple alignment of UDP-hexose 4-epimerases. mGalE, UDP-Glc(NAc) 4-epimerase from 
Marinithermus hydrothermalis; eGalE, UDP-Glc 4-epimerase from E. coli, hGalE, human UDP-Glc(NAc) 4-
epimerase; WbpP, UDP-GlcNAc 4-epimerase from Pseudomonas aeruginosa. Different walls of the hexagonal box 
model are enlightened in the colors in accordance with the figure in [71] and Figure VII.3. Yellow, blue and orange 
correspond to the three conserved walls, green indicates the wall containing the gatekeeper, red and purple the other 
variable walls. In grey the GxxGxxG motif involved in β-NAD+ binding 
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Figure VII.3 Homology model of mGalE. The position of S116 and T117 indicates that the latter is most likely the 
catalytic residue. The NAD+ forms the bottom of the ‘hexagonal box’, whereas T117 (yellow), Y143 (blue) and N172 
(orange) are the three conserved walls. The gatekeeper S279 (green) and its tyrosine mutant are both shown to 
emphasize their impact on the size of the active site. Of the two other variable walls, only A77 (red) is shown, since 
Q178-V186 (purple in Figure VII.2) would be blocking the view 
 
Homology models had been created for the wild-type mGalE as well as for the six different 
mutants (see chapter VIII). Superimposing the created homology models with the structures 
available from the different types of UDP-hexose 4-epimerases revealed no major differences in 
global structure, except for a greater variation in the positioning of the G118-P139 loop or coil in 
the wild-type and a 310-helix being formed in the two double glycine mutants (GG→A, GG→S) 
at A/S118-Y121. The created homology models will be used to interpret the activity 
measurements and kinetic determinations. 
3.2. Construction of the expression vectors 
The pIXhPtrc-mGalE vector was successfully created by ligation of the codon optimized 
mGalE gene that was cut from the by GenScript supplied vector into the pIXhPtrc expression 
vector, as described above. Sequencing of the plasmid confirmed correct insertion in the plasmid 
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and the plasmid could serve as a template for mutagenesis. Furthermore, recombinant expression 
of the enzyme was successfully achieved in BL21 cells, and His-tag purification gave rather 
pure, active and highly concentrated epimerase useful for the activity assays. 
3.3. Determination of optimal conditions 
3.3.1. Temperature optimum and range 
Optimal conditions for the Marinithermus epimerase were determined using UDP-Gal as 
substrate. As expected for an enzyme from a thermophilic organism, the optimal reaction 
temperature is rather high, at about 70 °C (Figure VII.4). This corresponds to the optimal growth 
temperature of M. hydrothermalis [222]. At 60 °C, around 55% of activity is found compared 
with activity at 71°C whereas 25 % of activity  is retained at 45 °C. At 100 °C, no epimerase 
activity is observed most likely due to fast heat inactivation of the enzyme, rendering heat 
inactivation possible when taking samples. The optimal temperature is higher than that of its 
homologues from Thermus species [187] but 10 °C lower than that of the GalE from the 
hyperthermophilic archaeon Pyrobaculum calidifontis [223].  
 
 
Figure VII.4 Temperature profile of mGalE activity 
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3.3.2. pH optimum and range 
The mGalE was found to be active in a broad pH range (pH 6-9), which is rather typical for 
this enzyme class (Figure VII.5). However, the highest activity was measured at pH 7-7.5, 
whereas the optimum for the related GalE enzymes from T. thermophilus and T. aquaticus was 
reported to be pH 8.6 [187]. Less than 10% activity is found at pH value ≤5 or ≥10.6 and no 
activity is found at pH 2. This latter result, allows us to easily stop the reaction by addition of 
acid, which is also a necessary step for acid hydrolysis of the formed UDP-Glc/UDP-Gal for 
further analysis. 
 
 
Figure VII.5 pH profile of mGalE activity, including Gaussian curve fit (3 parameters) 
 
3.3.3. Thermostability at 45 °C and 60 °C: half-life (t50)  
As previously mentioned, fast heat inactivation was observed at higher temperatures. As the 
conversion of free and/or phosphorylated monosaccharides is expected to be rather low, longer 
incubation times are favorable and therefore half-life values (t50) at 60 °C and 45 °C were 
determined. Residual activity was plotted against pretreatment time and with Sigma Plot the t50 
value was determined (Figure VII.6). The half-life of mGalE at 60 °C and 45 °C is 23 min and 
13.5 h, respectively, and almost no activity was lost after 3h incubation at 45 °C. Therefore, it 
was chosen to perform the reactions at 45 °C, especially for the reactions on free and 
phosphorylated monosaccharides. The Marinithermus enzyme, however, does not display the 
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same thermostability as these counterparts, since it is quickly inactivated at temperatures above 
75°C. In contrast, the Thermus epimerases retain most of their activity after 10 min incubation at 
80 °C [187], whereas the P. calidifontis epimerase remains fully active even after 10 min at 90 
°C [223]. 
 
 
 
Figure VII.6 Inactivation of mGalE at 60 °C (top) and 45 °C (bottom) 
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3.4. Substrate preference and kinetic parameters 
The mGalE was found to display activity on acetylated as well as non-acetylated UDP-
hexoses and can thus be classified as type 2 epimerase. However, a small preference for the latter 
substrates could be detected, with a specific activity on UDP-Gal and UDP-Glc of 3.0 and 6.7 
U/mg, respectively, compared to 1.2 and 0.3 U/mg on their respective acetylated counterparts. 
The determination of kinetic parameters (Hanes-Woolf linearization) confirmed this observed 
difference in activity (kcat), whereas the enzyme’s affinity (Km) is much less affected by the 
presence of an N-acetyl group. The obtained kinetic values (Km, kcat and kcat/Km) are given in 
Table VII.1. 
 
Table VII.1 Kinetic parameters from mGalE wild-type 
 kcat (s
-1) Km (µM) kcat/Km (s
-1mM-1) 
UDP-Gal 2.62 ± 0.49 362 ± 38 6.61 ± 2.39 
UDP-GlcNAc 0.58 ± 0.09 519 ± 35 1.11 ± 0.17 
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4 Conclusion 
A novel UDP-Glc(NAc) 4-epimerase from the thermophilic bacterium Marinithermus 
hydrothermalis is described in this chapter. The enzyme was recombinantly expressed in E. coli 
and thoroughly characterized with respect to its substrate specificity and thermal behavior.  
 
Since it is active on both non-acetylated and acetylated UDP-sugars, it belongs to the type 2 
GalE epimerases. Nonetheless, it has been found to have a slight preference for non-acetylated 
UDP-hexoses. This can be seen both in its specific activity and the kinetic parameters. The 
specific activity on UDP-Gal and UDP-Glc (3.0 and 6.7 U/mg, respectively) was found to be 
higher than those for their respective acetylated counterparts (1.2 and 0.3 U/mg, respectively). 
On the other hand, the determined kinetic parameters validate this observation as higher activity 
(kcat) is detected and higher affinity (lower Km) in the absence of an N-acetyl group. 
 
The optimal conditions for the Marinithermus epimerase were pH 7-7.5 and temperature of 
around 71 °C. Like for other GalE enzymes, the mGalE was also active in a broad pH range (pH 
6-9). At temperatures above 75 °C, fast inactivation was observed, whereas at 60 °C and 45 °C 
around 55 % and 25 % of activity is retained, respectively. At these temperatures, the epimerase 
shows prolonged stability, namely half-life values (t50) at 60 °C and 45 °C were 23 min and 13.5 
h, respectively. Since long incubation times might be necessary for measurements with 
alternative substrates and/or mutant enzymes, it was decided to perform all other activity tests at 
45 °C, to avoid the risk of protein denaturation during enzyme assays. 
 
Furthermore, analysis of its sequence and structure generated new insights in the 
mechanism of GalE enzymes. These new insights are examined by site-directed mutagenesis, 
which is discussed in the next chapter. 
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VIII. MUTATIONAL ANALYSIS OF 
UDP-HEXOSE 4-EPIMERASE 
 
 
 
 
 
 
 
A part of this chapter has been published as:  
Beerens, K., Desmet, T., Soetaert, W. (Epub ahaed of print, 2012). Characterization and 
mutational analysis of the UDP-Glc(NAc) 4-epimerase from Marinithermus hydrothermalis. 
Applied Microbiology and Biotechnology, DOI: 10.1007/s00253-012-4635-6 
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1 Introduction 
After the successful cloning and expression of the Marinithermus UDP-Glc(NAc) 4-
epimerase, it was thoroughly characterized concerning optimal conditions, substrate specificity 
and thermal stability. Now, mutational analysis can be applied to further examine the 
Marinithermus epimerase and some of its features.  
 
In this chapter, the determinants of its specificity are analyzed by means of sequence 
alignments, homology modeling and site-directed mutagenesis. Mutational analysis is focused on 
4 different parts of the epimerase, namely the catalytic triad (S116A, T117A, T117S), the unique 
double glycine motif found in Thermus GalE (GG→A, GG→S), the gatekeeper residue for 
(S279Y) and the 77-82 loop (Loop1_HRDD, Loop2_ARDD). Furthermore, the effects of these 
mutations on activity and affinity will be examined and explained with the help of homology 
models for each of the different mutants. 
 
Finally, the activity of mGalE (as well as E. coli GalE) on the free monosaccharides Glc/Gal 
and Fru/Tag as well as the phosphorylated α-Glc-1-P will be tested. Monosaccharide 
epimerization will be tested with and without addition of UDP(-like) components as so-called 
‘cofactors’, in order to test whether the activating effect of the UDP-group (see chapter II 3.3.3) 
can improve the epimerization reaction on monosaccharides. 
 
2 Material & Methods 
2.1. Bacterial strains, plasmids, growth conditions and chemicals 
The pIXhPtrc-mGalE expression plasmid containing the E. coli codon optimized gene for 
mGalE with an N-terminal His-tag was created earlier (see chapter III). Kits for gel extractions, 
PCR purifications and plasmid isolation were obtained from Qiagen. PfuUltraTM High-Fidelity 
DNA polymerase was purchased from Stratagene, restriction enzyme was obtained from New 
England Biolabs. UDP-sugars, UDP, UMP and uridine were obtained from Carbosynth. Tagatose 
was a kind gift from Nitrilab. All other chemicals were obtained from Sigma Aldrich unless 
otherwise stated. 
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E. coli BL21 (DE3) was used for expression of the GalE variants as described in chapter 
VII. On the other hand, large protein expression experiments were performed in a Biostat-B5L 
fermentor (B. Braun) in double LB, supplemented with 20 g/l glucose. Cells were grown until 
OD600nm reached 0.6, then IPTG was added to a final concentration of 150 µM to induce 
recombinant protein expression and growth was continued until maximal growth had been 
reached. 
 
For the cloning of the E. coli GalE (eGalE), the gene was amplified from E. coli K-12 
MG1655 gDNA with a high fidelity PCR and the following primers (Fw: 5’- CTTAAGATGAG-
AGTTCTGGTTACCGGT-‘3, Rv: 5’- ACTAGTCATGGTCGTTCCTTAATCG-‘3, AflII and 
SpeI restriction sites are underlined, respectively). Like before, cloning in the pIXhPtrc vector 
was achieved with AflII and SpeI restriction enzyme and T4 DNA ligase (see chapter III 2.2.2). 
2.2. Rational mutagenesis: Site directed mutagenesis (SDM) 
For single side directed amino acid mutation, the Sanchis protocol was used [227]. Briefly 
summarized, reaction mixtures contained 50–100 ng of wild-type plasmid as template, 5 pmol of 
mutagenic primer and a non-mutagenic reverse primer (for primer sequence see Table VIII.1), 
0.2 mM dNTP mix, 2.5 U of PfuUltraTM High-Fidelity DNA polymerase and the supplied buffer 
(Stratagene) in a final volume of 50 μl. The PCR program consists of the following steps: initial 
denaturation during 3 min at 95 °C, followed by 5 cycles of 30 s denaturation at 95 °C, annealing 
45 s at 53 °C, extension 1 min/kb according to the megaprimer size at 72 °C. The second stage 
contained the whole plasmid amplification starting from the created megaprimer by 20-25 cycles 
of 30 s at 95 °C and extension at 2 min/kb of template at 68 °C The program was ended by a 
final extension of 2 min/kb of template at 68 °C. PCR mixtures where then digested with DpnI to 
remove template DNA, purified using the QIAquick PCR purifcation kit (Qiagen) and 
transformed into electrocompetent BL21 cells as described above. Plasmids were then extracted 
and mutagenesis was checked by sequencing. 
 
Reactions for the loop exchange mutant (Loop1_HRDD) had the same composition, except 
that both a forward and reverse mutagenic primer were added (Table VIII.1). This PCR program 
consists of an initial denaturation for 3 min at 95 °C, followed by 30 cycles of 30 s denaturation 
at 95 °C, annealing for 45 s at 53 °C and an extension of 2 min/kb at 68 °C, and ended with a 
final extension of 7 min at 68 °C. The second loop mutant  (Loop2_ARDD) was created using 
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the Sanchis protocol and the Loop_HRDD plasmid as template. Again, the PCR mixtures were 
DpnI digested, purified and transformed into electrocompetent BL21 cells as described earlier. 
Mutagenesis was checked by sequencing after plasmid extraction. 
 
Table VIII.1 Primers used for site directed mutagenesis and loop exchange of the mGalE gene. Target codon are 
underlined, codon deletions are marked with a * per deleted codon 
Primer Sequence (5’→3’) 
Reverse primer GAGCTCTCCCATATGGTCGAC 
S116A_Fw CAGAAAATTGTTTTTGCAGCCACCGGTGGCGCAATTTATGGT
GAAGTTC 
T117A_Fw GTTTTTGCAAGCGCCGGTGGCGCAATTTATG 
T117S_Fw GTTTTTGCAAGCAGCGGTGGCGCAATTTATG 
S279Y_Fw GTGATGGTGACCTGGAAGTTTATGTTCTGGATCCGACACAGC 
GG118/119A_Fw GAAAATTGTTTTTGCAAGCACC*GCTGCAATTTATGGTGAAGT 
GG118/119S_Fw GAAAATTGTTTTTGCAAGCACC*AGTGCAATTTATGGTGAAGT 
Loop_HRDD_Fw CCCATGTTGCACATCAGGCAGCACAGCAT**AGGGATGATGT
TCAGAATCCGTGTAAAGATGCCGA 
Loop_HRDD_Rv TCGGCATCTTTACACGGATTCTGAACATCATCCCT**ATGCTG
TGCCTGCCTGATGTGCAACATGGG 
Loop2_ARDD_Fw GCACATCAGGCAGCACAGGCTAGGGATGATGTTCAGAATCCG 
 
2.3. Expression, purification and activity assays 
Expression and purification of the created mutants, and the wild-type as reference, was 
achieved as described in chapter VII. The same counts for activity assays of these mutants on 
UDP-Gal and UDP-GlcNAc, whereas activity on free monosaccharides and α-Glc-1-P is 
described in the next paragraph. 
2.4. mGalE activity on free monosaccharides and α-Glc-1-P 
To check whether the epimerase was able to interconvert the free monosaccharides 
glucose/galactose (Glc/Gal) or fructose/tagatose (Fru/Tag) as well as convert α-Glc-1-P into α-
Gal-1-P, coupled enzyme assays were checked for their appliance. Glucose detection in the 
presence of excess of galactose was checked using the GOD-POD method described above (see 
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chapter VI 2.3.2). The other way around, Gal in excess of Glc, was checked using the Lactose/D-
Galactose Assay Kit (Megazyme) according to the suppliers instructions. α-Gal-1-P in the 
presence of α-Glc-1-P was checked with this commercial kit as well; however, the phosphate 
moiety was first removed by a treatment with alkaline phosphatase (AP). Therefore, 15 µl of AP 
solution (50 U/ml AP, 1 mg/ml MgCl2, 1 mg/ml BSA in 250 mM Tris-HCl pH 7.5) was added to 
15 µl of sample and incubated at 37 °C for 1 h.  
 
Fructose formation from tagatose was checked using the GOD-POD method which was 
preceded this time by an isomerization step using soluble glucose isomerase (SGI, Genencor). In 
the first step of the SGI-GOD-POD method, 10 µL of SGI-solution (30 U/ml SGI, 100 mM 
MgSO4, 5 mM CoCl2 in 250 mM Tris pH 9.5) are added to 40 µl of sample and then incubated 
for 1.5 h at 60 °C, afterwards 50 µl of the isomerized sample is checked with 200 µl of GOD-
POD solution. 
 
Next to these coupled enzyme assays, the samples were also diluted to a maximum of 5 mM 
substrate concentration and then analysed using the previously mentioned HPAEC-PAD system. 
Free monosaccharides (Fru, Tag, Glc, Gal) were separated using an isocratic flow of 10 mM 
NaOH during 25 min on a PA20 column at 30°C (0.5 ml/min). A gradient was applied for the 
separation of the phosphorylated sugars, α-Gal-1-P and α-Glc-1-P. While NaOH concentration 
was kept constant at 100 mM, the NaOAc concentration was gradually increased from 100 mM 
to 175 mM in 7.5 min at a 0.5 ml/min flow rate. 
 
The wild-type mGalE and the S279Y mutant were tested on their ability to epimerize free 
monosaccharides and α-Glc-1-P. The reaction was performed in 5 mM Tris pH 7.5 and at 45°C 
to ensure prolonged incubation times. High enzyme concentrations (finally 1 mg/ml) were 
achieved by concentration of the purified enzyme solutions with the Centricon YM-30 
(Millipore) before adding them to the substrate (500 mM). Uridine, UMP and UDP (12.5 mM) 
was added to the mixtures as a so-called ‘cofactor’ to check their activating effect on the 
epimerase, whereas double distilled water was added as a negative control. Samples were taken 
after 0 h, 2 h, 4 h, 6 h and 21 h. 
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3 Results and Discussion 
3.1. Site directed mutagenesis (SDM) 
All previously mentioned mutants were successfully created, as was confirmed by 
sequencing. Afterwards all 6 mutants and the wild-type enzyme were expressed in BL21 cells, 
subsequently His-tag purified and the buffer was changed to 5 mM Tris-HCl pH 7.5 as described 
before. The purified mutants were then tested for activity on both non-acetylated and acetylated 
UDP-sugars and kinetic experiments were performed on all active variants (results are given in 
the next paragraphs). 
3.2. Mutational analysis of mGalE 
3.2.1. Catalytic triad TxnYx3K (S116A, T117A and T117S) 
As was previously mentioned (see chapter VII 3.1), sequence alignment of the mGalE with 
other GalE members is insufficient to designate the S116 or T117 as part of the catalytic triad. 
This is particularly due to the presence of 2 consecutive glycine residues (G118-G119) directly 
next to these candidates, impeding the alignment. Small errors in the alignment could lead to the 
hasty and incorrect conclusion of appointing the serine as catalytic residue. According to the 
homology model we created based on multiple GalE crystal structures, the hydroxyl group from 
the serine is positioned away from the active site and that of the threonine is pointing towards the 
4’-hydroxyl group of the substrate (Figure VII.3), suggesting the threonine to possess the 
catalytic function. Since both S116 and T117 carry a hydroxyl group that could be part of the 
catalytic triad, both residues were mutated to alanine. Variant S116A was found to possess 
activity in the same range as the wild-type enzyme on UDP-Gal, whereas no activity could be 
detected with variant T117A (Figure VIII.1). Activity could not be restored by increasing 
enzyme concentration to 0.5 mg/ml and using much longer incubation times. Interestingly, the 
activity of the latter could be restored by a substitution with serine (T117S) (Figure VIII.1), 
confirming that both types of residues can function as catalytic amino acid in GalE enzymes. 
Both S116A and T117S were also tested on UDP-GlcNAc and found to be more or less equally 
active as the wild-type enzyme (Figure VIII.1). Interestingly, the determination of kinetic 
parameters has revealed that the catalytic threonine’s methyl group is involved in a specific 
interaction with the substrate’s N-acetyl group (Table VIII.2). Indeed, the affinity of T117S for 
UDP-GlcNAc decreased significantly but that is much less the case for UDG-Gal.  
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Figure VIII.1 Specific activity of different mGalE variants. The activity is reported relative to the wild-type enzyme, 
and was measured on UDP-Gal (brown) as well as UDP-GlcNAc (orange). Standard deviation = 1σ (P = 68 %) 
 
3.2.2. Two consecutive glycine residues (G118-G119) 
As previously mentioned, the mGalE and the other GalE enzymes from Thermus species 
[187] exhibit the unique feature of having two consecutive glycine residues directly next to the 
threonine from the catalytic triad, whereas the others possess a single alanine or single serine. 
Introducing the corresponding mutations in mGalE reduces the specific activity on UDP-Gal to 
approximately 10-30% of that of the wild-type enzyme (Figure VIII.1). The activity of both 
mutants on UDP-GlcNAc was reduced even more, to about 3-7% of the wild-type activity. Thus, 
exchanging this double glycine motif by a single alanine or serine influences the activity on 
acetylated UDP-hexoses more than on the non-acetylated counterparts, thus pointing to a role in 
determining substrate specificity. These effects were found to involve changes in kcat as well as 
in Km (Table VIII.2). Indeed, the affinity of both mutants for UDP-Gal has clearly increased, 
whereas the turnover number has significantly decreased. A possible explanation might be found 
in the homology models of these variants, which suggest the formation of a 310-helix between 
residues 118 and 121 instead of the coil or loop in the wild-type enzyme (Figure VIII.2). As a 
consequence, A120 is pushed into the active site, thereby decreasing the cavity size and limiting 
the rotational freedom of acetylated substrates. On the other hand, a smaller cavity could improve 
the interactions with non-acetylated substrates, which is observed in the form of an increased 
affinity. In turn, the 310-helix could explain the variants’ decreased turnover number as this more 
stable structure would limit the flexibility of the catalytic threonine residue.  
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Figure VIII.2 Close-up view of residues 118-121 in mGalE (blue) and its GG→S variant (green). The homology 
models suggest that a 310-helix is formed in the variant, which pushes A120 towards the substrate, hereby creating a 
more narrow active site cleft 
 
3.2.3. The gatekeeper residue (S279Y) 
The mGalE can be classified as a type 2 UDP-hexose 4-epimerases since it displays activity 
on both non-acetylated and acetylated UDP-hexoses, albeit with a slight preference for the 
former. The serine at position 279 constitutes the so-called gatekeeper residue in the hexagonal 
box model [110] (Figure II.20). Depending on the type of residue found here, the epimerase does 
or does not have activity on N-acetylated UDP-sugars. In agreement with the proposed model, 
variant S279Y (Figure VII.3) was found to lose nearly all activity on UDP-GlcNAc whereas 
nearly 40 % of its activity on UDP-Gal is retained (Figure VIII.1). More specifically, only a 
small decrease in Km value for the latter substrate can be observed, whereas the kcat shows a 
much larger decrease (Table VIII.2). Thus, mutating its so-called gatekeeper residue S279 to a 
larger tyrosine made the enzyme specific for non-acetylated substrates. Similar observations 
were reported for the C307Y and C297Y variants of human GalE [101] and Yersinia 
enterocolitica Gne [26], respectively. Similarly, the reverse mutation in the E. coli enzyme 
(Y299C) lowered the activity on UDP-Gal almost 5-fold, while the activity on UDP-GalNAc 
increased more than 230-fold [95]. As such, it can be stated that the gatekeeper is indeed a prime 
determinant for substrate specificity in UDP-hexose 4-epimerases, especially in type 1 and type 2 
enzymes. However, their possible conversion into type 3 epimerases is complicated by the need 
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for a hydrophobic ‘297-308 belt’ in the latter enzymes [32]. Furthermore, introducing a mutation 
in the active site can also affect other parameters of the protein. For example, the substitution of 
serine by tyrosine in mGalE resulted in complete inactivation after overnight storage at 4 °C, 
whereas the wild-type retained most of it activity under those conditions. 
 
Table VIII.2 Kinetic parameters from mGalE variants on UDP-Gal and UDP-GlcNAc.  
Standard deviation = 1σ (P = 68 %) (n.d. = not determined) 
 UDP-Gal UDP-GlcNAc 
 kcat 
(s-1) 
Km 
(µM) 
kcat/Km 
(s-1mM-1) 
kcat 
(s-1) 
Km 
(µM) 
kcat/Km 
(s-1mM-1) 
WT 2.62 ± 0.49 362 ± 38 6.61 ± 2.39 0.58 ± 0.09 519 ± 35 1.11 ± 0.17 
S116A 2.32 ± 0.07 437 ± 75 5.39 ± 0.77 1.00 ± 0.07 578 ± 17 1.73 ± 0.07 
T117S 2.50 ± 0.16 426 ± 65 5.92 ± 0.54 0.83 ± 0.08 887 ± 35 0.93 ± 0.16 
S279Y 0.99 ± 0.02 316 ± 9 3.13 ± 0.07 n.d. n.d. n.d. 
GG→A 0.37 ± 0.02 243 ± 42 1.55 ± 0.21 n.d. n.d. n.d. 
GG→S 0.78 ± 0.04 146 ± 25 5.43 ± 0.90 n.d. n.d. n.d. 
 
3.2.4. Loop exchange mutants 
For the first loop mutant, loop77-82 (ASVKHS) was exchanged by the loop that is 
encountered in genuine UDP-GlcNAc 4-epimerases, namely a HRDD loop. This mutant was 
made to check whether the epimerase could be made more specific towards N-acetylated UDP-
sugars. However, no activity could be detected for the loop mutant, not even with higher enzyme 
concentrations and prolonged incubation times. According to the homology model that was made 
for this loop exchange mutant, the Gln76 present at the beginning of the loop was positioned into 
the active site, pushing away the catalytic tyrosine (Tyr143) and hereby disrupting the 
mechanism (Figure VIII.3). Therefore, a second loop mutant (ARDD) was created in which this 
histidine was replaced by an alanine residue hoping that this smaller residue’s side chain would 
allow a better positioning of Gln76 and hereby not disrupt the delicate chemistry of the 
mechanism. However, no activity could be found for this loop mutant either. The homology 
model of this mutant reveals that the positioning of the catalytic tyrosine is better but still not 
ideal (Figure VIII.3). According to the homology models, the tyrosine’s hydroxylic group had 
dislocated by 5.5 Å in the first loop mutant, while for the second loop mutant the dislocation was 
only 1.8 Å but it also pushed the catalytic threonine away from the substrate (Figure VIII.3). 
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Figure VIII.3 Overlapping homology models of the loop exchange mutants and wild-type. The catalytic tyrosine 
(Tyr143) is pushed away by both loop exchanges, hereby disrupting the delicate chemistry of the mechanism. Left: 
positioning of Tyr143 and Thr117 near the substrate. Right: Positioning of Gln76 has a big effect on the dislocation of 
Tyr143. Wild-type, Loop1_HRDD and Loop2_ARDD are given in blue, green and purple, respectively 
 
3.3. Free monosaccharides detection assays 
From the previously mentioned enzyme assays for free monosaccharides (and α-Glc-1-P) 
detection, the assays for detection of galactose in excess of glucose (Lactose/D-Galactose Assay 
Kit, Megazyme) and the previously developed detection of fructose in access of tagatose (see 
chapter VI) are useful as a nice standard curve could be obtained without big interference of 
excess amounts of the substrate. The GOD-POD method as such was insufficient to detect 
glucose in the presence of high concentration of galactose. Nevertheless, for each of the desired 
reactions, one of the screening directions was available: Fru in Tag, Gal in Glc, α-Gal-1-P in α-
Glc-1-P. 
 
Furthermore, chromatographic separation (HPAEC-PAD) of the four monosaccharides and 
2 phosphorylated sugars was achieved. However, due to high substrate concentration, samples 
had to be diluted much, which impedes the detection since product peaks are diluted equally. On 
the other hand, high concentrations may lead to peak broadening and overlapping of the product 
peak. 
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3.4. GalE activity on free monosaccharides and α-Glc-1-P 
Although very low activity on free monosaccharides has been reported for the E. coli 
epimerase [130], a similar observation could not be made with mGalE even when high enzyme 
concentrations and long incubation times were used. In order to trigger the activating effect of 
the nucleotide group [226], either uridine, UMP or UDP was added to the reaction but activity 
could still not be detected. Since eGalE is a type 1 epimerase that harbors a small active site and 
large gatekeeper, the S279Y mutant of mGalE was also checked for activity on free 
monosaccharides but no such activity could be detected for the mutant. Finally, α-glucose 1-
phosphate was tried as substrate, since this compound resembles UDP-Glc more closely than a 
free monosaccharide. However, activity could again not be detected, neither with wild-type 
mGalE, nor with its S279Y variant. 
 
In contrast to previous observations with the GalE from E. coli [130], no activity on free 
monosaccharides could be detected with the E. coli K-12 MG1655 GalE we had cloned. 
Furthermore, it is well known that the presence of the UDP-group is required for tight binding of 
the substrate as well as to increase the reactivity of the enzyme-bound NAD+ cofactor [272, 275]. 
As such, GalE would only be able to oxidize free sugars to the C4-ketose intermediate, leaving 
behind an inactivated enzyme in its NADH-bound form [30, 34].  
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4 Conclusion 
In this chapter, the mutational analysis of the Marinithermus UDP-hexose 4-epimerase is 
described. Via site directed mutagenesis, 8 mutants were created and tested for their activity on 
both non-acetylated and acetylated UDP-sugars. 
 
At first, Thr117 is identified as part of the catalytic triad instead of Ser 116 as was 
previously postulated [187], confirming the correct positioning of both residues in the homology 
model. However, not only a threonine can act as part of the catalytic triad as also the T117S 
mutant shows a similarly active epimerase, clearly indicating this residue as crucial for activity. 
Secondly, the consecutive glycine residues next to the catalytic threonine (G118-G119) have 
been shown to be of importance for activity and affinity, with a bigger effect on activity. 
Furthermore, they seem to be more important for the enzyme’s activity on N-acetylated 
substrates since loss of the double glycine motif lowered the specific activity more drastically. 
 
Furthermore, mutating the gatekeeper towards a bigger residue like found in type 1 
epimerases, clearly converted the mGalE from a type 2 towards a type 1 epimerase. This 
confirms the hexagonal box model [110] that states that type 1 and type 2 epimerases are easily 
switched into one another by mutating a single residue, namely this gatekeeper residue [232]. 
However, the connection with type 3 epimerases is likely to be less simple as was also 
demonstrated by the importance of extra interactions like the hydrophobic ‘297-308 belt’ [32]. 
The loop exchange mutants that were created to make the mGalE more active on and/or specific 
for N-acetylated UDP-sugars were inactive. This in accordance with the created homology 
models that suggest a dispositioning of the catalytic triad’s tyrosine (Tyr143).  
 
At last, the enzyme’s epimerization capacity on glucose/galactose, fructose/tagatose and α-
Glc-1-P/α-Gal-1-P was examined. However, no such activity could be detected under any of the 
conditions tested. No free monosaccharide 4-epimerization was observed when using the GalE 
from E. coli either, contrary to what was previously reported [130]. However, free 
monosaccharides epimerization is not obvious since after the (slow) oxidation step, the enzyme is 
most likely incapable of holding the C4-ketose intermediate long enough to reduce it again, 
leaving behind a NADH-bound and inactivated enzyme [30, 34]. 
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IX. GENERAL DISCUSSION & 
FUTURE PERSPECTIVES 
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1 Introduction 
Rare Sugars are defined as monosaccharides and their derivatives that are scarce in nature 
[91]. Only a small set of monosaccharides is considered to be naturally present in significant 
amounts (Glc, Gal, Man, Fru, Xyl, Rib and L-Ara), whereas twenty hexoses and nine pentoses 
were described as rare sugars. Furthermore, deoxygenated, aminated or methylated 
monosaccharides form another group of rare sugars, which often play a crucial role as 
recognition elements in bioactive molecules [87, 160, 264]. Notwithstanding their low natural 
abundance, rare sugars are (potentially) useful in a wide range of applications, as can be seen in 
Table II.1.  
 
Since rare sugars are scarce in nature, they cannot be extracted from natural resources and 
thus have to be produced by (bio)chemical reactions. The challenge lies in the optimization and 
expansion of these production routes in order to synthesize rare sugars with higher yields and at 
lower costs. More efficient production routes will increase their availability for research 
purposes, resulting in the discovery of new applications and/or yet unidentified characteristics 
[91]. Furthermore, increased production efficiency will reduce their cost and increase their use. 
 
The current biochemical production routes have been summarized in the Izumoring [91]. 
Nevertheless, a large set of potential biocatalysts is missing in this schematic representation, 
namely the epimerases. Only one type of epimerization is mentioned in the Izumoring, that are 
ketose 3-epimerizations. More recently, some other epimerases have been found to possess 
activity on free monosaccharides or hold this potential, see chapter II section 1 (Biocatalytic 
production routes for rare sugars) [20]. In this work, two different C4-epimerases were 
investigated for their potential as rare sugar producing biocatalysts, namely a L-ribulose-5-
phosphate 4-epimerase and a UDP-hexose 4-epimerase. 
 
In summary, the major achievements of this PhD thesis are  
 
1) The construction of the inducible expression vector pIXhPtrc, which is fully 
complementary with the 4 constitutive expression vectors (pCXhPxx) that were earlier 
created at InBio.be [1] (Chapter III). 
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2) The construction of an inducible and constitutive expression system for L-ribulose-5-
phosphate 4-epimerase from G. thermodenitrificans, from which the inducible expression 
system gave higher expression levels (Chapter III). 
 
3) The construction of an inducible expression system for L-ribulokinase from E. coli, 
which was then heterologously expressed and His-tag purified for the production of L-
ribulose-5-phosphate starting from L-ribulose and ATP (Chapter III). 
 
4) Characterization of the G. thermodenitrificans L-ribulose-5-phosphate 4-epimerase with 
respect to affinity for L-Ru5-P, metal ion activation and stability at 37 °C (Chapter III). 
 
5) The development of 2 selection strains (SelTag2 and SelTag3) for the detection of 
tagatose 4-epimerase activity (Chapter IV), which were then transformed with mutant 
libraries created by both random and site saturation mutagenesis for selection towards 
improved variants (Chapter V). 
 
6) The development of a screening assay that can be applied in search for tagatose 4-
epimerase activity that was afterwards applied on libraries of random and site saturation 
mutagenesis; however, no improved variants have been detected (Chapter VI). 
 
7) The construction of an inducible expression system for the UDP-hexose 4-epimerases 
from Marinithermus hydrothermalis (Chapter VII) and E. coli (Chapter VIII), which have 
successfully been overexpressed in E. coli. 
 
8) The thorough characterization of the Marinithermus UDP-hexose 4-epimerase with 
respect to its substrate specificity and thermal behavior (Chapter VII).  
 
9) New insights were found for the mechanistical aspects of the Marinithermus UDP-
hexose 4-epimerase, as such it was found to be the first UDP-hexose 4-epimerase for which 
a TxnYx3K catalytic triad instead of the usual SxnYx3K is evidenced (Chapter VIII). 
 
10) Mutational analysis also demonstrates a new substrate determinant for UDP-GlcNAc 4-
epimerase activity, namely the double glycine motif found in Thermus GalEs that seems to 
be of bigger importance for activity on N-acetylated substrates and confirmed the 
interconversion of type 1 and type 2 epimerases by simply mutating a single residue, 
namely the gatekeeper (Chapter VIII). 
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2 General Discussion & Future perspectives 
2.1. Rare sugars and potential of epimerases: ‘Epimering’ 
As can be deduced from Table II.1, rare sugars have a wide range of applications and thus 
hold tremendous economical value. Nonetheless, due to their low natural abundance they have to 
be produced from more abundant substrates. To date, the biochemical production of all rare, 
unmodified monosaccharides is summarized in the Izumoring [91]. Nevertheless, this schematic 
overview only contains one type of epimerases, i.e. the ketose 3-epimerases like D-tagatose 3-
epimerase (D-TE). Since other epimerases can create shortcuts in the current production routes, 
the discovery or creation of such enzymes is both scientifically and economically interesting. 
Scientifically because the discovery of new enzymes will give new insights in natural processes 
and pathways, while redesign of existing epimerases will provide more knowledge on structure-
function relationships and enzyme-substrate interactions.  
 
On the other hand, new and/or more efficient production routes will increase the availability 
of rare sugars for both research purposes and industrial applications. For the application of rare 
sugars, both the price and availability can be an obstacle. For example, for food applications, the 
price needs to be as low as possible and availability should be high (cfr. bulk) in order to 
compete with refined sugars and corn-derived sweeteners. On the other hand, when rare sugars 
are applied in ‘high-value’ products like pharmaceuticals, a higher price is less of a bottleneck 
but availability should still be high enough (cfr. specialty chemicals). New research will result in 
the discovery of new applications and/or yet unidentified characteristics of rare sugars, as was 
also stated by Granström et al. [91]. The rare sugar psicose is a clear example that production is 
the key for application. Only since the discovery of D-tagatose 3-epimerase, it can easily be made 
from the widely available fructose and since then several applications have been reported (Table 
II.1 and references herein) and still research is performed in order to further investigate this 
sugar. As such, one of the four sessions of the latest Rare Sugar Congress (2011 in Kagawa, 
Japan) was fully dedicated to psicose [111]. In total, over 10 oral presentations were given and 
over 10 posters presented research on psicose. 
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 Figure IX.1 Overview of the theoretical C2-, C3-, C4- and C5-epimerase that can use  glucose as substrate for the 
synthesis of mannose, allose, galactose and L-idose, respectively 
 
To point out the potential of other new epimerases for rare sugar production, I have made an 
‘Epimering’ (Figure IX.2 and Figure IX.3). These ring-like schemes that are similar to the 
Izumoring [91] demonstrate what different epimerases can mean for rare sugar synthesis. In 
Figure IX.1, the theoretical options are given for the different epimerization reactions starting 
from glucose, the most abundant sugar. Glucose could be used to produce mannose, allose, 
galactose and L-idose if a C2-, C3-, C4- and C5-epimerase would be available, respectively. All 
theoretical epimerizations for ketohexoses and aldohexoses are given in the Epimerings in Figure 
IX.2 and Figure IX.3, respectively. 
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Figure IX.2 The ‘Epimering’ emphasizes the potential of epimerases for rare sugar synthesis: ketohexoses  
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Figure IX.3 The ‘Epimering’ emphasizes the potential of epimerases for rare sugar synthesis: aldohexoses 
 
2.2. Evaluation of the present project and used epimerases 
In this project two epimerases have been subjected to enzyme engineering in order to 
redesign them to rare sugar producing biocatalysts. Despite the fact that the engineering of these 
two epimerases did not result in an enzyme harboring tagatose 4-epimerase activity, the choice to 
start with these enzymes was not a thoughtless idea. For both epimerases there were reasons to 
believe that the engineering thereof could lead to the desired activity. An evaluation of both 
enzymes as starting point for the creation of a tagatose 4-epimerase is given.  
2.2.1. L-Ru-5-P 4-epimerase: a bad choice as starting point or not? 
The attempt to convert a L-Ru-5-P 4-epimerase into a tagatose 4-epimerase was not an 
unrealistic idea since a mutant of the related L-rhamnulose-1-phosphate aldolase was found to 
show L-rhamnulose aldolase activity [244], in other words, it had become active on the non-
phosphorylated form of the substrate. Also other enzymes have been found active on substrates 
lacking a phosphate group, as such the fructose-1,6-bisphosphate aldolase is used for the 
condensation of dihydroxyacetone phosphate onto non-phosphorylated aldehydes, instead of on 
the natural substrate glyceraldehyde-3-phosphate [8]. Furthermore, a transaldolase could be 
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mutated towards a fructose aldolase, or accept non-phosphorylated glyceraldehyde as substrate 
rather than glyceraldehyde-3-phosphate [230, 231]. On the other hand, very recently Thermotoga 
maritime was found to possess a tagaturonate 4-epimerase [217]. This enzyme is predicted to be 
a distant homologue of class II aldolases, utilizing a divalent metal ion for catalysis. Thus, 
resemblance with the L-Ru-5-P 4-epimerase is striking, showing that such an aldolase-type 
epimerase can be active on a hexose-like substrate. However, both L-Ru-5-P 4-epimerase and the 
tagaturonate 4-epimerase are active on substrates with a negatively charged group, whereas in 
our attempt the substrate would be uncharged (Figure IX.4). This negatively charged group (the 
phosphate moiety or the carboxylic group, respectively) could be important to hold the 
intermediate bound in the active site, while the second intermediate is also retained via 
interactions between its negative charge and the positive charge from the metal cation. Loss of 
the first interaction might lead to loss of the intermediate, hereby precluding the second step 
needed for epimerization. The importance of the phosphate group for epimerase activity is also 
evidenced by mutagenesis studies that have been performed on the E. coli epimerase. The loss of 
the lysine in the phosphate binding pocket resulted in a much lower affinity, the Km-value of the 
K42M mutant had drastically increased up to more than 2 mM, while that of the wild-type was 
only 0.047 mM. On the other hand, the related L-fuculose-1-phosphate aldolase has a Km-value 
of 2.2 mM for the wild-type [225]. This could also indicate that the salt bridge between the K42 
and the phosphate moiety is necessary to retain the intermediate in order to complete the 
epimerization reaction, while for the aldolase retention of the intermediate is not needed and 
therefore no salt bridge is needed/present. Furthermore, the loss of a stronger salt bridge (12.5-17 
kJ/mol, and up to 30 kJ/mol) [204] between new substrate (tagatose/fructose) and the binding 
pocket, as a result of the lack of a charged (phosphate) group, is bigger than the new hydrogen 
bond (2-6 kJ/mol) [204] that can be formed between the extra hydroxymethyl group and the 
binding pocket (wild-type or mutant). 
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Figure IX.4 Comparison of the L-Ru-5-P 4-epimerase and tagaturonate 4-epimerase with the desired reaction 
(tagatose 4-epimerase). Substrate and product are given in black-green and black-red 
 
Secondly, the L-Ru-5-P 4-epimerase has only a few related enzymes (the 6-deoxysugar-1-
phosphate aldolases) and thus little natural variation is known among this enzyme family. Since 
the desired substrates are hexoses instead of phosphorylated pentoses, the majority of the 
targeted residues is located in the phosphate binding pocket of the epimerase. Since all AraD-like 
aldolase/epimerase family members are active on phosphorylated carbohydrates, it is not unlikely 
that (semi-)conserved residues were targeted. Due to their (semi-)conservation, these residues 
might not only be of importance for interactions with the phosphate, but also for other enzyme 
features, like folding or stability. If so, mutation of such residues are likely to be detrimental for 
the enzyme, lowering chances that mutants are still active ánd will be active on non-
phosphorylated sugars.  
 
Due to problems with the selection strains, it is likely that the mutants found via selection 
are not real hits. Indeed, none of the potential hits were confirmed to possess tagatose 4-
epimerase activity by activity measurements using the developed screening assay and HPLC 
analysis. A possible explanation why these specific mutants were found enriched in the selection 
cultures could be that they have fewer negative effects on growth, while the minimal growth 
observed was not a result of little activity but of growth on Luria broth remainders. These traces 
had been inoculated with the library and thus provide nutrients. For example, the mutant bearing 
the stop codon will result in a truncated form of the enzyme, producing less useless protein and 
thus leaving more building blocks and energy for other proteins or functions. Loss of the 
conserved lysine (K42S/A) or the introduction of positively charged residues (N28R and S73R) 
might destabilize the recombinant protein, which might then be degraded and recycled faster, 
returning energy and building blocks for growth. Destabilizing effects can result from the loss of 
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interactions with the hydrophobic part (-(CH2)4-) of the lysine’s side chain and its charged head 
(-NH3
+) or from repulsion between the lysine and the introduced arginines (Figure IX.5). 
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 Figure IX.5 The conserved lysine can interact with multiple neighboring residues and these interactions might have a 
stabilizing effect on the enzyme, loss of these interactions (K42S/A) might lead to an instable variant. Introduction of 
a second charged residue (N28R and S73R) might destabilize the enzyme due to repulsion between the two charges 
 
Since only a limited number of residues was targeted, the right residue(s) or changes needed 
for activity on tagatose might not have been targeted. Therefore, more mutagenesis and screening 
would therefore be advisable. Furthermore, the L-Ru-5-P epimerase might need substantial 
changes to be converted into a tagatose 4-epimerase. Perhaps multiple residues should be 
mutated at the same time or insertions and deletions might be needed. Multiple residues have 
been targeted simultaneously but due to the ‘numbers problem’ in enzyme engineering [212], 
these libraries of  simultaneous saturating or Combinatorial Active-site Saturation Test 
(CASTing) become very large quickly, making it very labor-intensive to do all the screening via 
the developed screening assay. Saturating two residues at the same time requires the screening of 
around 3000 mutants to have a 95 % chance of full library coverage [212]. For triple and 
quadruple saturation the amount of mutants increases to almost 100000 and over a million, 
respectively. Using a NDT codon could decrease library size and still cover most of the amino 
acids’ functionalities, but eight amino acids will not be tested [212]. Library size for single, 
double, triple and quadruple saturation using NNS or NDT, respectively, is given in Table IX.1. 
The introduction of insertions and/or deletions is much more complicated since the amount of 
residues inserted or deleted can be different and in this case a very thorough computational 
analysis is needed to maximize the chance of success. In fact, in this case de novo enzyme design 
might be a better option (see also below). Furthermore, the detection of desired mutants should 
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also be optimized by improvements in the selection and screening system, which is discussed 
below as well.  
 
Table IX.1 Screening effort of CASTing libraries using NNS and NDT codons 
SSM NNS NDT 
# positions # codons # CFU # MTPs # codons # CFU # MTPs 
1 32 94 1 12 34 0.4 
2 1024 3066 32 144 430 4.5 
3 32768 98163 1023 1728 5175 54 
4 1048576 3141251 32721 20736 62118 647 
 
2.2.2. UDP-hexose 4-epimerase: epimerase for free monosaccharides? 
According to our activity measurements on glucose/galactose, fructose/tagatose and α-Glc-
1-P/α-Gal-1-P, C4-epimerase activity could not be observed for the Marinithermus enzyme or its 
S279Y mutant. No C4-epimerization of free (or phosphorylated) monosaccharides was observed 
when using the GalE from E. coli either, unlike what was previously reported [130]. Indeed, 
epimerization of free monosaccharides is not evident, since the enzyme is most likely incapable 
of holding the C4-ketose intermediate long enough to reduce it again, leaving behind a NADH-
bound and inactivated enzyme [30, 34]. The UDP-hexose 4-epimerases need to undergo rather 
substantial changes in order to become active on free monosaccharides because the nucleotide 
group of the substrate is of importance for both substrate binding and activation of the enzyme by 
promotion of the conformational shift [272, 275]. Mutations would be needed to induce this 
conformational shift without the UDP-moiety or permanently activate the enzyme as well as to 
increase affinity for the free monosaccharides in order to bind them and hold the intermediate 
properly in the active site. The E. coli epimerase was previously tested using a fructose 
dehydrogenase assay and HPLC analysis after derivatization [130], whereas we used our 
developed screening assay (chapter VI). Nonetheless, according to the specific activity  reported, 
similar amounts of activity should be able to be detected by this screening assay. However, even 
with longer incubation times, increased enzyme and substrate concentrations, no epimerase 
activity was observed, nor could the addition of UDP, UMP or uridine as cofactor trigger 
epimerase activity. 
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2.3. Where to find or how to create new epimerases? 
As was discussed above, the chance of obtaining a tagatose 4-epimerase by directed 
evolution of a L-Ru-5-P 4-epimerase or a UDP-hexose 4-epimerase seems rather small. In order 
to obtain such an enzyme, different aspects could (or should) be changed. Among these aspects 
are starting from another enzyme (fold), a rational approach using de novo design, and 
optimization of the selection and screening strategies. 
 
Thus, how to create or where to find this new biocatalyst (or for the production of other rare 
sugars) remains an important question to be answered. Nature might hide some of these 
biocatalysts in the genetic code of one of the millions of creatures inhabiting earth. Genome 
sequencing has provided scientists with massive amounts of yet uncoded DNA, perhaps 
somewhere hiding a new epimerase active on free monosaccharides, like the ketose 3-epimerases 
(e.g. D-tagatose 3-epimerase) [114] or the recently discovered tagaturonate 4-epimerase [217]. 
Many genes can be given a ‘putative’ function based on homology with known/existing enzymes 
but for totally new enzymes and/or enzyme folds this cannot be done. On the other hand, 
galactose 4-epimerization has been reported in cell extract from Kluyveromyces species induced 
with xylose [73]. Nevertheless, the responsible enzyme has not been identified, nor is it known 
whether one or more enzymes are responsible for this reaction. Identification of this (these) 
enzyme(s) can be achieved by separation of different enzyme fractions of the Kluyveromyces cell 
extract by for example ammonium sulfate or solvent precipitation or separation based on protein 
size. The enzymes in the fraction containing the activity can further be separated and analyzed. 
Finally, protein sequencing can be applied to determine the primary structure of the responsible 
enzyme. However, when multiple enzymes are involved, these different biocatalysts must always 
be found in the same fraction. Another option to identify the responsible enzyme(s) is by 
comparing cell extract of xylose-induced Kluyveromyces with that of normally grown 
Kluyveromyces on a 2D-PAGE to look for differently expressed proteins. Spots that are only 
observed in the xylose-induced cell extract can then be tested for activity and/or identified by 
protein sequencing. 
 
However, repetitions of the described experiments on a Kluyveromyces marxianus strain 
(MUCL 30062) failed to confirm this galactose 4-epimerization activity (data not given). The K. 
marxianus strain that we have used might be different from the one that was found to have 
galactose 4-epimerase activity, explaining why experiments could not be repeated. Nevertheless, 
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there were no new papers published dealing with this very interesting topic, although it was 
stated in the article (in 1996) that ‘it is the beginning of a series of investigations on the 
mentioned enzyme’. This might also mean that the ‘weak epimerase activity’ found in the 
‘preliminary assays’ had been a hasty conclusion or that they were unable to repeat and/or isolate 
the enzyme responsible for the galactose 4-epimerization. On the other hand, xylose can induce 
the UDP-hexose 4-epimerase in the yeast Pachysolen tannophilus [239], so it might have done 
the same in the Kluyveromyces strain. However, it would be unlikely that the UDP-hexose 4-
epimerase from Kluyveromyces is active on only 1 g/l (5.55 mM) of galactose. 
 
Another option to look for tagatose converting enzymes are Mucoraceae fungi. They can be 
applied in a two step production route towards tagatose starting from fructose, in combination 
with tagatose 3-epimerase [114]. At first, the fructose is converted to psicose, which can then be 
converted to tagatose via biotransformation with the help of Mucoraceae fungi (Figure IX.5). 
Various Mucoraceae strains have been reported to be able to carry out this reaction [289]. 
Neither the availability, nor the price of psicose are limiting factors here, as psicose mass 
production has become industrially feasible since the discovery of ketohexose 3-epimerases [129, 
250]. The two-step tagatose production from fructose over psicose is a good alternative method; 
however, it still requires further intensive investigation [191]. Similar experiments as described 
for the galactose 4-epimerase identification in the Kluyveromyces strain could be applied for the 
identification of the responsible enzymes for psicose to tagatose conversion in Mucoraceae 
fungi. Most likely, one or two oxidoreductases are involved and conversion proceeds over D-
talitol. 
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 Figure IX.6 Conversion of fructose into tagatose using D-tagatose 3-epimerase (D-TE) and Mucoraceae fungi 
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Another place to look for new epimerases active on rare sugars are niches in which they are 
found. For example, since tagatose is found in the gum of Sterculia setigera [80, 191], this tree 
needs to have a pathway to produce tagatose. Nonetheless, synthesis could also proceed using 
aldolases or an isomerase instead of an epimerase. 
 
In order to overcome this issue of screening in nature, enzyme engineering remains an 
interesting and promising field. By mutagenesis of an existing biocatalyst, new biocatalysts 
might be created. More recently, also de novo enzyme design has become an option. As the name 
suggests, de novo enzyme design is making an enzyme from scratch, using computational tools 
and complicated algorithms [119, 216, 218, 219, 221]. An example hereof is the computational 
design of enzymes to catalyze the Kemp elimination, a reaction not found in nature, that was 
made by the research group of David Baker [221]. The Kemp elimination enzyme that was 
created is far from optimal but it can be further improved by enzyme engineering, like via 
random or site saturation mutagenesis.  
 
An important starting point is the choice of enzyme (fold) to use as template for rational 
design. It can be based on binding of the substrate or product instead of the performed reaction. 
Several enzymes would then be eligible, like the tagatose 3-epimerase [114] but also L-arabinose 
isomerase, tagatose-6-phosphate isomerase, and other monosaccharide isomerases, since these 
enzymes are known to bind free monosaccharides. Starting from these enzymes has the 
advantage that the enzyme is already able to bind the substrate but its catalytic machinery should 
be repositioned or changed. Their natural reaction could easily be inactivated by mutation of the 
catalytic residues, while their ability to bind the monosaccharides is (most likely) maintained. 
The big challenge is then to introduce new catalytic residues that catalyze a different reaction. 
For the tagatose 3-epimerase, it might also be worth looking for a way to move the catalytic 
machinery to the next hydroxyl group or to make the enzyme bind the substrate in a slightly 
rotated position. Since the catalytic residues need to be positioned correctly in order to make the 
enzyme active, this should be thoroughly analyzed by using computational models. It is 
necessary to have as much information as possible on how the current fold binds the substrate 
and what other interactions are present within the enzyme fold itself since mutations can disrupt 
this fine equilibrium. However, these interactions can also be monitored using bioinformatics and 
visualization programs like the YASARA program [139] or the YASARA/WHATIF twinset 
[268]. 
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The easiest ways for the inactivated enzymes to become active again by directed evolution 
is by reintroduction of its original catalytic residues. Since this is of course not the purpose, it 
would be advisable to engineer the enzyme folds via a rational approach. This rational approach 
would also overcome the disadvantages of directed evolution, for example the insufficiency 
when multiple mutations are needed [22], narrow range [21], limits in introducing new function 
[84]. In order to minimize lab work, but maximize the chance of finding a positive mutant, the 
technique of de novo design is recommend. Using computer tools like the Rossetta algorithms 
[216, 219, 221] a small set of potential enzymes could be designed. These computer algorithms 
are based on all ‘restrictions and rules’ that have been found to occur in natural protein folding 
and catalysis. This would also decrease the mutagenesis and screening work in the ‘wet lab’. As 
mentioned above, the more information that is available, the more accurate the algorithms can 
predict correct folds. Computer scientists need to have information on how nature and its 
building blocks work in order to translate it to algorithms and programs that can be used to create 
and analyze computational models.  
 
Not only computational tools are needed but also easy and efficient screening assays to test 
these theoretical catalysts in a ‘wet lab’. The methods to check whether these theoretical 
enzymes are truly active enzymes harboring the desired activity need to be – preferably – simple 
and easy. These techniques should also be applicable in random or site saturation mutagenesis 
experiments as the in silico designed enzymes will need further optimization. In this way new 
information can also be gained and later be translated into new or better algorithms to improve 
the current bioinformatics tools. The screening assay that was developed during this doctoral 
research could be used to test a set of theoretical biocatalysts. A set of 96 proteins could be tested 
in a single microtiter plate. However, the bigger the in silico library, the more work that has to be 
done on the bench and the higher the costs. It would for instance demand the chemical synthesis 
of all these genes, which becomes expensive, and transformation into an expression system, 
while expression of each of these enzymes should be optimized.  
 
Despite having developed an easy and accurate screening assay, further optimization can be 
achieved for screening in order to increase the chance of success. Furthermore, the selection 
system can also be improved since the one developed in this project was not perfect. For the 
selection strain, potential problems that could occur are the lack of tagatose transport systems, 
too low concentration of  tagatose in the cells and problems downstream of the epimerization 
reaction. Since E. coli K-12 MG1655 is able to absorb tagatose via the methylgalactoside 
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transport system, mglABC [132], uptake of tagatose should not be the problem. Even though it 
has a higher flux transporting tagatose out than in, due to high concentration of tagatose in the 
medium, the mlgABC transport system should be able to transport it inside the cells [132]. 
Nonetheless, intracellular levels of tagatose might not reach high levels which could be a 
problem. This potential problem could also be solved by overexpression of the methylgalactoside 
transporter mglB. Similarly, the overexpression of the galP transporter could restore growth on 
glucose in strains lacking the PTS system [98].  
 
Furthermore, it can be assumed that a second bottleneck, downstream of the epimerization 
reaction, was present in the selection strains, that is the first step in fructose utilization (Figure 
IX.7). Due to this second bottleneck, the growth and consequently the selection is hampered. In 
the growth tests, fructose was imported as fructose-1-phosphate that is easily further broken 
down, resulting in proper growth, whereas in the selection system, fructose would be present 
inside the cells instead of fructose-1-P. A consequence hereof is that the fructose has to be 
phosphorylated first in order to further metabolize it [136]. The responsible enzyme, a 
manno(fructo)kinase (MAK) is only slightly active in E. coli K-12 MG1655 and thus the 
phosphorylation of fructose is a problem in the selection strains based on E. coli K-12 MG1655. 
A perfect selection strain would only have one bottleneck and that is the target enzyme. The 
constitutive overexpression of an active fructokinase could overcome this second bottleneck and 
improve the selection strain. Nonetheless, the choice of the right fructokinase and promoter is not 
an easy task and would be very time-consuming (personal communication Joeri Beauprez). Since 
also a screening assay was developed to detect tagatose 4-epimerase activity, this optimization of 
the selection strain was omitted. 
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Figure IX.7 Normal fructose utilization goes via the PTS system, immediately phosphorylating it. However, in the 
selection strains fructose would be formed inside the cell, needing prior phosphorylating to fructose-6-phosphate by 
manno(fructo)kinase. Since only low fructokinase activity is found in E. coli, growth and selection are hampered 
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Another option to overcome the fructose phosphorylation problem as well as the possibly 
low substrate levels is by expressing the epimerase in the periplasm. Tagatose concentration in 
the periplasm will be higher than that measured in the cytoplasm since the inner membrane is 
much more disciminating than the outer membrane [169]. Periplasmatic expression can be 
achieved by expressing the target enzyme with a N-terminal signal peptide in order to transport 
the (pro)enzyme from the cytoplasm to the periplasm. Two systems are available in E. coli 
namely the secretion pathway (Sec) and the twin-arginine translocation system (Tat) [173, 265, 
271]. Nevertheless, selection of the optimal signal peptide is crucial and is mostly performed 
by trial-and-error [54]. Furthermore, informatics tools are available to help with the selection 
of the appropriate signal peptide, for example SignalP [24, 25, 79, 186, 203]. Periplasmatic 
expression would also facilitate further uptake of the formed fructose since the fructose present 
in the periplasm will easily be taken up by the cell via its PTS system and in this way avoid the 
need of cytosolic MAK activity.   
 
On the other hand, the screening assay should be able to screen as much mutants as 
possible in a minimum of time. In the setup of the presented research (search for a tagatose 4-
epimerase), the application of Fluorescence-Activated Cell Sorting (FACS) could be an option 
[99]. Using FACS, 108 mutants can be tested per day [281]. Nevertheless, as the technique 
FACS needs fluorescence to be able to detect and separate cells, the desired activity should be 
directly coupled to a fluorescent outcome. If the product of the reaction can be used to induce 
protein expression, it can be used to induce for instance green fluorescent protein (GFP) [57]. 
Fluorescence can then be used to sort cells via FACS. Despite the fact that this idea is written 
down in one sentence, it is not that simple. At first, one must have a protein expression system 
that is only triggered when the target enzyme is active and thus the product is formed. For a 
tagatose 4-epimerase, this would mean that the formed fructose may not be consumed but must 
trigger expression. As such, there is the need for a fructose induced promoter, a fructose 
sensitive repressor or another fructose sensitive biomarker. When no fructose is present, 
expression is not induced or repressed by binding of the repressor, meaning that no GFP 
(fluorescence) is present in the cells. If active epimerase would be expressed, fructose would be 
formed that can in turn induce GFP expression or bind to the fructose sensitive repressor 
enabling GFP expression. Again, the question is where or how to find such a ‘fructose sensitive 
promoter/repressor system’. Also here, protein engineering and bio-informatics can be used as 
tools to redesign existing promoter/repressor systems. Starting points could be the lac repressor 
system or the L-arabinose-inducible araBAD promoter (PBAD) that induce protein expression in 
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the presence of lactose (and IPTG) or L-arabinose, respectively. Nevertheless, it will take a lot 
of work and time to convert such a system into a desired and useful system.  
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Summary 
 
Tagatose is a rare sugar that can be applied for multiple reasons in different industries, for 
instance as a low-caloric sweetener in dietary food, as well as additive in detergents, cosmetics, 
and pharmaceutical formulations, but also as drug molecule itself in diabetes treatment. As for 
other rare sugars, tagatose is not abundantly present in nature and therefore it has to be made 
from more available sugars in order to use it. It is currently being produced starting from 
galactose. However, to be able to compete with the current predominant sweeteners (like sucrose 
and high fructose corn syrup), it should be produced in much higher quantities than is possible 
when starting from galactose. In order to overcome this issue, tagatose production should start 
from a more widely available (and cheaper) substrate. Fructose and glucose are two such very 
abundant substrates; however, no (bio)catalysts are available to convert fructose or glucose into 
tagatose. Nevertheless, some enzymes were found to perform similar reactions and therefore are 
promising to one day become biocatalysts for tagatose production. 
 
In this work, the cloning and analysis of two totally different C4-epimerases is described in 
respect to their capability of tagatose production. The first enzyme is L-ribulose-5-phosphate 4-
epimerase from Geobacillus thermodenitrificans, an aldolase-related epimerase that would 
require an adaptation of the substrate binding site around the phosphate moiety of the substrate. 
The second C4-epimerase is naturally active on nucleotide activated sugars, namely the UDP-
Glc(NAc) 4-epimerase from Marinithermus hydrothermalis. The major challenge in the 
engineering of this UDP-hexose 4-epimerase is trying to get rid of the necessity of the UDP-
group of the substrate and making it active on free monosaccharides. 
 
At first, the Geobacillus L-ribulose-5-phosphate 4-epimerase gene was cloned in an 
appropriate expression vector and expressed in E. coli. The recombinant enzyme was first 
characterized with respect to affinity for L-ribulose-5-phosphate, metal ion activation and 
stability at 37 °C. To that end, its natural substrate had to be produced first, which was 
accomplished by phosphorylation of L-ribulose using ATP as phosphate donor and 
recombinantly expressed L-ribulokinase as biocatalyst. 
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After characterization, mutagenesis was achieved both randomly and semi-rationally by 
error-prone PCR and site saturation mutagenesis, respectively. To be able to detect enzyme 
variants harboring (improved) tagatose 4-epimerase activity among the thousands mutant 
enzymes, two ‘identification’ systems were developed. Two selection strains were developed that 
can be used for the Darwinian selection of improved enzyme variants, while also a colorimetric 
screening assay has been created. Although several millions and thousands of mutants were 
analyzed using the selection strains and screening assay, respectively, no variants were 
confirmed to possess (improved) tagatose 4-epimerase activity. 
 
Secondly, the UDP-hexose 4-epimerase from Marinithermus hydrothermalis was also 
cloned and heterologously expressed in E. coli. A thorough characterization of this second 
epimerase was performed, revealing that it belongs to the type 2 UDP-hexose 4-epimerases. As 
expected for a type 2 epimerase, its substrate specificity could easily be altered by mutagenesis 
of a single residue, namely the so-called gatekeeper. This also confirms the previously reported 
hypothesis about substrate specificity in type 1 and type 2 epimerases.  
 
Mutational analysis of the UDP-hexose 4-epimerase uncovered two new features that can be 
found in these epimerases. The Marinithermus enzyme was found to possess a TxnYx3K catalytic 
triad, rather than the usual serine containing triad (SxnYx3K). The presence of the threonine’s 
methyl function was found to be of more importance for the enzyme’s affinity for N-acetylated 
UDP-sugars than for non-acetylated substrates. As such, the TxnYx3K triad might be a new 
substrate specificity determinant for type 2 UDP-hexose 4-epimerases. The second new feature 
was the presence of two consecutive glycine residues next to the catalytic threonine, which were 
found to be important for activity of the enzyme with non-acetylated and even bigger importance 
for activity on N-acetylated substrates. In an attempt to identify new determinants for specificity 
towards UDP-GlcNAc, two loop mutants were created but they were found to be inactive, most 
likely due to dispositioning of the catalytic tyrosine, which results in the disruption of the subtle 
catalytic chemistry.  
 
In addition, the Marinithermus UDP-hexose 4-epimerase was also tested for its ability to 
convert the free monosaccharides fructose/tagatose, glucose/galactose and the phosphorylated α-
Glc-1-P. Furthermore, also the E. coli UDP-hexose 4-epimerase was cloned and also here no 
epimerase activity could be detected on free monosaccharides, in contrast to what has previously 
been reported.  
185 
 
Samenvatting  
 
Tagatose is een zeldzame suiker die om meerdere redenen kan worden toegepast in 
verschillende industrietakken, bv. als lage-energie suiker in dieetvoeding, maar ook als additief 
in detergent, cosmetica en farmaceutische formuleringen, en zelfs als medicatie op zichzelf in de 
behandeling van diabetes. Net als de andere zeldzame suikers is tagatose niet overvloedig 
aanwezig in de natuur en daarom moet het (bio)chemisch worden aangemaakt startende van meer 
abundante suikers vooraleer het gebruikt kan worden voor een van zijn toepassingen. Momenteel 
wordt het gemaakt uit galactose, maar om de competitie met de huidige zoetstoffen (zoals 
sucrose en high fructose corn syrup) aan te gaan, zou het in grotere hoeveelheden moeten kunnen 
worden aangemaakt dan mogelijk is uit galactose. Om dit euvel te overwinnen, zou tagatose 
productie moeten starten van meer abundante suikers, zoals fructose and glucose. Er zijn echter 
geen (bio)katalysatoren beschikbaar die deze suikers kunnen omzetten in tagatose. 
Desalniettemin zijn er enzymen die gelijkaardige reacties katalyseren en die mogelijks 
interessant zijn voor de synthese van tagatose. 
 
In dit proefschrift wordt de klonering en analyse van twee totaal verschillende C4-
epimerasen besproken in relatie tot hun mogelijkheid of potentieel voor tagatose productie. Het 
eerste enzym is het L-ribulose-5-fosfaat 4-epimerase van Geobacillus thermodenitrificans en dit 
aan aldolasen verwante enzym vereist een aanpassing ter hoogte van de fosfaatbindende regio. 
Het tweede C4-epimerase is van nature actief op nucleotide geactiveerde suikers, namelijk het 
UDP-Glc(NAc) 4-epimerase van Marinithermus hydrothermalis. De grote uitdaging voor dit 
epimerase is om komaf te maken met de nood aan de UDP-groep voor activiteit en het actief te 
krijgen op niet-gemodificeerde suikers. 
 
Ten eerste werd het L-ribulose-5-fosfaat 4-epimerase gen van Geobacillus gekloneerd in een 
geschikt expressieplasmide en vervolgens tot expressie gebracht in E. coli. Het recombinant 
enzym werd gekarakteriseerd met zijn natuurlijk substraat, L-ribulose-5-fosfaat, om meer te 
weten te komen over de affiniteit hiervoor, activatie door metaalionen alsook thermostabiliteit. 
Hiervoor werd eerst L-Ru-5-P aangemaakt startende van L-ribulose en ATP en gebruikmakend 
van L-ribulokinase als biokatalysator. 
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Na karakterisatie, werden twee verschillende mutagenesetechnieken toegepast, namelijk 
random mutagenese via error-prone PCR en een semi-rationele aanpak door site saturation 
mutagenesis. Om enzymvarianten te identificeren die (verbeterde) tagatose 4-epimerase activiteit 
bezitten, werd enerzijds een selectiestam en anderzijds een screeningsmethode ontwikkeld. De 
selectiestam maakt gebruik van Darwins ‘survival of the fittest’ theorie, terwijl met de screening 
alle mutanten afzonderlijk worden geanalyseerd. Ondanks de miljoenen en duizenden mutanten 
die via respectievelijk selectie en screening werden geanalyseerd, werden geen (verbeterde) 
tagatose 4-epimerase varianten gevonden. 
 
Ten tweede werd ook het UDP-hexose 4-epimerase van Marinithermus hydrothermalis 
gekloneerd en tot overexpressie gebracht in E. coli. Een grondige karakterisatie van dit 
epimerase toonde aan dat het behoort tot de type 2 UDP-hexose 4-epimerasen. Zoals verwacht 
voor dit type epimerasen kon de substraatspecificiteit simpelweg worden aangepast naar een type 
1 door middel van mutatie van één enkel residue, de gatekeeper. Dit bevestigt eveneens oudere 
hypothesen rond de substraatspecificiteitsdeterminanten van de type 1 en type 2 epimerasen. 
 
Mutationele analyses van het UDP-hexose 4-epimerase brachten ook twee nieuwe  
kenmerken aan het licht. Het enzyme blijkt een TxnYx3K katalytische triade te bezitten in plaats 
van de gewoonlijke SxnYx3K. De extra methylgroep van de threonine is belangrijker voor de 
activiteit op N-geacetyleerde UDP-suikers dan voor niet-geacetyleerde substraten. Alsdusdanig 
zou een TxnYx3K katalytische triade een nieuwe determinant kunnen zijn voor 
substraatspecificiteit van type 2 UDP-hexose 4-epimerasen. Daarnaast werden ook twee 
opeenvolgende glycines gevonden vlak naast de katalytische threonine, dewelke belangrijk 
blijken te zijn voor de activiteit van het enzym, met een grotere invloed voor de geacetyleerde 
substraten. In een poging om meer te weten te komen over de 
substraatspecificiteitsdeterminanten voor UDP-GlcNAc werden twee loopmutanten gemaakt, 
maar deze bleken inactief. Volgens de homologiemodellen wordt door deze mutaties de delicate 
chemie van het katalytisch centrum verstoord door  verplaatsing van de katalytische tyrosine.  
 
Bovendien werd het Marinithermus UDP-hexose 4-epimerase ook getest op zijn vermogen 
voor het omzetten van de vrije monosachariden fructose/tagatose, glucose/galactose en het 
gefosforyleerde α-Glc-1-P. Daarnaast werd ook het E. coli UDP-hexose 4-epimerase gekloneerd, 
maar voor beide enzymen kon geen C4-epimerase activiteit op vrije monosachariden worden 
waargenomen, in tegenstelling tot wat eerder gemeld was voor het E. coli epimerase. 
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Appendix I: Nucleotides (IUPAC-IUB code) 
 
Nucleotide Name Complement 
A Adenine T 
C Cytosine G 
G Guanine C 
T Thymine A 
U Uracyl (RNA) A 
R Purine (A or G) Y 
Y Pyrimidine (C or T) R 
W Weak (A or T) S 
S Strong (C or G) W 
M Amino (A or C) K 
K Keto (G or T) M 
V A, C or G B 
B C, G or T V 
H A, C or T D 
D A, G or T H 
N A, C, G or T N 
 
  
196 
 
Appendix II: The standard genetic code 
 
  Second position   
  U C A G   
F
ir
st
 p
o
si
ti
o
n
 
U 
UUU 
Phe 
UCU 
Ser 
UAU 
Tyr 
UGU 
Cys 
U 
T
h
ir
d
 p
o
sitio
n
 
UUC UCC UAC UGC C 
UUA 
Leu 
UCA UAA 
Stop 
UGA Stop A 
UUG UCG UAG UGG Trp G 
C 
CUU 
Leu 
CCU 
Pro 
CAU 
His 
CGU 
Arg 
U 
CUC CCC CAC CGC C 
CUA CCA CAA 
Gln 
CGA A 
CUG CCG CAG CGG G 
A 
AUU 
Ile 
ACU 
Thr 
AAU 
Asn 
CGU 
Ser 
U 
AUC ACC AAC CGC C 
AUA ACA AAA 
Lys 
CGA 
Arg 
A 
AUG Met ACG AAG CGG G 
G 
GUU 
Val 
GCU 
Ala 
GAU 
Asp 
GGU 
Gly 
U 
GUC GCC GAC GGC C 
GUA GCA GAA 
Glu 
GGA A 
GUG GCG GAG GGG G 
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Appendix III: SSM – Library size (top) and screening effort (bottom) 
 
Amino acid NNN NNK/NNS NDT 
Ala 4 2 0 
Arg 6 3 1 
Asp 2 1 1 
Asn 2 1 1 
Cys 2 1 1 
Glu 2 1 0 
Gln 2 1 0 
Gly 4 2 1 
His 2 1 1 
Ile 3 1 1 
Leu 6 3 1 
Lys 2 1 0 
Met 1 1 0 
Phe 2 1 1 
Pro 4 2 0 
Ser 6 3 1 
Thr 4 2 0 
Trp 1 1 0 
Tyr 2 1 1 
Val 4 2 1 
STOP 3 1 0 
Total codons 64 32 12 
Total amino acids 20 20 12 
Screening effort 190 CFU 94 CFU 34 CFU 
 
# NNS # codons # CFU # MTPs 
1 32 94 1 
2 1024 3066 32 
3 32768 98163 1023 
4 1048576 3141251 32721 
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Appendix IV: Amino acid terminology 
 
Amino acid 3-letter code 1-letter code 
Alanine Ala A 
Arginine Arg R 
Asparagine Asp N 
Aspartic acid Asn D 
Cysteine Cys C 
Glutamic acid Glu E 
Glutamine Gln Q 
Glycine Gly G 
Histidine His H 
Isoleucine Ile I 
Leucine Leu L 
Lysine Lys K 
Methionine Met M 
Phenylalanine Phe F 
Proline Pro P 
Serine Ser S 
Threonine Thr T 
Tryptophan Trp W 
Tyrosine Tyr Y 
Valine Val V 
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Every story has an end.  
But in life, every ending is just a new beginning. 
- Ray, Uptown girls (2003) 
 
